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Abstract i 
ABSTRACT 
 
Short helical peptides 
Peptides with a well-defined helical conformation were examined with the aims of reinforcing 
their secondary structure or using their rigid conformation to control asymmetric induction 
over long distances. 
In the first example, two consecutive i, i+4 intramolecular side chain-to-side chain 
macrocyclization reactions of different type, carried out on a preformed, partially helical 
linear peptide resulted in a double stapled, overlapping, bicyclic oligopeptide system. A 
detailed CD and NMR conformational study revealed that the mixed 310/α-helical 
conformation exhibited by the original linear peptide is converted into a fully-developed α-
helix in the bicyclic peptide. In parallel, both the helix overall content and stability are 
significantly increased. In the second part, an achiral Aib-based helical foldamer was 
appropriately functionalized with the photoswitchable fumaramide/maleamide linkage, thus 
obtaining a system in which a screw sense preference may be activated by the absorption of 
UV light. The trans configuration in the fumaramide linkage holds the chiral residue away 
from the achiral portion of the oligomer, preventing the induction of a conformational 
preference. However, after photoisomerization, the cis configuration of the maleamide brings 
the chiral and achiral portions into proximity, generating a pronounced preference for one of 
the two possible, helical screw senses. In conclusion, we showed that it is feasible to use light 
to switch on and off the ability of the molecules to react strereoselectively in a chain 
extension reaction, or to modulate helix-to-helix communication. 
 
Functionalized helical polypeptides 
The well-known, rod-like α-helical polypeptide poly(γ-benzyl-L-glutamate) (PBLG) was 
selected for this study. The possibility to create self-assembled microstructures with different 
characteristics, shapes and functions from different PBLG-conjugates was explored. 
Mono- and bis-fullerene (C60)-PBLG conjugates were obtained by one-pot thiol-ene 
chemistry. These systems showed the propensity to self-assemble in water creating precise 
bulky microstructures of toroidal or vesicular shape. In a second part, we reported the 
synthesis of star-shaped carbon quantum dots (CQDs)-PBLG conjugates that self-assemble 
into microstructures and retain the characteristic emission properties of the native dots. CQDs, 
prepared by microwave-assisted carbonization of Arg and 1,2-ethylendiamine in water, were 
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used either as initiators to afford a daisy-like peptide-polymer structure, or as capping agents 
towards more elaborated hybrid nanostructures that self-assemble into supramolecular 
aggregates of spherical shape. Finally, smart microstructures with photoresponsive behavior 
was obtained by the insertion of azobenzene-containing α-amino acids in PBLG systems. We 
created two systems, with either C2- or C3-symmetry, that self-assemble in spherical 
structures. The change in their 3D-structure after light irradiation is followed by a variation in 
the morphology of the aggregates. 
 
Self-assembling short peptides 
The synthesis and self-assembly properties of two different peptide systems were studied. The 
first series of compounds contain the photoswitchable α-amino acid bis[p-
(phenylazo)benzyl]glycine, which undergoes a reversible cis-trans isomerization upon 
exposure to light at the appropriate wavelengths. Derivatives and short peptides containing 
this α-amino acid are able to promote the formation of well-ordered supramolecular 
structures. Interestingly, the morphological transition observed after UV-light irradiation 
proved to be reversible due to the presence of the two side-chain azobenzene groups. 
In the second part, we investigated the hydrophobic, terminally-protected dipeptide Boc-L-
Cys(Me)-L-Leu-OMe that it is able to hierarchically self-assemble producing nano-, micro- 
and macroscale complex architectures, including hollow rods, under appropriate conditions. 
Our results suggested that its self-assembly properties might be related to the occurrence in its 
single crystal structure of a supramolecular sixfold helix motif. Subsequently, we decided to 
chemically modify the molecule to obtain a diacetylene derivative. This final compound is 
able to form an organogel or spherical aggregates, which undergo a topochemical 
polymerization under UV-light irradiation. 
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Peptidi elicoidali corti 
In questo lavoro di tesi sono stati studiati diversi peptidi caratterizzati da una ben definita 
conformazione elicoidale con lo scopo di stabilizzarne la struttura secondaria oppure di 
sfruttare la loro conformazione rigida come mezzo per controllare l’induzione asimmetrica su 
lunghe distanze. 
Il primo esempio, un sistema oligopeptidico biciclico doppiamente stabilizzato, è stato 
ottenuto tramite due reazioni di macrociclizzazione che hanno coinvolto le catene laterali dei 
residui in posizione i e i+4 di un peptide lineare. Un’indagine conformazionale dettagliata, 
condotta utilizzando le spettroscopie CD ed NMR, ha rivelato che la conformazione mista 
310/α-elica, osservata per il peptide lineare, risulta completamente convertita in una struttura 
ad elevato contributo α-elicoidale nel peptide biciclico. In parallelo, sia il contenuto totale di 
elica sia la stabilità risultano significativamente aumentati. Nel secondo caso, un foldamero 
achirale elicoidale a base di Aib è stato opportunamente funzionalizzato con il gruppo 
fotoisomerizzabile fumarammide/maleammide contenente un residuo chirale. In questo modo 
è stato ottenuto un sistema in cui è stato possibile influenzare il senso di spiralizzazione 
dell’elica grazie all’uso di luce ultravioletta. La configurazione trans nella fumarammide, 
infatti mantiene il residuo chirale lontano dal segmento achirale dell’oligomero, rendendo 
impossibile l’induzione di una conformazione preferenziale. Tuttavia dopo l’isomerizzazione, 
la configurazione cis della maleammide consente alla parte chirale e a quella achirale di 
essere spazialmente vicine, con conseguente induzione di chiralità e adozione di un senso 
preferenziale di spiralizzazione. Sfruttando questo principio è stato quindi possibile utilizzare 
la luce per accendere o spegnere la capacità del sistema di reagire stereoselettivamente, 
oppure di modulare la comunicazione di chiralità tra due segmenti elicoidali. 
 
Polipeptidi elicoidali funzionalizzati 
Con lo scopo di ottenere tramite self-assembly microstrutture con differenti caratteristiche, 
forme e funzioni sono stati sintetizzati diversi sistemi coniugati a base di poli(γ-benzil-L-
glutammato) (PBLG). Sistemi polipeptidici contenenti una o due unità di fullerene sono stati 
ottenuti tramite reazione tiol-ene one-pot. Questi due polimeri hanno mostrato una diversa 
propensione ad auto-assemblarsi in ambiente acquoso, formando microstrutture di forma 
toroidale oppure di tipo vescicolare. Come ulteriore esempio è stata riportata la sintesi di 
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sistemi coniugati a base di PBLG e carbon quantum dots. I CQDs, preparati per trattamento 
in microonde a partire da una soluzione acquosa di arginina e 1,2-etilendiammina, sono stati 
usati come iniziatore, ottenendo una struttura polimerica a forma di stella, oppure come 
agente cappante, portando alla formazione di microstrutture più complesse. I sistemi ottenuti 
sono in grado di autoassemblarsi formando aggregati supramolecolari di forma sferica che 
mantengono le caratteristiche proprietà di emissione dei dots originali. Infine, microstrutture 
“smart” con comportamento fotoresponsivo sono state ottenute inserendo amminoacidi a 
base di azobenzene all’interno del sistema polipeptidico. Sono state quindi sintetizzate due 
strutture polipeptidiche con simmetria C2 e C3 che hanno evidenziato la formazione di 
strutture sferiche tramite self-assembly. Il cambiamento della loro struttura tridimensionale in 
seguito ad irraggiamento è accompagnato da una variazione nella morfologia degli aggregati. 
 
Peptidi corti auto-assemblanti 
In questo ultimo capitolo sono discusse la sintesi e le peculiari proprietà di self-assembly 
mostrate da due diversi sistemi peptidici. La prima serie di composti contiene l’amminoacido 
fotoisomerizzabile bis[p-(fenilazo)benzil]glicina, che è in grado di isomerizzare 
reversibilmente tra le due forme cis/trans in seguito ad irraggiamento con luce di adeguata 
lunghezza d’onda. Derivati e peptidi corti contenenti questo amminoacido sono in grado di 
promuovere la formazione di strutture supramolecolari ordinate. Inoltre, grazie alla presenza 
delle due unità di azobenzene sulle catene lineari, la transizione morfologica osservata in 
seguito ad irraggiamento si è dimostrata essere reversibile. 
Nella seconda parte di questo studio è stato esaminato il comportamento del dipeptide 
idrofobico protetto Boc-L-Cys(Me)-L-Leu-OMe. La formazione di nano-, micro- e macro- 
architetture complesse, tra cui bacchette caratterizzate da una cavità interna, è stata osservata 
in diverse condizioni sperimentali. I risultati ottenuti suggeriscono che le proprietà di self-
assembly sono correlate all’organizzazione delle molecole nel cristallo singolo in cui è stata 
osservata la presenza di una particolare struttura supramolecolare elicoidale formata da sei 
molecole. Successivamente è stato deciso di modificare il dipeptide in modo da ottenere un 
derivato diacetilenico. Questo derivato è in grado di formare un organogel o delle strutture 
sferiche che possono subire polimerizzazione topochimica per irraggiamento UV. 
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Abbreviations 
(αMe)Val = Cα-methylvaline 
Ac = acetyl 
Ac2O = acetic anhydride 
AcOH = acetic acid 
AFM = atomic force microscopy 
Aib = α-aminoisobutyric acid 
AIBN = 2,2′-Azobis(2-methylpropionitrile) 
Ala = alanine 
Aloc = allyloxycarbonyl 
Arg = arginine 
BLG = γ-benzyl-L-glutamate 
Boc = tert-butyloxycarbonyl 
Boc2O = di-tert-butyl dicarbonate 
CD = circular dichroism 
CF = carboxyfluorescein 
COSY = correlation spectroscopy 
CQDs = carbon quantum dots 
Cys = cysteine 
DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene 
DIC = N,N'-diisopropylcarbodiimide 
DIPEA = N,N-diisopropylethylamine 
DLS = dynamic light scattering 
DMAP = 4-dimethylaminopyridine 
DMF = N,N-dimethylformamide 
DMPA = 2,2’-dimethoxy-2-phenylacetophenone 
DMSO = dimethylsulphoxyde 
DPPA = diphenylphosphoryl azide 
EDC = N-ethyl-N'-(3-dimethylamino)propyl-carbodiimide 
ESI = electrospray ionization 
Et2O = diethyl ether 
EtOAc = ethyl acetate 
EtOH = ethanol 
Fmoc = (9H-fluoren-9-yl)methoxycarbonyl 
FT-IR = Fourier transform infrared spectroscopy 
Gly = Glycine 
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HFIP = 1,1,1,3,3,3-hexafluoro-2-propanol 
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HPLC = high performance liquid chromatography 
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MALDI = Matrix-Assisted Laser Desorption/Ionization 
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THF = tetrahydrofuran 
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Project aims 
The main purpose of this Ph.D. project was the development of new families of peptides and 
peptide-based microstructures, based on chemically modified peptides and peptide hybrid-
organic polymers. In recent years, peptides have found a growing interest in various scientific 
areas not only for their intrinsic biological functions, but also for their potential innovative 
applications in materials science. In this context, peptides may offer attractive features related 
to their ability to fold into precise structures also when appropriately linked to other 
functional molecules. Moreover, under suitable conditions peptides possess an enormous 
potential as smart materials, due to their ability to self-assemble into nano- and microscale 
ordered structures through non-covalent interactions. 
The final results discussed in this Thesis were obtained by combining knowledge of organic 
synthesis, peptide science and supramolecular chemistry. 
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1. Introduction 
1.1 Peptides helical structures: α- and 310-helix 
The helix is a central structural motif found in numerous biopolymers, including DNA and 
proteins, which play a fundamental role in living systems. Therefore, taking inspiration from 
nature, research on artificial helical molecules has found application in various areas, not only 
to mimic biological helices and functions but also for their potential applications in different 
fields such as materials science. 
The classical α-helix is the most common secondary structure of peptides and proteins (Figure 
1.3 A). Another helical structure that occurs in peptides is the 310-helix (Figure 1.3 B). These 
helical conformations differ by the number of residues per turn, the pitch, the φ, ψ, ω torsion 
angles (as defined in Figure 1.1) in the peptide backbone
[1]
 (Table 1.1), and the number of the 
atoms in the pseudo-cycle formed by the C=O···H-N intramolecular H-bonds (Figure 1.2). 
Figure 1.1 Representation of a segment of polypeptide chain in the fully-extended 
conformation (φi = ψi = ωi = 180°). 
The α-helix is characterized by 3.63 residues per turn and it is stabilized by intramolecular H-
bonds between the carbonyl group of a residue at position i and the N-H group at the i + 4 
position, forming the pseudo-cycle of 13 atoms (α-turn or C13-structure) (Figure 1.2 A).
[2] 
The 310-helical structure has 3.24 residues per turn. The pseudo-cycle is formed between the 
residues at position i and i + 3 and is composed of 10 atoms (β-turn or C10-structure) (Figure 
1.2 B). The sets of , torsion angles of the α- and 310-helices do not differ significantly, but 
the latter helix is more tightly bound and more elongated than the α-helix (Figure 1.2). 
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Figure 1.2 Intramolecular (backbone) C=O···H–N (backbone) H-bonds: i ← i+3 for the 310-
helix and i ← i+4 for the α-helix. 
Figure 1.3 (A) The α-helix and its basic unit, the helical α-turn and view along helix axis. (B) 
The 310-helix and its basic unit, the helical type-III β-turn and view along helix axis. 
Table 1.1 Structural parameters for the α- and 310-helical conformations.
[2]
 
Parameter -helix 310-helix 
 -63° -57° 
 -42° -30° 
number of residues per turn 3.63 3.24 
pitch 5.67 Å 6.29 Å 
 
 
 
N C C N C C N C C N C C N C C 
H O H O H O H O H O 
α-helix (i ← i+4) 
310-helix (i ← i+3) 
i+4 i i+2 i+3 i+1 
 
-helix 
-turn -turn 
A 
310 helix 
B 
1
2
3
4
5 1
2
3
45 1
2
3
4
5 1
2
3
45
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In a long polypeptide chain based on C
α
-trisubstituted (e.g. protein) α-amino acid residues, the 
310-helix is less stable than the α-helix due to the larger distortion of the H-bonds and some 
unfavorable van der Waals interactions.
[3]
 In contrast the C
α
-tetrasubstituted α-amino acids are 
extremely strong promoters of 310-helical structures. C
α
-tetrasubstituted amino acids differ 
from protein amino acids by the substitution of the hydrogen at the α-carbon atom by an alkyl 
or an aryl group (Figure 1.4). The noticeable sterical hindrance induced by these substituents 
drastically limits the N-C
α
 and C
α
-C' (φ and ψ torsion angles, respectively) bond rotations.[4] 
Figure 1.4 Chemical structures of C
α
-tri- (a) and (b) tetra-substituted amino acids. 
The simplest C
α
-tetrasubstituted α-amino acid, found in natural antibiotic peptides,[5] is the 
achiral α-aminoisobutyric acid (Aib). The presence of α,α-dimethyl substituents severely 
restricts its conformational freedom compared to less congested residues. Oligomers of Aib 
have a strong preference for adopting helical conformations.
[6]
 and in particular its 
homopeptides typically form 310 helices.
[7]
 In the case of peptides containing Aib and protein 
amino acids as well, in the crystal state only helical structures of the α-, 310- or α/310-“mixed” 
type were found.
[8]
 Many factors govern the peptide conformational preference toward a 
specific type of helix including the length of the polypeptide chain, the Aib content, and the 
amino acid sequence. In general, the α-helix formation tends to be favored when the main 
chain is lengthened and the number of Aib residues is decreased.
[6]
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1.2 Polypeptides 
Poly(α-aminoacids) are a class of bio-inspired synthetic polymers derived from naturally 
occurring amino acids. In comparison with other synthetic polymers, polypeptides have 
several potential advantages that inherit from proteins such as excellent biocompatibility, 
biodegradability, versatile structures and functionalities, and unique hierarchical assembly 
property.
[9]
 Typically polypeptides adopt well-defined secondary structure, α-helix and β-
sheet have been found both in solution phase and in solid state. Vastly different functions can 
be originated from a wide choice of α-amino acid monomers which provide a variety of 
reactive groups ranging from hydroxyl, carboxyl, thiol, to amino groups, rendering the 
polypeptides particularly appealing in design and development of multi-functional materials. 
Polypeptides are mainly synthesized by α-aminoacid N-carboxyanhydrides (NCA) ring 
opening polymerization (ROP).
[10]
 NCA-ROP allows large-scale preparation of high 
molecular weight polypeptides with no detectable racemization at the chiral centers. 
In the past decade a remarkable progress has been made in controlled NCA polymerization, 
thus polypeptide and hybrid materials with various architectures (block copolymers, graft 
copolymers, random copolymers, star-shaped polymers, and dendrimers), secondary 
structures and functionalities have been achieved using NCA monomers.
[10,11]
 
The most widely used method for the preparation of the NCA involves the direct 
phosgenation of side-chain protected α-amino acids in inert polar solvents (such as EtOAc, 
dioxane, THF, and CH3CN) (Fuchs-Farthing method).
[12]
 Pure NCA monomers with good 
yields and no racemization can be easily obtained with this synthetic method. Hydrochloride 
scavengers like α-pinene and limonene were proved effective in preventing byproducts 
formation, especially in the large scale synthesis.
[13]
 
Depending on the relative nucleophilicity and basicity of initiator, NCA polymerizations have 
been reported to follow mainly two polymerization mechanisms: i) normal amine mechanism 
(NAM) and ii) activated monomer mechanism (AMM).
[11a,b,14]
 
Nucleophiles such as primary amines, secondary amines and alcohols, that display stronger 
nucleophilicity than basicity, promote NCA polymerization most likely via an NAM 
mechanism (Scheme 1.1). After the nucleophilic attack, ring opening of NCA results in the 
release of one molecule of carbon dioxide and exposure of a primary amine, which behaves as 
the active species to open the next NCA monomer and the repetition of this step finally 
generates the polypeptides. Primary amines are generally excellent initiators, in fact they are 
more nucleophilic than the ω-amino group of the propagating chain leading to polypeptides 
with low polydispersity index (PDI), since initiation is faster than propagation. 
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Scheme 1.1 Mechanism for NCA-ROP initiated by nucleophilic amines (NAM).
[14b] 
In the case of initiators such as metal alkoxides and tertiary amines, which show stronger 
basicity than nucleophilicity, NCA polymerization most likely proceeds via an AMM 
mechanism. These kind of initiators can easily abstract the acidic N–H proton of NCA and 
generate negatively charged NCA molecules that are sufficiently nucleophilic to attack 
another NCA monomer and initiate polymerization (Scheme 1.2). Polypeptides with very 
large PDI values and uncontrolled molecular weights are generally produced via AMM 
because initiation is slower than propagation and both AMM and NAM occur simultaneously. 
Scheme 1.2 Mechanism for NCA-ROP initiated by activated monomer (AMM).
[14b]
 
Other methods to obtain poly(amino acid)s with controlled molecular weight and low 
polydispersity by NCA-ROP have been obtained using as initiator other species such as 
transition metal complexes
[11a,15]
, organosilicon reagent derivatives
[16]
 and primary amine 
hydrochloride.
[17] 
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1.3 Supramolecular chemistry and self-assembly process 
The supramolecular chemistry, commonly referred as the “chemistry beyond the 
molecule”, was introduced by Lehn (Nobel Laureate 1987), who defined it as the “chemistry 
of molecular assemblies and of the intermolecular bonds”.[18] As in the molecules atoms are 
connected by covalent bonds, in supramolecular systems molecules are bonded by additive 
and cooperative noncovalent interactions. The power of supramolecular chemistry lies in the 
combination of a number of weak interactions, relatively insignificant alone, but that are able 
to held together small molecules forming very complex systems. 
There are a number of noncovalent interactions that can be utilized for the construction of 
supramolecular structure, which include:
[19]
 
- electrostatic interactions [ion-ion (100-350 kJ/mol), ion-dipole (50-200 kJ/mol), dipole-
dipole (5-50 kJ/mol)]; 
- hydrogen bonds (4-120 kJ/mol); 
- π-π stacking interactions (2-50 kJ/mol); 
- van der Waals forces (< 5 kJ/mol). 
Electrostatic interactions are based on the Coulombic attraction between opposite charges and 
tend to be relatively strong. Ion-ion interactions are comparable in strength to covalent 
bonding. Ion-dipole and dipole-dipole interactions result from an electrostatic attraction 
between an ion and a neutral molecule with a dipole or two molecules with dipoles, 
respectively. 
A hydrogen bond can be describe as an attractive interaction between a hydrogen atom 
attached to an electronegative atom (or electron withdrawing group) and a neighbouring 
dipole on an adjacent molecule or functional group. In general, hydrogen bonds, commonly 
represented as D-H∙∙∙A, involve a hydrogen atom attached to an electronegative atom such as 
O or N as the donor (D) and a similarly electronegative atom, often bearing a lone pair, as the 
acceptor (A). Hydrogen bonds are ubiquitous in living systems and considered as the 
‘masterkey interaction in supramolecular chemistry”.[20] In fact they have a relatively strong 
and highly directional nature, making them especially attractive to molecular designers.  
The π-π stacking forces occur between systems containing aromatic rings, often in situations 
where one is relatively electron rich and one is electron poor. These interactions commonly 
occur in a-face-to-face or edge-to-edge manner, although a wide variety of intermediate 
geometries are known. 
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Van der Waals interactions occur when instantaneous dipoles in the electron clouds around 
each molecule interact favorably, resulting in a weak electrostatic attraction. They are 
nondirectional and hence possess only limited scope in the design of specific interacting 
molecules. 
Another aspect that is worth considering for the creation of supramolecular system is the 
hydrophobic effect. The hydrophobic effect is the specific driving force for the association of 
apolar binding partners in polar solvent, in particular in aqueous environment. Essentially, the 
strong inter-solvent interactions between the water molecules give rise to the exclusion from 
the solvent of the apolar molecules and the formation of aggregates. 
The self-assembly process, defined as the “spontaneous assembly of molecules into 
structured, stable, noncovalently joined aggregates”,[21] has emerged as a powerful approach 
to create novel multi-nanometer scale structures and systems. Self-assembly allows access to 
unprecedented and very complex molecular architectures that are inaccessible using 
traditional multi-step synthesis. Novel molecular architectures can be produced by 
combination of appropriately designed sub-units, which contain all information necessary to 
spontaneously organize. 
The fabrication of new materials through self-assembly of natural building blocks, including 
proteins and peptides, has become a subject of major interest.
[22]
 In particular peptides can 
spontaneously self-assemble into nanospheres, nanotubes, nanofibrils, nanotapes and other 
ordered structures.
[23]
 In addition, peptides have drawn significant attention due to their 
simple structure, diversity in functions and shapes, biocompatibility and well-establish 
synthetic methods permit to obtain them in large scale.
[24]
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2. Short helical peptides: synthesis and secondary structure 
control 
There is great interest in developing molecules which can mimic α-helices since this motif 
has been found at the binding interface between two proteins and is involved in the protein-
protein interactions.
[1]
 In medicinal chemistry, the ability to selectively inhibit protein-protein 
interactions may enable therapeutics to be developed against a wide range of diseases. 
It is not surprisingly that peptides received the greatest deal of attention since they offer a 
great variety and the intrinsic ability to fold in stable conformations. For these reasons, 
synthetic methods for modifying peptides with the aim of reinforcing their native helical 
conformation have been investigated.
[1b,2]
 In particular, it is hoped that these modifications on 
peptide molecules will display significantly improved pharmacological properties, including 
bioactivity, receptor binding selectivity, metabolic stability, cell permeability, and rapid 
clearance in vivo. One of the most established methods for generating helical conformations is 
peptide stapling in which naturally occurring or appropriately modified amino acid side 
chains are covalently linked together forming a macrocycle.
[3]
 
In this context, the group where I carried out my PhD previously applied this approach in 310-
helical peptide sequences containing the strongly helicogenic α-aminoisobutyric acid (Aib). 
The selected intramolecular cross-linking reactions between the side chains of residues i and 
i+3, namely the ring-closing metathesis (RCM)
[4]
 or the photo induced Paternò-Yang-
macrocyclization reaction,
[5]
 did not modify the regularity of the 310-helix backbone. 
Moreover, we further exploited intramolecular macrocyclization reactions with the aim to 
obtain an i, i+4 intramolecularly double stapled, overlapping, bicyclic oligopeptide system 
with α-helical conformation.[6] The results obtained will be presented in the first part of this 
chapter. 
Furthermore, since the helical conformation is intrinsically chiral, helices have been 
considered also as potential conveyors of stereochemical information. Helical foldamers,
[7]
 
which are synthetic molecules that likewise adopt well-defined conformations, have been 
successfully used as rigid medium to achieve asymmetric induction over long distances.
[8]
 
Oligomers of Aib are achiral peptides that typically adopt stable 310 helical conformations, but 
left- and right-handed screw sense conformations are equally populated in the absence of an 
external chiral influence.
[9]
 This ratio of conformers can be biased by the incorporation of a 
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single stereogenic center into the peptide chain, e.g. by the insertion of a chiral amino acid at 
the N-terminus,
[10]
 or at the C-terminus.
[11]
  
Recently, it has been shown that helical Aib peptides with an induced preferred screw-sense, 
even if remotely induced by the incorporation of a single chiral residue at the N-terminus, 
exhibit enantioselectivity in their chain-extension reactions at the C-terminus.
[12]
 
In order to exploit stereochemical reactions in Aib oligomers, I had the opportunity to spend a 
research period of six months as a Visiting Student in the group of prof. J. Clayden, (School 
of Chemistry, University of Manchester, UK) during the third year of my Ph.D. work. 
In this period, I worked on the functionalization of Aib oligomers with the photoswitchable 
fumaric/maleic linkage with the aim of developing a system in which the stereoselectivity of a 
reaction can be controlled using light. The work described in the second part of this chapter 
started in UK and it was then continued in Italy during the last months of the third year. 
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2.1 Stapled peptide 
We focused our attention on the realization of a bicyclic peptide system in which a reaction 
covalently joining the side chain of residue 1 of a linear nonapeptide to the side chain of 
residue 3, is combined with a macrocyclization from residue 2 to residue 4 (Figure 2.1). 
The resulting bicyclic peptide is overlapping, with an amino acid stretch in common between 
the two ring systems. Furthermore both macrocyclizations are of the i, i+4 class appropriate 
for an α-helix peptide substrate. Also, these reactions are orthogonal, in fact a sulphydryl bis-
alkylation is followed by an RCM reaction. 
Figure 2.1 (A) Representation of a completely preformed linear peptide with four reactive 
side chains (1, 2, 3, and 4) numbered starting from the N-terminus of the backbone. (B) 
Representation of the resulting, overlapping, peptide motif after the two macrocyclizations 1-
to-3 and 2-to-4. The backbone segment of the peptide product highlighted in bold is in 
common between the two ring systems. 
The sequence of the linear peptide 1 [Ac-Aib
1
-Cys
2
-Aib
3
-Lys(Aloc)
4
-Aib
5
-Cys
6
-Aib
7
-
Lys(Aloc)
8
-Aib
9
-NH2], shown in Figure 2.2, was designed: (i) to generate a model which 
would exhibit a considerable level of α-helicity as it contains five helicogenic Aib residues 
and (ii) to precisely locate the two amino acid dyads, Cys
2
/Cys
6
 and Lys(Aloc)
4
/Lys(Aloc)
8
 at 
relative positions i, i+4 in the internal part of the sequence. Peptide 1 was synthesized via 
SPPS and Fmoc chemistry, using a Rink-amide resin as solid support and following the 
conventional HOAt/HATU/DIPEA C-activation protocol.
[13]
 Acetylation at the N-terminus 
was accomplished with a large excess of acetic anhydride. In the last step, the peptide was 
removed from the resin by use of TFA in the presence of TIS as scavenger. Then, nonapeptide 
1 was purified by reverse-phase semi-preparative HPLC. 
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Figure 2.2 Syntheses and chemical formulas of peptides 1-3. The i, i+4 intramolecularly 
cross-linked side chains connecting Cys
2
 to Cys
6 
(red) and Lys(Aloc)
4
 to Lys(Aloc)
8
 (blue) 
are shown. In peptide 3, the -CO-Aib
5
-NH- backbone segment is in common between the two 
macrocycles. Lower part, left: Perpendicular and axial projections of the linear peptide 1. This 
3D-model was computer generated using a regular α-helical backbone. 
The first conformational restriction of peptide 1 was achieved by converting it into peptide 2 
via double Cys alkylation. Recently, from screening a library of potential intramolecular 
cross-linkers, the meta-xylyl group was carefully demonstrated to be an excellent bis-Cys 
spacer.
[14]
 Indeed, it was found optimal to match the inter-thiol distance of two Cys side 
chains placed at relative positions i, i+4 in an α-helical peptide. To perform the “template-
constrained thioeher cyclization”,[14] we initially reacted a small volume of a diluted (0.45 
mmolar) solution of peptide 1 in MeOH with a slight excess (1.1 eq.) of 1,3-
bis(bromomethyl) benzene in the presence of DIPEA (Figure 2.2). These conditions were 
designed to increase the rate of intramolecular cyclization over those of intermolecular bis-
alkylations. However, the progress of the reaction was extremely slow. An HPLC-mass 
spectrometry analysis of the crude after four hours revealed the presence of only a small 
amount of the desired cyclized product 2, accompanied by various types of monoalkylated 
and non-cyclic bis-alkylated peptides. Then, we decided to repeat this procedure with a larger 
volume of the same solution of peptide 1, but adding slowly and dropwise an increasing 
excess (to 4:1) of the cross-linker over a period of two hours. In this case, it was gratifying to 
find that the yield of the purified, monocyclized peptide 2 was satisfactory (60%). We believe 
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that this result is mainly related to the marked α-helical content of the starting linear 
compound 1, which in turn is responsible for directing the two Cys
2
 and Cys
6
 side chains 
outwards from the same face of the peptide backbone. 
In the second step, peptide 2 (1.8 mmol) was treated with the 2
nd
-generation Grubbs catalyst 
in CH2Cl2 solution. Under these conditions, the Lys(Aloc)
4
 and Lys(Aloc)
8
 residues of 
macrocyclic peptide 2 underwent a rapid RCM reaction to afford the bicyclic [31,22,5] ene 
peptide 3 in an almost quantitative yield (Figure 2.2). The completeness of the reaction was 
monitored by HPLC by following the disappearance of the starting material (peptide 2). After 
each synthetic step, peptides 2 and 3 were purified by flash chromatography. Obtaining pure 
peptide 3 without any catalyst contamination required an extensive chromatographic 
treatment which, unfortunately, reduced its overall yield to 31%. In Figure 2.3 (left) the 
analytical HPLC chromatograms and ESI-ToF mass spectra of peptides 1-3 are shown. In the 
mass spectra, peaks as intense as those for the correct peptides and consistent with a 
deficiency of 17.0 Da are seen. We associated them to loss of ammonia from the protonated, 
labile, C-terminal primary amide functionality. 
 
Figure 2.3 Left: Analytical HPLC profiles of the purified peptides 1-3. Inset: Corresponding 
ESI-ToF mass spectra where the [M+2H]
2+
 ions are visible. Right: Far-UV ECD spectra of 
peptides 1-3 recorded in MeOH solution at 20°C (concentration: 1 x 10
-3
M). 
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The analysis of the ellipticity ratio (R) between the negative Cotton effects at 223 nm (peptide 
n → π* transition) and near 210 nm (parallel component of the split peptide π → π* 
transition)
[15]
 allows the discrimination between the 310- and α-helix structures by circular 
dichroism (CD).
[16]
 A value of 0.15-0.35 for R is considered diagnostic of an extensively 
developed 310-helix, while a value close to the unity is typical of an α-helix. Based on these 
considerations, peptides 1-3 were analyzed by CD (Figure 2.3, right). Peptide 1 exhibits an R 
value of 0.76, which indicates that a mixed 310-/α-helix conformation (with a considerable α-
helical amount) is that preferred for this compound. In contrast, both monocyclic peptide 2 
and bicyclic peptide 3 are characterized by an R value close to one, which suggests a complete 
α-helix folding for these two compounds. Moreover, a comparison of the ellipticity values at 
222 nm highlights a significant helix enhancement (37% and 43%, respectively) for both the 
single (2) and double (3) macrocyclized motifs as compared to that of the linear peptide 1. 
1
H-NMR and 2D-NMR spectra (the latter carried out using DQF-COSY,
[17] 
TOCSY
[18]
 and 
NOESY experiments) were recorded for the 1-3 peptide series in DMSO-d6 solution. From a 
comparison of the 
1
H-NMR spectra, we found a number of variations in the chemical shift 
and signal shape characterizing the protons directly involved in or spatially located near the 
sites of the macrocyclization. In particular, the two Cys residues of the monocyclized peptide 
2, alkylated with the meta-xylyl moiety, show a downfield shift of their αCH protons with 
respect to the corresponding protons of peptide 1 (Figure 2.4 A). Concomitantly, new signals, 
assigned to the protons of the aromatic (Ar) meta-xylyl group, are seen in the 3.8-3.5 ppm and 
7.3-7.1 ppm regions of peptide 2 (Figures 2.4 A-B). In the amide NH spectral region (Figure 
2.4 B) we observed a larger spread in the chemical shifts not only for the Cys NH protons, but 
for those of the αNH protons of the Lys residues as well, suggesting that peptide 2 is more 
conformationally constrained than peptide 1. 
After the RCM reaction and the accompanied loss of the ethylene molecule, the signals at 
5.24 and 5.14 ppm of peptides 1 and 2, corresponding to the terminal alkene protons (Figure 
2.4 A), are missing in the spectra of bicyclic peptide 3. Moreover, the complex signal at 5.85 
ppm of the –CH=CH– ethylene bridge of peptide 3 appears as a broad singlet (Figure 2.4 A), 
and the εCH2 and ζNH protons of the Lys
4
 and Lys
8
 residues are more spread (Figure 2.4 
B).In addition, the generally broad 
1
H-NMR spectrum of peptide 3 at 25 °C (Figures 2.4 A-B 
and 2.5) indicates the simultaneous occurrence of more than one conformer, due to the large 
number of atoms in the Lys
4
/Lys
8
macrocyclic system. Indeed, after heating from 25 to 65 °C 
all broad peaks, including that at 5.85 ppm, become sharper (Figure 2.5). 
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Figure 2.4 (A) Overlap of the 
1
H-NMR and TOCSY 2D-NMR spectra for the alkene (allyl) 
and αCH regions of peptides 1 (black), 2 (red), and 3 (blue) recorded in DMSO-d6 solution at 
25°C (concentration: 1 x 10
-3
M). Insets: Effects of macrocyclizations and proton assignments. 
(B) Overlap of the 
1
H-NMR and TOCSY 2D-NMR spectra for the NH region of peptides 1 
(black), 2 (red), and 3 (blue) under the same experimental conditions as above. Insets: Effects 
of macrocyclizations and proton assignments. 
Interestingly, in the spectra recorded at the two highest temperatures (55 and 65 °C), we 
observe a major peak (5.76 ppm) which we assign to the protons of the –CH=CH– ethylene 
bridge
[4]
 of the major configurational isomer that is formed. Moreover, another peak 
(indicated in Figure 2.5 by an arrow), albeit very small (less than 10% of the major peak after 
integration), is clearly visible at 5.67 ppm. We assign it to the same type of protons of the 
minor configurational isomer. We attribute the major peak to the E isomer on the basis of 
literature data (in particular, NMR chemical shifts, E/Z ratio values, and ring size) on the 
RCM reaction where strictly similar (helical peptides)
[4]
 or related
[19]
 substrates were used. 
More specifically, the 2
nd
 generation Grubbs catalyst employed in the present work was 
shown to produce large-sized cyclic compounds (as the one synthesized here) in very good 
yields and high E-selectivities.
[19]
 Unfortunately, our NMR attempts to confirm this 
configurational assignment via COSY phase-sensitive and J-resolved experiments at different 
frequencies (500 and 600 MHz) failed to give a clear-cut information, most probably because 
αCH
Cys2
Cys6 Lys4
Lys8
ArCH2
a
b
c d
a
b
c
d
a
b
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b
c d
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a
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of the complexity of the hyperfine system (the –CH=CH– moiety is coupled to the nearby –
CH2– protons) under the peak. 
 
Figure 2.5 Partial 
1
H-NMR spectrum of peptide 3 recorded in DMSO-d6 solution as a 
function of heating (from 25 to 65 °C). 
Furthermore, from a comparison of the spectral region of the Aib βCH3 protons (1.5-1.3 
ppm), we noted a greater dispersion of the resonances for peptide 3 as compared to those for 
peptides 1 and 2. This finding might be taken as an evidence for a more structured bicyclic 
peptide 3. 
All sequential αNH(i)→αNH(i+1) connectivities, characteristic of a well-developed helical 
conformation,
[20]
 are seen in the NOESY spectra of peptide 1 and 3 in DMSO-d6 solution 
(Figure 2.6). Additional information was obtained from the large number of sequential 
αCH(i)→αNH(i+1) connectivities observed, along with some long-range NOE signals, which 
further support the presence of an helical structure (Figure 2.7). When an αCH is not present 
in the amino acid (in correspondence to the Aib residues), we looked at the 
βCH3(i)→αNH(i+1) connectivities: these parameters are exhibited by all three peptides (not 
shown). As a further test of peptide helicity, we determined the temperature coefficients of the 
αNH protons. Although there is not a big difference in the behavior of the three peptides, we 
noticed that the Aib
1
 and Lys
4
 residues (near the N-terminus) of peptide 1 are more mobile 
than the corresponding residues of peptides 2 and 3 (not shown). 
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Figure 2.6 NH→NH region of the NOESY spectra of peptides 1 (A) and 3 (B) in DMSO-d6 
solution at 25 °C. 
Figure 2.7 αCH→NH region of the NOESY spectra of peptides 1 (A) and 3 (B) in DMSO-d6 
solution at 25 °C. 
In general, for the three peptides all other residues are significantly fixed, except Cys
2
. We 
also measured the JαNH-αCH coupling constants for the four non-Aib (two Cys and two Lys) 
residues. For all three peptides the experimental values are compatible with helical 
structures,
[20]
 as they range between 5.0 and 7.0 Hz. However, these values are only slightly 
affected by the temperature increment. 
In addition, peptide 3 displays NOE cross-peaks between the αCH protons of Cys2 and Cys6 
and the H
a
 aromatic proton of the meta-xylyl moiety in their vicinity (Figure 2.8 A). The 
proximity of Aib
5
 to the two Cys residues constrained by formation of the meta-xylyl ring 
structure is highlighted by NOE cross-peaks between the αCH protons of Cys2/Cys6 and the 
βCH3 protons of Aib
5
 (Figure 2.8 B). 
 
A B 
A B 
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Figure 2.8 NOESY spectrum of peptide 3 in DMSO-d6 solution at 25 °C. (A) Cross-peaks 
between the αCH protons of Cys2/Cys6 and Ha proton of the meta-xylyl moiety. (B) Cross-
peaks between the αCH protons of Cys2/Cys6 and the βCH3 protons belonging to Aib
5
. 
Next, to understand the role played by the double stapled
[21] 
motif on the stability of the 
helical structures, we recorded a series of CD curves for peptides 1-3 in MeOH at different 
temperatures (Figure 2.9). After heating at 60 °C, both the linear peptide 1 and the 
monocyclic peptide 2 underwent a 37-38 % loss of their original helical contents (as referred 
to the measurement at 20 °C). In contrast, peptide 3 did not display any significant change in 
its CD spectrum during an identical heating process. These results suggest a remarkable 
thermal stabilization effect on the α-helix induced by the second cyclization, which affords 
the bicyclic [31,22,5](E)ene motif of 3. 
Figure 2.9 Far-UV CD spectra of peptides 1-3 recorded in MeOH solution at 20 °C (black), 
40 °C (red) and 60 °C (green) (concentration: 1 x 10
-3
M). 
 
 
1 2 3 
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Conclusions 
We reported the synthesis of an i, i+4 intramolecularly double stapled, overlapping, bicyclic 
oligopeptide system generated by two side chain-to-side chain macrocyclization reactions of 
different type on a completely preformed sequence. Moreover, by use of NMR and CD 
spectroscopies, the resulting final 9-mer peptide (3) was characterized in detail. Upon 
bicyclization, the mixed 310/α-helical conformation exhibited by the original linear peptide 1 
is converted into a fully developed α-helix in peptide 3. In parallel, both the helix overall 
content and stability are significantly increased. 
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2.2 Light-mediated modulation of screw sense communication in helical 
foldamers 
The light-induced isomerization between a fumaramide (E-isomer) and a maleamide (Z-
isomer) linkage was successfully employed in the field of molecular machines, in particular as 
a switchable component of peptido[2]rotaxanes.
[22]
 The isomerization between this pair of 
diamides can be obtained using light at different wavelengths, from E to Z at 254 nm and for 
the reverse process, Z→E, at 312 nm.[23] 
By taking advantage from this system, we decided to opportunely introduce the fumaramide 
linkage by stepwise amide bond formation on one side to a chiral residue capable of inducing 
a conformational preference and on the other to a series of achiral Aib oligomers. Our aim 
was to create a molecular system in which conformational induction is restored or interrupted 
as a result of a photochemical switch. In our studies, we choose as chiral inducers the amino 
acids L-valine (L-Val) and L-α-methylvaline [L-(αMe)Val]. In particular, we expected that 
the incorporation of L-(αMe)Val would maximize the chances to induce a high degree of 
preference for the right-handed screw-sense,
[10a]
 since this chiral quaternary residue is 
compatible with the 310-helical structure of Aib oligomers.
[10i,16a]
 
Thus monoethyl fumarate was coupled with H-L-(αMe)Val-OtBu and H-L-Val-OtBu under 
standard coupling conditions (EDC/HOAt) (Scheme 2.1). After basic hydrolysis, the 
carboxylic acids 5a and 5b were recovered in quantitative yield. 
Scheme 2.1 Synthesis of fumaric acid derivatives 4a-b and 5a-b. Reagents and conditions: i) 
Monoethyl fumarate, EDC, HOAt, TEA, CH2Cl2, r.t.; ii) LiOH, THF/H2O 3:1, r.t., 1 h. 
The synthetic strategy used to synthesize Aib homopeptides for this study is based on the 
well-established solution-phase, iterative coupling procedure
 [10b]
 via azido acyl chloride.
[24]
 
The achiral Aib oligopeptides were built up from the C-terminal protected ester (H-Aib-OtBu) 
by acylation with α-azidoisobutyryl chloride (Azib-Cl) followed by catalytic hydrogenation of 
the azide (Scheme 2.2).
[10b]
 Repetition of the procedure gave fully protected Aib fragments. 
Selective functionalisation can be subsequently achieved at the N-terminus by reduction of its 
azido group, or at the C-terminus after removal of the orthogonal tertbutyl ester protection. 
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Scheme 2.2 Iterative coupling procedure applied in the synthesis of Aib homopeptides. 
Functionalized Aib oligomers 6a-c were obtained by reaction of 5a (containing L-(αMe)Val) 
or 5b (containing L-Val) with H-AibnGlyNH2 (n= 4, 8) under standard coupling conditions 
(EDC/HOAt) (Scheme 2.3). The fumaramide peptides 6a-c were converted to their 
maleamide Z isomers 7a-c by irradiation (UV-light at 254 nm) of solutions in MeOH. 
Scheme 2.3 Synthesis of the series of fumaramides 6a-c and conversion to maleamide 
isomers 7a-c. Reagents and conditions: i) H-Aibn-GlyNH2, EDC, HOAt, DIPEA, CH2Cl2, r.t.; 
ii) hν 254 nm, MeOH, 1 h. 
Compounds 6a-c and 7a-c contain a C-terminal glycinamide residue to provide an NMR 
reporter of screw-sense preference.
[10c,25]
 The quantification of the chemical shift separation 
(Δδ) between the anisochronous peaks arising from diastereotopic protons of glycinamide 
(αHa and αHb) allows the determination of relative screw-sense control in helical 
foldamers.
[10a,10e]
 The 
1
H NMR in CD3OD of 6a, that contains L-(αMe)Val, was recorded 
before irradiation (Figure 2.10, blue line) and after irradiation at 254 nm for different times 
(1h, green line and 3h, red line). The isomerization of 6a to 7a was almost quantitative in an 
hour (> 97%). 
The inversion of double bond geometry has significant consequences for the conformational 
preference of the Aib4 portion of the oligomer. Concurrent with the change in the olefinic 
region of the 
1
H NMR spectrum as 6a was converted into 7a, the 2H singlet arising from the 
glycinamide methylene group became split into an AB system, with a chemical shift 
separation of 218 ppb. (Figures 2.10 A-B). Because the screw sense conformers of the Aib 
helix are in fast exchange on the NMR timescale, and the chiral influence is remote from the 
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glycinamide residue, this change in chemical shift separation indicates that the level of screw 
sense control transmitted through the oligomer increases from zero in the E derivative 2a (Δδ 
= 0 ppb) to 41% helical excess in the Z derivative 3a (Δδ = 218 ppb) (calculated as outlined in 
ref. 10e). 
Figure 2.10 (A-B) Details of the 
1
H NMR spectra of 6a before irradiation (blue line) and after 
irradiation at 254 nm for different times (30 min, green line and 1h, red line), showing (left) 
the olefinic signals and (right) the glycinamide methylene signals. 
The configuration around the double bond evidently plays a key role in the induction of the 
helical preference on Aib oligomers. The same behaviour was also observed in the 
glycinamide signals of the longer oligomers 6b, which indicated no helical screw-sense 
preference, and 7b, in which a chemical shift separation Δδ = 145 ppb indicated a helical 
excess of 27% (Table 1). Conversely, the compounds containing L-Val (6c and 7c) showed 
lower level of control (Table 1). We found a small chiral induction also in the fumaramide 
derivative 6c (Δδ = 16 ppb, 3% helical excess), and a slightly larger value for the maleamide 
isomer 7c (Δδ = 67 ppb, 13% helical excess). 
time 0 min
time 30 min
time 1 h
hv 254 nm
40% d.e. 
Right-Handed (P) Helix
Leftt-Handed
(M) Helix
Righ-Handed
(P) Helix
Fast Inversion
Uv-Vis
CD
A
B
C
D
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Table 1. Anisochronicity in the terminal CH2 group of 6a-c, before [Δδ (E)] and after [Δδ (Z)] 
photo-isomerization. 
compound amino acid R n Δδ (E) ppb Δδ (Z) ppb 
6a L-(αMe)Val Me 4 0 218 
6b L-(αMe)Val Me 8 0 145 
6c L-Val H 4 16 67 
 
The consequences of isomerizing the E double bond of 6a to the Z double bond of 7a were 
further studied using 
1
H and 2D-NMR (NOESY) experiments in CD3CN. Comparison of the 
two 
1
H NMR spectra (Figure 2.11) reveals significantly different chemical shifts for the NH 
signals of Aib
2
 and L-(αMe)Val in the two isomers. In particular, the Aib2 NH signal of 6a 
moves to higher chemical shift when isomerized to the Z isomer 7a (from 7.14 to 8.61 ppm). 
This suggests that the E to Z photo-switch allows a new intramolecular H-bond to form, 
involving the NH of Aib
2
 residue and the carbonyl of the maleamide unit adjacent to the L-
(αMe)Val residue (Figure 2.11, right part). 
 
Figure 2.11 
1
H NMR spectra (500 MHz in CD3CN) and assignments showing the NH and 
olefinic signals of E isomer 6a (red line) and Z isomer 7a (pure sample isolated by HPLC, 
blue line). Right, representation of the two different H-bond networks occurring (as 
hypothesis) for isomers E and Z. 
(E) 2a linear structure
(Z) 3a linear structure
(E) 2a folded structure
(Z) 3a folded structure
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Moreover sequential αNH(i)→αNH(i+1) and βCH3(i)→αNH(i+1), and some medium range 
βCH3(i)→αNH(i+2) connectivities, characteristic of a well-developed helical 
conformation,
[20]
 are seen in the NOESY spectra of peptides 6a/7a (Figures 2.12-2.14). These 
findings suggest that the Aib4 segment is folded in a helical conformation, which is not 
modified by the isomerization. 
Figure 2.12 βCH3 → αNH region of the NOESY spectra (500 MHz, CD3CN) of peptides 6a 
(A) and 7a (B). Sequential (i → i+1) and medium-range (i → i+2), diagnostic of the presence 
of a 310-helical structure are visible in both spectra. 
Figure 2.13 Amide region of the NOESY spectrum (500 MHz, CD3CN) of 6a. Sequential 
αNH(i)→αNH(i+1) are assigned in the spectrum. 
2. Short helical peptides 27 
Figure 2.14 Amide region of the NOESY spectrum (500 MHz, CD3CN) of 7a. Sequential 
αNH(i)→αNH(i+1) are assigned in the spectrum. 
The molecular structure of 6a was also determined by single crystal X-ray diffraction analysis 
(Figure 2.15). All of the amide and ester bonds are found in the usual trans disposition, none 
of them deviating by more than 9.0° from the ideal trans-planarity (180°). The conformation 
adopted by L-(Me)Val is right-handed helical [, = -58.4(3)°, -47.9(3)°], as expected, and 
its isopropyl side chain is found in the common tg
–
 disposition.
[16a,26]
 The value of the torsion 
angle about the double bond of the fumaric acid unit (C1F-C2F-C3F-C4F) is -174.6(3)°. Both 
fumaramide carbonyl oxygen atoms are in a cisoid arrangement relative to the double bond, 
the values of the torsion angles O1F-C1F-C2F-C3F and C2F-C3F-C4F-O2F being -17.5(5)° 
and -11.4(5)°, respectively. As a result, the two oxygen atoms are slightly displaced from the 
average plane defined by the C1F, C2F, C3F and C4F atoms, namely O1F by 0.229(3) Å 
while O2F by 0.122(2) Å. 
The -Aib4- segment is folded in a right-handed 310-helix, stabilized by four intramolecular H-
bonds involving the NH groups of Aib
3
, Aib
4
 and Gly as the donors, and the carbonyl oxygen 
atoms O2F, O1, and O2, respectively, as the acceptors. The average values of the , 
backbone torsion angles for the -(Aib)4- segment are -55°,-32°. The C-terminal Gly residue 
adopts a semi-extended conformation with the sign of the  torsion angle opposite with 
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respect to that of the preceding Aib residues, thus precluding the C-terminal primary amide 
moiety from being involved in any intramolecular H-bond. 
Figure 2.15 X-Ray structure of (E) 6a with atom numbering. H-bonds are indicated by 
dashed lines. 
The distance between the C

 atoms of L-(Me)Val (the only chiral center) and Aib1 is 8.54 Å. 
There is no obvious reason why the chiral information should be transferred across the 
fumaramide linkage to the helical -Aib4- segment. Indeed, although in this structure the -Aib4- 
segment is right-handed helical, a model built by reversing the sign of all torsion angles from 
Aib
1
 to the C-terminal primary amide clearly showed that a left-handed helix is fully 
compatible with the occurrence of an L-(Me)Val residue at the other end of the fumaramide 
spacer. 
The secondary structure of peptides 6a-b and 7a-b were explored further using UV-Vis and 
CD measurements in MeOH solution (Figure 2.16). The chromophores of 6a and 7a have 
distinctively different UV-Vis spectra. 6a is characterized by a more intense UV-Vis profile 
with a maximum absorption located at 200 nm and a pronounced shoulder located at 260 nm 
(Figure 2.16 A). With regard to far-UV CD analyses, E isomer 6a displayed a moderately 
intense negative band with maximum at 212 nm followed by two weak bands of opposite 
sign, one positive at 238 nm and one negative at 255 nm, respectively (Figure 2.16 B, blue 
line). Conversely, the Z isomer 7a displayed a very different CD profile (Figure 2.16 B, red 
line). In this case the far-UV CD profile is characterized by an intense negative maximum at 
228 nm (having a shoulder at 212 nm) followed by a weak band of opposite sign at 265 nm. 
The compounds 6b and 7b displayed similar CD profiles (Figure 2.16 C). 
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Figure 2.16 (A) UV-Vis spectra of (E) 6a (blue line) and (Z) 7a (red line) in MeOH solution. 
(B) Far-UV CD spectra of (E) 6a (blue line) and (Z) 7a (red line) in MeOH solution (0.3 
mM). (C) CD spectra of 6b in MeOH before irradiation (blue line) and after irradiation (red 
line) at 254 nm (0.2 mM). 
In order to rationalize the CD spectra of 6a-b and 7a-b, we synthesized a second group of 
compounds (8a-d) which provides a series of Aib homo-peptides methyl esters of increasing 
length (1, 2, 4 or 8 residues, Scheme 2.4). Fumaramide peptides 8a-d were converted to their 
corresponding maleamide (Z) isomers 9a-d by UV-light irradiation of solutions in MeOH. 
Scheme 2.4 Synthesis of compounds 8a-d and conversion to their isomers 9a-d. Reagents and 
conditions: i) H-Aibn-OMe, EDC, HOAt, DIPEA, CH2Cl2, r.t.; ii) hν 254 nm, MeOH, 1 h. 
Surprisingly, UV-light photoisomerization gave only 65% conversion of 8a (E) to 9a (Z). 9a 
was consequently synthesized directly by reaction with the maleic acid derivative Z5a 
(Scheme 2.5). Z5a was obtained by one pot reaction between maleic anhydride and L-
(αMe)Val under basic conditions and then coupled to H-Aib-OMe obtaining 9a. 
In order to characterize the influence of the fumaramide and the maleamide chromophores in 
the CD spectra we initially compared the spectra of the two shortest analogues 8a and 9a, 
lacking a helical tail (Figure 2.17 A). 
A B C
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Scheme 2.5 Synthesis of maleamide derivatives Z5a and 9a. Reagents and conditions: i) 
TEA, CH3CN, r.t., overnight;  ii) H-Aib-OMe, EDC, HOAt, DIPEA, CH2Cl2, r.t. 
Compound 8a presents a CD signature comparable to those of 6a-b, while 9a displays a very 
weak CD signal, comparable in profile to that of its E-isomer 8a. The CD spectra of the series 
of E configured Aib peptide methyl esters 8b-d are all similar to the spectra recorded both for 
6a-b and the non-helical homologue 9a (Figures 2.17 B-D, red lines). Their Z configured 
homologues 9b-d (formed by photoisomerization) provided more interesting information. In 
the case of 9b (with only two Aib residues, Figure 2.17 B, blue line) the resulting spectrum, 
even resembling in shape those of 7a-b, showed intriguing features. It reveals a negative 
maximum at 208 nm followed by a pronounced shoulder at 227 nm and a positive maximum 
at 270 nm. The CD spectrum of 9c (with four Aib residues, Figure 2.17 C, blue line) shows 
two intense negative maxima characterized by similar intensity located at 209 and 228 nm 
(and preserve the positive maximum at 260-270 nm). Finally compound 9d (with eight Aib 
residues, Figure 2.17 D) displays a CD signature almost superimposable with the curve shown 
by 6b. We can conclude that the CD signature of the E isomers containing more than two Aib 
residues arises from the adoption of a preferred helix screw-sense, which is induced by the 
fumaramide-to-maleamide photoisomerization. 
Figure 2.17 CD spectra in MeOH (0.3 mM) of 8a and 9a (A, blue and red line respectively); 
8b and 9b (B, blue and red line respectively); 8c and 9c (C, blue and red line respectively); 8d 
and 9d (D, blue and red line respectively). 
helix deracemization
A B DC
i) ii) 
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1
H-NMR and 2D-NMR spectra (NOESY experiment) were recorded also for the 8a-c and 9a-
c peptide series in CD3CN (Figures 2.18-2.20). From a comparison of the 
1
H NMR spectra, 
we found a number of variations in the chemical shift of NH signals after photoisomerization. 
In the case of the shortest compounds 8a/9a, both NH [Aib and (Me)Val] signals possess 
higher chemical shift in the spectrum of the Z isomer 9a (Figure 2.18). Similar behavior was 
observed for 8b/9b but the variation of chemical shift was less pronounced (Figure 2.19). The 
spectra of 8c/9c resemble in shape those of 6a/7a, in which only the Aib
2
 and (Me)Val NH 
signals revealed significantly different chemical shifts (Figure 2.20). 
 
Figure 2.18 Upper part: 
1
H NMR spectra (500 MHz, CD3CN) of 8a and 9a. βCH3 → αNH 
region of the NOESY spectra of peptides 8a (A) and 9a (B). 
Additional information was obtained from the NOESY spectra, in which different 
connectivities are seen for fumaramide and maleamide isomers (Figures 2.18 A-B). We found 
the sequential connectivities βCH3(i)→αNH(i+1) in the NOESY spectra of 8b (Aib
1
 →Aib2) 
αMeVal
Aib1
Aib1
αMeVal
A B
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and 8c (Aib
1
 → Aib2, Aib2 → Aib3). Coversely only in the spectra of Z isomers 9b-c, we 
observed a cross-peak between Aib
2
 NH and (Me)Val γCH3, which suggests the close 
spatial proximity of these residues after isomerization. All sequential αNH(i)→αNH(i+1) 
connectivities are visible in the NOESY spectra of peptides 8c/9c, confirming the presence of 
a well-developed helical conformation throughout the –Aib4- segment (Figure 2.18).  
 
Figure 2.19 Upper part: 
1
H NMR spectra (500 MHz, CD3CN) of 8a and 9a. βCH3 → αNH 
region of the NOESY spectra of peptides 8b (A) and 9b (B). 
 
 
 
αMeVal
Aib1
Aib2
Aib1αMeValAib2
A B
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Figure 2.20 Upper part: 
1
H NMR spectra (500 MHz, CD3CN) of 8c and 9c. βCH3 → αNH 
region of the NOESY spectra of peptides 8c (A) and 9c (B). NH → NH region of the NOESY 
spectra of peptides 8c (C) and 9c (D,E). 
  
αMeValAib1
Aib4
Aib3 Aib2
αMeVal
Aib1
Aib2
Aib4 Aib3
A B
C
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E
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As previously reported in literature, the secondary structure plays a key role in the 
enantioselective chain extension reactions of helical peptides.
[12,27]
 Induction of a globally 
chiral secondary structure in an achiral peptide chain by a single remote chiral residue at the 
N terminus, is on its own sufficient to allow enantioselective chain extension at the C 
terminus.
[12]
 To demonstrate the potential of our system in which a helical screw sense 
preference can be turned on or off using light, we exploited 5(4H)oxazolones (azlactones) 
from the tetra- and octa-Aib peptides 8c and 8d as activated compound for chain extension 
reactions. To this end, peptides 8c and 8d were hydrolyzed under basic conditions to the 
corresponding E configured carboxylic acids 10a-b (Scheme 2.6). The corresponding (Z) 
isomers 11a-b were easily formed on irradiation with UV light. 
 
Scheme 2.6 Synthesis of the carboxylic acids 10a-b and 11a-b. Reagents and conditions: i) LiOH, 
THF/H2O 3:1, 40-60 °C, 24 h; ii) hν 254 nm, MeOH, 1 h. 
The peptide oxazolones 12a-b, 13a-b were synthesized by reaction with EDC in an 
appropriate solvent. To run the diastereoselection experiments, the oxazolones 12a-b and 13a-
b were allowed to react with a large excess (8 equiv.) of H-D,L-Val-OMe (Scheme 2.7). 
The ratios of the pairs of diastereoisomers formed were quantified by reverse phase HPLC. A 
first set of experiments was performed in acetonitrile at different temperatures (20, 40 and 70 
°C). In no case was stereoselectivity observed: the pairs of diastereoisomers (14a/c or 14b/d, 
15a/c or 15b/d) were formed in a 50:50 ratio. The reactions were repeated in CH2Cl2 (at 20 
°C, 35 °C and under reflux). Interestingly, we found that only 13b (Z isomer, 8 Aib residues) 
showed a remarkable stereoselectivity in chain extension reaction by incorporating 
preferentially L-Val-OMe (Figure 2.21). Moreover, in this solvent we found a kinetic control, 
as we observed an increase of diastereoselection ratio with decreasing temperature (Table 2). 
 
i) 
ii) 
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Scheme 2.7 Diastereoselection experiments of peptide oxazolones (E) 12a-b (A) and (Z) 13a-
b (B) with H-D,L-Val-OMe. 
 
Table 2. Diastereoselection experiment of (Z) 13b with H-D,L-Val-OMe. Reaction conditions 
(solvent and temperature) and ratio between the two diastereoisomers, calculated as the 
relative peak areas % from HPLC trace. 
solvent temperature 9b : 9d 
CH2Cl2 20 °C 74 : 26 
CH2Cl2 35 °C 62 : 38 
CH2Cl2 reflux 57 : 43 
CH3CN 20 °C 51 : 49 
 
These findings are in agreement with previous results on related systems which demonstrated 
that low polarity solvent and low temperature markedly favor a higher stereoselectivity.
[27c]
 
Additionally, as it was stated above, only (Z) 13b was able to give a diastereoselection and 
this critical main-chain length suggests that only at the octamer level the C-terminal 
oxazolone is “buried” enough to be affected by the overall chirality of the system, and this 
means that the helical structure is stabilized in a preferred screw-sense by a sufficient number 
of intramolecular H-bonds. Importantly, the solvent effect may be rationalized on the basis on 
the H-bonding competition. A polar solvent such as CH3CN, in contrast to CH2Cl2, can be 
considered as a moderately competitive H-bonding acceptor and for this reason may have a 
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critical effect on the stabilization of the overall constrained structure, thus facilitating helix 
screw-sense inversion. 
Figure 2.21 Scheme of diastereoselection experiments of peptide oxazolone (Z) 13b with H-
D,L-Val-OMe; (A) HPLC traces of (i) an authentic sample of (Z) 15b; (ii) reaction mixture of 
13b with H-D,L-Val-OMe in CH2Cl2 at 20 °C, at (iii) 40 °C and (iv) under reflux; (v) reaction 
mixture of 13b with H-D,L-Val-OMe in CH3CN at 20 °C. 
 
Finally we investigated the behavior of a more complex system in which the photoswitchable 
linker serves as a means of conducting or insulating conformational communication between 
two helical Aib4 domains linked head-to-head (N-terminus to N-terminus) (Scheme 2.8). A 
chiral inducer (L-Ala-O
t
Bu and a glycinamide NMR reporter were each located at the C-
terminus of the Aib4 domains. L-Ala can participate in a 310 helical structure and as its ester 
derivative induces high levels of left-handed screw-sense control when located at the C-
terminus of an Aib oligomer.
[11]
 
Monoethyl fumarate was coupled to the N-terminus of H-Aib4GlyNH2 and the free carboxylic 
acid 16 was recovered after basic hydrolysis (Scheme 2.8). H-L-Ala-O
t
Bu was linked at the 
C-terminus of N3-Aib4-OH, catalytic hydrogenation yielded 17. Compound 18 was obtained 
by coupling the two fragments 16 and 17. 18 was converted to its corresponding maleamide 
(Z) isomer 19 in 85% selectivity by irradiation (UV light 254 nm). 
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Scheme 2.8 Synthesis of compounds (E) 18 and (Z) 19. Reagents and conditions: i) 
Monoethyl fumarate, EDC, HOAt, TEA, CH2Cl2, r.t.; ii) LiOH, THF/H2O 3:1, r.t., 1 h; iii) H-
L-Ala-OtBu, EDC, HOAt, TEA, CH2Cl2, r.t.; iv) H2, Pd/C, EtOH, 24 h; v) EDC, HOAt, 
DIPEA, CH2Cl2, r.t.; vi) hν 254 nm, MeOH, 2 h. 
The far UV CD spectrum of (E) 18 recorded in MeOH solution revealed some preliminary 
interesting information (Figure 2.22). Despite the spatial separation of the fumaramide 
chromophore and the chiral inducer (Ala), the spectrum shows a CD signature from the 
fumaramide characterized by two maxima (one positive located at 212 nm, and one negative 
located at 235 nm) of equal intensity. Comparison with 6a-b and 8c-d (the four longest 
homopeptide sequences Figures 2.16 and 2.17) reveals similar profiles but opposite sign. In 
the case of 18, the fumaramide chromophore is affected by the chiral environment imposed by 
the left-handed helix originating from the C-terminal L-Ala-OMe residue.
[11]
 In the CD 
spectrum of the Z isomer 19 the positive band around 210 nm is markedly less intense than 
that observed for the corresponding E isomer, while the intensity of the negative band around 
235 nm is only slightly modified. 
The details of 
1
H NMR spectra of 18 illustrate the signals due to the glycinamide methylene 
group before (blue) and after (red) irradiation at 254 nm (Figura 2.22). A singlet for 18 
indicates no induction of screw sense preference, but the chemical shift separation Δδ = 31 
ppb indicates that in the case of 19 the maleamide communicates conformational information 
from the left-handed helical domain adjacent to the L-Ala residue to the more remote helical 
domain carrying the Gly residue. 
The CD spectra of both 18 and 19 show that a preferred screw sense preference pass from the 
chiral inducer (L-Ala) to the unsaturated moiety, NMR shows that only the maleamide 
communicates this conformational information further, to the GlyNH2 residue. Despite this, 
the CD signal of 19 is less intense than that of 18, suggesting that in the case of the (Z) 19 
isomer the screw sense induced in the remote helical domain is of opposite chirality to that in 
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the domain adjacent to the L-Ala residue. Because of the chemical differentiation of the two 
helical parts is slight (L-Ala vs. Gly) the two helices of opposite screw-sense tend towards a 
pseudo-meso structure, leading to the less intense CD spectrum of the (Z) 19 isomer. 
Figure 2.22 (A) CD spectra of
 
18 before (blue) and after (red) irradiation at 254 nm. Center: 
schematic view of the photo-induced molecular rearrangement occurring for 19. (B and C) 
 
Details of the 
1
H NMR spectra glycinamide signals before (blue) and after (red) irradiation at 
254 nm. 
 
 
Conclusions 
To summarize, we presented a novel approach to control asymmetric induction over long 
distances (up to 20Å, and up to 30 covalent bonds) by using helical molecules in which a 
screw-sense preference may be activated by the absorption of UV light. In the molecules we 
presented here, a trans configuration in the fumaramide linkage holds the chiral residue away 
from the achiral portion of the oligomers, preventing the induction of a conformational 
preference. However, after photoisomerization, the cis configuration of the resulting 
maleamide brings the chiral and achiral portions into proximity, and results in a pronounced 
preference for one of the two possible, helical screw senses. As a result, we showed that it is 
C N N C
C N N C
B
C
A
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possible to use light to switch on or off the ability of the molecules to react stereoselectively 
in a chain extension reaction. Finally, we reported an example of helix-to-helix 
communication of conformational preference modulated by the absorption of light. 
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2.3 Experimental Section 
Instruments and Methods 
High-Performance Liquid Chromatography. The HPLC measurements were performed using 
an Agilent 1200 apparatus (Palo Alto, CA), equipped with a UV detector at 226 nm and a 
column Agilent Extend-C18 (stationary phase). Eluants: A= 9:1 H2O/CH3CN, 0.05 % TFA; 
B= 1:9 H2O/CH3CN, 0.05 % TFA. 
Nuclear Magnetic Resonance. 
1
H NMR and 2D-NMR spectra (DQF-COSY, TOCSY and 
NOESY experiments) were recorded at 25, 45 and 65 °C on a Bruker Avance 400 or 500 
MHz instruments. 
1
H and 
13
C spectra were referenced relative to the solvent residual peaks 
and chemical shifts (δ) reported in ppm downfield of tetramethylsilane (CDCl3 δ H: 7.26 ppm, 
δ C: 77.16 ppm; CD3OD δ H: 3.31 ppm, δ C 49.05 ppm, CD3CN δ H: 1.94 ppm, δ C: 118.26 
ppm). The multiplicity of a signal is indicated as br, broad; s, singlet; d, doublet; t, triplet; m, 
multiplet. Where 
1
H NMR spectra were run in MeOD exchangeable protons (NH, OH) are 
reported only where observed. 
Mass Spectrometry. High-resolution (HR) mass spectra by electrospray ionization (ESI), 
collected in the positive mode, were performed on two different instruments: 
i) Perseptive Biosystem Mariner ESI-ToF5220 spectrometer (Foster City, CA);  
ii) Thermo Finnigan MAT95XP (data were recorded by staff at the University of Manchester 
and are accurate to ± 0.001Da). 
Circular Dichroism. CD measurements were carried using a Jasco J-715 spectropolarimeter at 
different temperatures (20, 40 and 60°C) and a thermostatic system to control the temperature 
of the sample. Fused quartz cells of 0.2-mm and 1-mm path length (Hellma, Müllheim, 
Germany) were used. The value are expressed in terms of []T, the total molar ellipticity (deg 
x cm
2
 x dmol
-1
). 
Fourier Transform-Infrared Spectroscopy. FT-IR absorption spectra were recorded with a 
ATi Perkin Elmer Spectrum RX1 FT-IR spectrometer. The ῡ maxima for the main absorption 
bands are given. 
Melting point. Mps were determined on a GallenKamp apparatus and are uncorrected. 
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Single cristal X-Ray diffraction. Single crystals of 6a were grown by slow evaporation from 
CH3CN. Relevant crystal data, structure refinement parameters and details specific to the 
individual structures are given below (Tables S1-3). 
X-Ray diffraction data were collected with a Gemini E four-circle kappa diffractometer 
(Agilent Technologies) equipped with a 92 mm EOS CCD detector, using graphite 
monochromated Cu K radiation ( = 1.54178 Å). Data collection and reduction were 
performed with the CrysAlisPro software (version 1.171.36.28, Agilent Technologies). A 
semi-empirical absorption correction based on the multi-scan technique using spherical 
harmonics, implemented in the SCALE3 ABSPACK scaling algorithm, was applied. The 
structure was solved by ab initio procedures of the SIR 2014 program,
[28]
 and refined by full-
matrix least-squares on F
2
, using all data, by application of the SHELXL-2014 program,
[29]
 
with anisotropic displacement parameters for all of the non-H atoms. H-Atoms were 
calculated at idealized positions and refined using a riding model. 
UV lamp. A handheld UV Lamp (mineralight lamp, Model UVG-54) with wavelength of 254 
nm (6W) was used in the photoisomerization experiments. 
Materials 
Protected amino acids Fmoc-Aib-OH and Fmoc-Cys(Trt)-OH, and 1-hydroxy-7-aza-1,2,3-
benzotriazole (HOAt) were purchased from GL Biochem (Shanghai). Fmoc-Lys(Aloc)-OH 
and Rink amide resin (loading 0.65 mmol/g) were obtained from Iris Biotech (Germany). 
O-(7-aza-1,2,3-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 
(HATU) was purchased from Novabiochem (San Diego, CA). H-L-(αMe)Val-OH, H-L-Val-
OMe and H-D,L-Val-OMe were obtained from Bachem. 
Grubbs (2
nd
-generation) catalyst [1,3-bis-(2,4,6-trimethylphenyl)-2-(imidazolidinylidene) 
(dichlorophenylmethylene)(tricyclohexylphosphine) ruthenium], piperidine, N,N-
diisopropylethylamine (DIPEA), triisopropylsilane (TIS), trifluoroacetic acid (TFA), 
monoethyl fumarate, LiOH, triethylamine (TEA), tertbutyl acetate, H-L-Val-OtBu∙HCl, 
HClO4, tert-butyl α-bromoisobutyrate, α-bromoisobutyric acid, Pd/C catalyst (10% wt. 
loading), 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC∙HCl), sodium 
azide, SOCl2, H-Gly-NH2∙HCl, solution of TMSCHN2 2M in hexane were obtained from 
Sigma-Aldrich. The deuterated solvents DMSO-d6, CDCl3, MeOH-d3 and MeOD-d4 were 
purchased from Euriso-Top (France).  
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a) Stapled peptide 
Ac-Aib-Cys-Aib-Lys(Aloc)-Aib-Cys-Aib-Lys(Aloc)-Aib-NH2 (1). Linear compound (1) 
was prepared using standard solid-phase peptide synthesis (SPPS) and Fmoc chemistry on a 
Rink amide resin. The dry resin was swelled with DMF for 30 min before use. In each step, 
the Fmoc protecting group was removed by treatment with a piperidine/DMF (2:8) solution 
for 10 min (2x), then washed with DMF and CH2Cl2. For all of the amino acid couplings, we 
used the following protocol: 5.0 eq. (relative to the resin loading) of Fmoc-protected amino 
acid were activated with 4.9 eq. of HATU,4.9 eq. of HOAt and 15 eq. of DIPEA in DMF (2.5 
mL/mmol of amino acid). This mixture was then added to a flask containing the resin-bound 
peptide and mixed for 2 h under a N2 flux. The resin was then drained and rinsed with DMF 
and CH2Cl2, and then allowed to dry. For the last coupling reaction, a mixture of Ac2O, 
DIPEA and DMF (1:1:3) was used and allowed to react for 20 min. For the cleavage step, the 
resin was prepared by washing with DMF and CH2Cl2, then drying under high vacuum. 
Cleavage from the resin and simultaneous removal of Cys side-chain protecting groups (Trt) 
were performed by stirring with a mixture of TFA, water and TIS (90:5:5) for 2 h. The resin 
was removed by filtration and washed with CH2Cl2. The filtrate was then evaporated under 
reduced pressure. The residue was dissolved in MeOH and precipitated by the addition of cold 
diethyl ether. The mixture was centrifuged and settled to obtain the crude peptide. Finally, the 
linear peptide was purified via semi-preparative reverse-phase HPLC and lyophilized to give a 
solid material (overall yield 65%). 
1
H-NMR (400 MHz, 25 °C, DMSO-d6) δ 8.52 (s, 1H, NH Aib
1
), 8.08 (d, 1H, NH Cys
2
), 7.87 
(s, 1H, NH Aib
3
), 7.84 (d, 1H, NH Lys
4
), 7.71 (s, 1H, NH Aib
7
), 7.69 (s, 1H, NH Aib
5
), 7.61 
(d, 1H, NH Cys
6
), 7.35 (s, 1H, NH Aib
9
), 7.31 (d, 1H, NH Lys
8), 7.02 (m, 2H, ζNH Lys4,8), 
6.92 (s, 1H, C-terminal NH), 6.77 (s, 1H, C-terminal NH), 5.88 (m, 2H, Hb Aloc
4,8
), 5.24 (d, 
2H, Hc Aloc
4,8
), 5.14 (d, 2H, Hd Aloc
4,8
), 4.42 (d, 4H, CH2 Aloc
4,8), 4.10 (m, 1H, αCH Cys2), 
3.98 (m, 1H, αCH Cys6), 3.91 (m, 1H, αCH Lys8), 3.79 (m, 1H, αCH Lys4), 2.91 (m, 4H, 
εCH2 Lys
4,8), 2.90 (m, 1H, βCH Cys6), 2.86 (m, 1H, βCH Cys6), 2.60 (m, 1H, βCH Cys2), 
2.53 (m, 1H, βCH Cys2), 1.92 (s, 3H, CH3 Ac), 1.81 (m, 1H, βCH Lys
8), 1.69 (m, 2H, βCH2 
Lys
4), 1.53 (m, 1H, βCH Lys8), 1.47 (s, 3H, βCH3 Aib
5), 1.41 (s, 6H, 2 βCH3 Aib
3
), 1.40 (s, 
6H, 2 βCH3 Aib
7), 1.38 (s, 3H, βCH3 Aib
5), 1.37 (s, 6H, 2 βCH3 Aib
9), 1.36 (s, 6H, 2 βCH3 
Aib
1), 1.33 (m, 4H, δCH2 Lys
4,8), 1.22 (m, 4H, γCH2 Lys
4,8
). HRMS (ESI+) m/z calcd. for 
C48H82N12O14S2 1114.5515; found 1115.5588 [M+H]
+
, 558.2808 [M+2H]
2+
. 
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Ac-Aib-Cys(X)-Aib-Lys(Aloc)-Aib-Cys(X)-Aib-Lys(Aloc)-Aib-NH2 (2, X, meta-xylyl). A 
solution of α,α′-dibromo-meta-xylene (96 mg, 0.36mmol) and DIPEA (125 µL, 0.72 mmol) in 
MeOH (50 mL) was added slowly and dropwise during 2 h to a solution of linear peptide (1) 
(100mg, 0.09 mmol) in MeOH (200 mL). The mixture was stirred at r.t. for additional 4 h and 
the conversion of the starting material was monitored by HPLC. Then, the solution was 
evaporated under reduced pressure and the residue purified by flash chromatography (silica 
gel) with a CH2Cl2/MeOH eluant mixture, by increasing the polarity from 95:5 to 9:1. The 
material recovered after evaporation of the solvent mixture was suspended in hot ethyl acetate 
and precipitated by addition of petroleum ether. The solid compound was filtered and rinsed 
with petroleum ether. The monocyclic product was recovered in 60% yield (65 mg). 
1
H-NMR (400 MHz, 25 °C, DMSO-d6) δ 8.58 (s, 1H, NH Aib
1
), 8.30 (d, 1H, NH Cys
2
), 7.98 
(d, 1H, Cys
6
), 7.75 (s, 1H, NH Aib
3
), 7.72 (s, 1H, NH Aib
7
), 7.63 (s, 1H, NH Aib
5
), 7.59 (d, 
1H, NH Lys
4
), 7.40 (d, 1H, NH Lys
8
), 7.38 (s, 1H, NH Aib
9
), 7.32 (s, 1H, Ar-H m-xylyl), 
7.20 (m, 1H, Ar-H m-xylyl), 7.25 (m, 1H, Ar-H m-xylyl), 7.12 (d, 1H, ζNH Lys4), 7.09 (d, 
1H, ζNH Lys8), 6.94 (s, 1H, C-terminal NH), 6.78 (s, 1H, C-terminal NH), 5.87 (m, 2H, Hb 
Aloc
4,8
), 5.24 (d, 2H, Hc Aloc
4,8
), 5.14 (d, 2H, Hd Aloc
4,8
), 4.42 (d, 4H, CH2 Aloc
4,8
), 4.22 
(m, 1H, αCH Cys2), 4.07 (m, 1H, αCH Cys6), 3.89 (m, 1H, αCH Lys8), 3.83 (m, 1H, αCH 
Lys
4
), 3.73 (t, 2H, CH2m-xylyl), 3.60 (t, 2H, CH2m-xylyl), 3.12 (m, 1H, βCH Cys
6
), 2.92 (s, 
4H, εCH2 Lys
4,8), 2.83 (m, 1H,βCH Cys2), 2.74 (m, 1H,βCH Cys6), 2.63 (m, 1H, βCH Cys2), 
1.93 (s, 3H, CH3 Ac), 1.81 (m, 1H, βCH Lys
8), 1.70 (m, 2H, βCH2 Lys
4),1.57 (m, 1H, βCH 
Lys
8
), 1.50 (s, 3H, βCH3 Aib
7), 1.43 (s, 6H, 2 βCH3 Aib
5),1.40 (s, 3H, βCH3 Aib
3
), 1.38 (s, 
3H, βCH3 Aib
7), 1.37 (s, 6H, 2 βCH3 Aib
9), 1.36 (s, 6H, 2 βCH3 Aib
1), 1.35 (m, 4H, δCH2 
Lys
4,8),1.33 (s, 3H, βCH3 Aib
3), 1.22 (m, 4H, γCH2 Lys
4,8
).HRMS (ESI+) m/z calcd. for 
C56H88N12O14S2 1216.5984; found 1217.6124 [M+H]
+
, 609.2972 [M+2H]
2+
. 
Ac-Aib-Cys(X)-Aib-Lys(Y)-Aib-Cys(X)-Aib-Lys(Y)-Aib-NH2 (3, X, meta-xylyl; Y, bis-
carbonyloxy-(E/Z)-but-2-ene). The monocyclic peptide (2) (44 mg, 0.036 mmol) was 
dissolved in 20 mL of dry CH2Cl2 in an N2-flushed flask equipped with a water-cooled 
condenser. A solution of the 2
nd
-generation Grubbs catalyst (6 mg, 20 mol%) in 1 mL of dry 
CH2Cl2 was added and the mixture was heated at 50 °C. The progress of the reaction was 
monitored by HPLC analysis. After refluxing for about 1.5 h, heating was stopped and the 
reaction was quenched by adding 25 µL of ethylvinyl ether. Stirring was continued for 15 
min, after which the solvent was evaporated under reduced pressure. The crude residue was 
directly and effectively purified by flash chromatography (silica gel) with a CHCl3/MeOH 
solvent mixture, by increasing the polarity of the eluant from 93:7 to 85:15. The solvent 
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mixture was evaporated. The recovered material was dissolved in MeOH and diethyl ether 
was added. The resulting suspension was centrifuged and settled to obtain the bicyclic product 
as a solid material (15 mg, yield 31%). 
1
H-NMR (400 MHz, 25 °C, DMSO-d6) δ 8.60(s, 1H, NH Aib
1
), 8.33 (d, 1H, NH Cys
2
), 8.02 
(m, 1H, Cys
6
), 7.77 (s, 1H, NH Aib
3
), 7.71 (s, 1H, NH Aib
5
), 7.63 (s, 1H, NH Aib
7
), 7.61 (s, 
1H, NH Lys
4
), 7.47 (d, 1H, NH Lys
8
), 7.31 (s, 1H, NH Aib
9
), 7.28 (m, 1H, Ar-H m-xylyl), 
7.21 (m, 1H, Ar-H m-xylyl), 7.18 (s, 1H, ζNH Lys4), 7.15 (m, 1H, Ar-H m-xylyl), 6.97 (s, 1H, 
ζNH Lys8), 6.97 (s, 1H, C-terminal NH), 6.75 (s, 1H, C-terminal NH), 5.70 (s, 2H, 2 CH 
alkene), 4.45 (m, 2H, CH2 former Aloc), 4.41 (d, 2H, CH2 former Aloc), 4.20 (m, 1H, αCH 
Cys
2), 4.10 (m, 1H, αCH Cys6), 3.86 (m, 1H, αCH Lys8), 3.80 (m, 1H, αCH Lys4), 3.73 (m, 
2H, CH2 m-xylyl), 3.60 (m, 2H, CH2 m-xylyl), 3.05 (m, 1H, βCH Cys
6), 2.90 (s, 2H, εCH2 
Lys
8), 2.88 (s, 2H, εCH2 Lys
4), 2.84 (m, 1H, βCH Cys2), 2.75 (m, 1H, βCH Cys6), 2.60 (m, 
1H, βCH Cys2), 1.94 (s, 3H, CH3 Ac), 1.85 (m, 1H, βCH Lys
8), 1.70 (m, 2H, βCH2 Lys
4
), 
1.63 (s, 1H, βCH Lys8), 1.52 (s, 3H, βCH3 Aib
5), 1.43 (s, 6H, 2 βCH3 Aib
7
), 1.41 (s, 3H, 
βCH3 Aib
3), 1.39 (s, 6H, 2 βCH3 Aib
1), 1.38 (s, 6H, 2 βCH3 Aib
9), 1.37 (s, 3H, βCH3 Aib
5
), 
1.34 (m, 4H, δCH2 Lys
4,8), 1.32 (s, 3H, βCH3 Aib
3), 1.24 (m, 4H, γCH2 Lys
4,8
). HRMS (ESI+) 
m/z calcd. for C54H84N12O14S2 1188.5671; found 1189.5785 [M+H]
+
, 595.2837 [M+2H]
2+
. 
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b) Light-mediated modulation of screw-sense communication in helical foldamers 
Fumaric acid derivatives 
H-L-(αMe)Val-OtBu.[30] H-L-(αMe)Val-OH (500 mg, 3.8 mmol) was dissolved in tert-butyl 
acetate (10 mL) and the solution cooled to 0 °C. HClO4 70% (750 μL, 5.8 mmol) was added 
dropwise and the reaction mixture was stirred at r.t. overnight. The solution was washed with 
H2O (30 mL) and HCl 1 M (15 mL). The resultant aqueous solution was treated with 
K2CO3(aq) 10% until pH= 9 and then extracted with CH2Cl2 (3x25 mL). The combined organic 
phases were dried over MgSO4, filtered and concentrated under reduced pressure. The product 
was recovered as a colorless oil (380 mg, 53% yield). 
1
H NMR (400 MHz, CDCl3) δ 1.94 (m, J = 6.8 Hz, 1H, βCH), 1.45 (s, 9H, OtBu), 1.44 (s, 
2H, NH2), 1.20 (s, 3H, βCH3), 0.90 (d, J = 6.9 Hz, 3H, γCH3), 0.85 (d, J = 6.9 Hz, 3H, γCH3). 
Data consistent with that reported in the literature.
[31]
 
OEt-Fum-(αMe)Val-OtBu (4a). Monoethyl fumarate (390 mg, 2.7 mmol) and HOAt (365 
mg, 2.7 mmol) were dissolved in CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl 
(500 mg, 2.7 mmol) was added. After complete dissolution H-(αMe)Val-OtBu (350 mg, 1.87 
mmol) and TEA (400 μL, 2.9 mmol) were added and the reaction mixture stirred overnight at 
r.t. The solvent was removed under reduced pressure and the residue dissolved in EtOAc. The 
organic phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, 
filtered and concentrated. The crude was purified via flash chromatography (eluant: petroleum 
ether/EtOAc increasing the solvent mixture polarity from 9:1 to 8:2). The product was 
obtained as a colorless oil (500 mg, 85 % yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C16H27NO5Na ([M+Na]
+
) 336.1787, found 336.1783. 
[ ] 
   = -36.3 (c 1, MeOH). FT-IR ῡmax 3351, 2977, 1727, 1682, 1259, 1368, 1296, 1272, 
1150 cm
-1
. 
1
H NMR (400 MHz, CDCl3) δ 6.91 (d, J = 15.3 Hz, 1H, CH Fum), 6.75 (d, J = 
15.3 Hz, 1H, CH Fum), 6.60 (s, 1H, NH), 4.24 (q, J = 7.1 Hz, 2H, CH2 Et), 2.42 (hept, J = 6.9 
Hz, 1H, βCH), 1.63 (s, 3H, βCH3), 1.47 (s, 9H, OtBu), 1.31 (t, J = 7.1 Hz, 3H, CH3 Et), 1.01 
(d, J = 7.0 Hz, 3H, γCH3), 0.90 (d, J = 6.9 Hz, 3H, γCH3). 
13
C NMR (101 MHz, CDCl3) δ 
172.57, 165.74, 162.55, 137.31, 130.19, 82.56, 64.33, 61.29, 34.17, 28.08, 19.28, 17.75, 
17.67, 14.29. 
OEt-Fum-Val-OtBu (4b). Monoethyl fumarate (1.0 g, 6.9 mmol) and HOAt (940 mg, 7 
mmol) were dissolved in 15 mL of dry CH2Cl2. The suspension was cooled to 0 °C and 
EDC∙HCl (1.3 g, 6.9 mmol) was added. H-Val-OtBu∙HCl (1 g, 4.8 mmol) and TEA (2 mL, 14 
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mmol) were dissolved in 10 mL of dry CH2Cl2 and added to the active ester solution. The 
reaction mixture was stirred overnight at r.t. The solvent was removed under reduced pressure 
and the residue dissolved in EtOAc. The organic phase was washed with KHSO4(aq) 5%, 
NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and concentrated. The crude was purified 
via flash chromatography (eluant: petroleum ether/EtOAc increasing the solvent mixture 
polarity from 95:5 to 9:1). The product was obtained as a white solid (1.2 g, 84 % yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C15H25NO5K ([M+K]
+
) 338.1370, found 338.1361. [ ] 
   
= -32.5 (c 1, MeOH). Mp 105-107 °C. FT-IR ῡmax 3310, 2971, 1728, 1667, 1645, 1538, 1368, 
1299, 1225, 1158 cm
-1
. 
1
H NMR (400 MHz, CDCl3) δ 6.97 (d, J = 15.4 Hz, 1H, CH Fum), 
6.82 (d, J = 15.4 Hz, 1H, CH Fum), 6.42 (d, J = 8.6 Hz, 1H, NH), 4.55 (dd, J = 8.7, 4.4 Hz, 
1H, αCH), 4.24 (q, J = 7.1 Hz, 2H, CH2 Et), 2.28-2.12 (m, 1H, βCH), 1.47 (s, 9H, OtBu), 1.31 
(t, J = 7.1 Hz, 3H, CH3 Et), 0.93 (dd, J = 9.6, 7.0 Hz, 6H, 2x γCH3). 
13
C NMR (101 MHz, 
CDCl3) δ 170.89, 165.62, 163.48, 136.13, 130.97, 82.59, 61.35, 57.68, 31.80, 28.15, 18.97, 
17.79, 14.28. 
OH-Fum-(αMe)Val-OtBu (5a). 4a (500 mg, 1.6 mmol) was dissolved in 30 mL of THF and 
a solution of LiOH (260 mg, 10.8 mmol) in 10 mL of H2O was added. The solution was 
stirred at r.t. until TLC indicated complete consumption of the starting material. The organic 
solvent was removed under reduced pressure and the aqueous residue was diluted with 10 mL 
of H2O. The aqueous solution was acidified with HCl 1M and extracted with EtOAc (3v). The 
combined organic phases were washed with KHSO4(aq) 5%, brine, dried over MgSO4, filtered 
and concentrated under reduced pressure. The compound was recovered as a white solid (400 
mg, 88 % yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C14H23NO5Na ([M+Na]
+
) 308.1474, found 308.1477. 
[ ] 
   = -38.4 (c 1, MeOH). Mp 213-215 °C. FT-IR ῡmax 3297, 2975, 1727, 1640, 1534, 1368, 
1276, 1147 cm
-1
. 
1
H NMR (500 MHz, MeOD) δ 8.42 (s, 1H, NH), 7.11 (d, J = 15.5 Hz, 1H, 
CH Fum), 6.64 (d, J = 15.5 Hz, 1H, CH Fum), 2.13-2.03 (m, 1H, βCH), 1.44 (s, 9H, OtBu), 
1.42 (s, 3H, βCH3), 1.01 (d, J = 6.9 Hz, 3H, γCH3), 0.95 (d, J = 6.9 Hz, 3H, γCH3). 
13
C NMR 
(101 MHz, MeOD) δ 173.48, 168.52, 165.68, 137.85, 131.35, 82.35, 64.55, 35.87, 28.20, 
17.71, 17.53, 17.50. 
OH-Fum-Val-OtBu (5b). 4b (1.1 g, 3.8 mmol) was dissolved in 30 mL of THF and a 
solution of LiOH (560 mg, 23 mmol) in 10 mL of H2O was added. The solution was stirred at 
r.t. until TLC indicated complete consumption of the starting material. The organic solvent 
was removed under reduced pressure and the aqueous residue was diluted with water. The 
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aqueous solution was acidified with HCl 1M. The successive day, the compound crystalized 
from the solution was recovered by filtration as a white solid (849 mg, 85 % yield). 
HRMS (ESI
+
, MeOH) m/z calcd. for C13H21NO5Na ([M+Na]
+
) 294.1317, found 294.1331. 
[ ] 
   = -36 (c 1, MeOH). Mp 170-172 °C. FT-IR ῡmax 3302, 2971, 1716, 1664, 1542, 1369, 
1151 cm
-1
. 
1
H NMR (400 MHz, CDCl3) δ 7.10 (d, J = 15.4 Hz, 1H, CH Fum), 7.02 (d, J = 9.0 
Hz, 1H, NH), 6.85 (d, J = 15.4 Hz, 1H, CH Fum), 4.63 (dd, J = 9.0, 4.4 Hz, 1H, αCH), 2.26-
2.18 (m, 1H, βCH), 1.48 (s, 9H, OtBu), 0.94 (dd, J = 12.6, 6.9 Hz, 6H, 2x γCH3). 
13
C NMR 
(101 MHz, CDCl3) δ 171.93, 169.18, 163.66, 137.97, 130.16, 83.28, 57.73, 31.86, 28.14, 
19.03, 17.68. 
Aib oligomers 
N3-Aib-OtBu. tert-Butyl α-bromoisobutyrate (12.5 mL, 67 mmol) was dissolved in dry DMF 
(65 mL) under N2 atmosphere. Sodium azide (6.65 g, 102 mmol) was added and the resulting 
solution stirred at r.t. for 72 h. The reaction mixture was diluted with water (30 mL), acidified 
to pH = 2 with HCl 1 M and extracted with tert-butyl methyl ether (2x 75 mL). The combined 
organic phase was washed with HCl 1 M (4x 20 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The pure product was recovered as a pale yellow oil 
(9.8 g, 80%). 
1
H NMR (500 MHz, CDCl3) 1.49 (9H, s, OtBu), 1.41 (6H, s, 2x βCH3). All 
other data consistent with that previously reported in the literature. 
H-Aib-OtBu. N3AibOtBu (9.8 g, 53 mmol) was dissolved in MeOH (50 mL) under a N2 
atmosphere. Pd/C (850 mg) was carefully added and the reaction mixture stirred under an H2 
atmosphere for 24 h. The mixture was filtered through a pad of Celite, washed with MeOH 
and the filtrate concentrated under reduced pressure. The compound was recoverd as a pale 
yellow oil (7.35 g, 87%). 
1
H NMR (500 MHz, CDCl3) δ 1.62 (s, 1H, NH2), 1.43 (s, 9H, 
OtBu), 1.27 (s, 6H, 2x βCH3). All other spectroscopic data consistent with that previously 
reported in the literature.
[32]
 
N3-Aib-OH. α-Bromoisobutyric acid (15 g, 90 mmol) was dissolved in dry DMF (80 mL) 
under N2 atmosphere. Sodium azide (8.7 g, 134 mmol) was added and the resulting solution 
stirred at r.t. for 72 h. The reaction mixture was diluted with water (30 mL), acidified to pH = 
2 with HCl 1 M and extracted with tert-butyl methyl ether (2x 75 mL). The combined organic 
phase was washed with HCl 1 M (4x 20 mL), dried over MgSO4, filtered and concentrated 
under reduced pressure. The pure product was recovered as a colourless oil (10.2 g, 88%). 
1
H 
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NMR (400 MHz, CDCl3) δ 10.47 (1H, br s, OH), 1.49 (s, 6H, 2x βCH3). All other data 
consistent with that previously reported in the literature.
[24]
 
α-Azidoisobutyryl chloride (AzibCl).[10b] N3Aib-OH (7 g, 54 mmol) was dissolved in dry 
CH2Cl2 (12 mL). SOCl2 (7.8 mL, 107 mmol) was added dropwise and the resulting solution 
stirred at reflux for 3 h. The mixture was concentrated and then distilled under reduced 
pressure to give the acid chloride as a colourless oil (6.15 g, 78%), that was used immediately. 
N3-Aib2-OtBu.
[10b]
 H-AibOtBu (6 g, 37.7 mmol) was dissolved in dry CH2Cl2 under N2 
atmosphere (25 mL) and TEA (7 mL, 50 mmol) was added. The solution was cooled to 0 °C 
and a solution of freshly distilled AzibCl (6.15 g, 41.7 mmol) in dry CH2Cl2 (8 mL) was 
added dropwise. The mixture was stirred at r.t. for 24 h. The reaction mixture was 
concentrated under reduced pressure. The residue was dissolved in EtOAc, washed with 
KHSO4(aq) 5%, NaHCO3(aq) 5% and brine. The organic phase was dried over MgSO4, filtered 
and concentrated. The crude was purified via flash chromatography (eluant: petroleum 
ether/EtOAc 95:5). The product was obtained as a waxy solid (8.5 g, 84 % yield). 
1
H NMR (400 MHz, CDCl3) δ 7.04 (1H, s, NH), 1.45 (12H, s, 4x βCH3), 1.39 (9H, s, 3x CH3 
OtBu). Data consistent with that reported in the literature.
[10b]
 
H-Aib2-OtBu.
[10b]
 N3Aib2OtBu (7.18 g, 26.5 mmol) was dissolved in EtOH (50 mL) under a 
N2 atmosphere. Pd/C (10%, 650 mg) was carefully added and the reaction mixture stirred 
under an atmosphere of H2 for 24 h. The mixture was filtered through a pad of Celite, washed 
with EtOH and the filtrate concentrated under reduced pressure. The compound was 
recovered as a white solid (6.2 g, 96%). 
1
H NMR (500 MHz, CDCl3) δ 8.07 (1H, s, NH), 1.53 
(2H, br s, NH2), 1.50 (6H, s, 2x βCH3), 1.44 (9H, s, 3x CH3 OtBu), 1.33 (6H, s, 2x βCH3). 
Data consistent with that reported in the literature.
[10b]
 
N3-Aib3-OtBu.
[10b]
 H-Aib2OtBu (4.15 g, 17 mmol) was dissolved in dry CH2Cl2 under N2 
atmosphere (25 mL) and TEA (4 mL, 28.7 mmol) was added. The solution was cooled to 0 °C 
and a solution of freshly distilled AzibCl (3 g, 20.3 mmol) in dry CH2Cl2 (8 mL) was added 
dropwise. The mixture was stirred at r.t. for 24 h. The reaction mixture was concentrated 
under reduced pressure. The residue was dissolved in EtOAc, washed with KHSO4(aq) 5%, 
NaHCO3(aq) 5% and brine. The organic phase was dried over MgSO4, filtered and 
concentrated. The crude was purified via flash chromatography using as eluent the solvent 
mixture petroleum ether/EtOAc 9:1 → 8:2. The product was obtained as a white solid (4.2 g, 
70 % yield). 
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1
H NMR (500 MHz, CDCl3) δ 7.19 (1H, s, NH), 6.97 (1H, s, NH), 1.55 (6H, s, 2x βCH3), 
1.53 (6H, s, 2x βCH3), 1.52 (6H, s, 2x βCH3), 1.45 (9H, s, OtBu). Data consistent with that 
reported in the literature.
[10b]
 
H-Aib3-OtBu.
[10b]
 N3Aib3OtBu (4.14 g, 11.7 mmol) was dissolved in EtOH (50 mL) under a 
N2 atmosphere. Pd/C (10%, 450 mg) was carefully added and the reaction mixture stirred 
under an atmosphere of H2 for 24 h. The mixture was filtered through a pad of Celite, washed 
with EtOH and the filtrate concentrated under reduced pressure. The compound was 
recovered as a white solid (3.7 g, 96%). 
1
H NMR (500 MHz, CDCl3) δ 8.16 (1H, s, NH), 7.46 
(1H, s, NH), 1.73 (2H, br s, NH2), 1.53 (6H, s, 2x βCH3), 1.49 (6H, s, 2x βCH3), 1.44 (9H, s, 
OtBu), 1.36 (6H, s, 2x βCH3). Data consistent with that reported in the literature.
[10b]
 
N3-Aib4-OtBu.
[10b]
 H-Aib3-OtBu (3.83 g, 11.7 mmol) was dissolved in dry CH2Cl2 under N2 
atmosphere (15 mL) and TEA (3 mL, 21.5 mmol) was added. The solution was cooled to 0 °C 
and a solution of freshly distilled AzibCl (2.7 g, 18.2 mmol) in dry CH2Cl2 (8 mL) was added 
dropwise. The mixture was stirred at r.t. for 24 h. The reaction mixture was concentrated 
under reduced pressure. The residue was dissolved in EtOAc, washed with KHSO4(aq) 5%, 
NaHCO3(aq) 5% and brine. The organic phase was dried over MgSO4, filtered and 
concentrated. The residue was triturated in cold Et2O and the pure product was obtained as a 
white solid (4.2 g, 82 % yield). 
1
H NMR (500 MHz, CDCl3) δ 7.02 (1H, s, NH), 6.97 (1H, s, NH), 6.47 (1H, s, NH), 1.52 
(6H, s, 2x βCH3), 1.51 (6H, s, 2x βCH3), 1.50 (6H, s, 2x βCH3), 1.47 (6H, s, 2x βCH3), 1.43 
(9H, s, OtBu). Data consistent with that reported in the literature.
[10b]
 
N3-Aib4-OH.
[10b]
 N3-Aib4-OtBu (1 g, 2.3 mmol) was treated with a 1:1 mixture of 
TFA/CH2Cl2 (10 mL). After stirring for 1 h, the solution was concentrated under reduced 
pressure and the residue suspended in Et2O. The compound was recovered by filtration as a 
white solid (790 mg, 91%). 
1
H NMR (400 MHz, CDCl3) δ 7.41 (s, 1H, NH), 7.04 (s, 1H, 
NH), 6.51 (s, 1H, NH), 1.56 (s, 6H, 2x βCH3), 1.53 (s, 6H, 2x βCH3), 1.49 (s, 6H, 2x βCH3), 
1.45 (s, 6H, 2x βCH3). Data consistent with that reported in the literature.
[10b]
 
N3-Aib4-GlyNH2.
[10a]
 N3-Aib4-OH (400 mg, 1 mmol) and HOAt (136 mg, 1 mmol) were 
dissolved in dry CH2Cl2. The resulting solution was cooled to 0 °C and EDC∙HCl (192 mg, 1 
mmol) was added. Then H-Gly-NH2∙HCl (230 mg, 2 mmol) and TEA (300 μL, 2 mmol) were 
added and the reaction mixture was stirred at r.t. for 4 d. The mixture was diluted with CH2Cl2 
washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and 
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concentrated under reduced pressure. The organic phase was washed with KHSO4(aq) 5%, 
NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and concentrated. After purification via 
flash chromatography (eluent: CH2Cl2/MeOH 95:5, the product was obtained as a white solid 
(345 mg, 78 % yield). 
1
H NMR (500 MHz, CDCl3) δ 7.76 (1H, t, J=6.5, NH Gly), 7.44 (1H, s, NH), 7.42 (1H, br s, 
NH), 6.93 (1H, s, NH), 6.34 (1H, s, NH), 5.42 (1H, br s, NH), 3.92 (2H, d, J=6.5, CH2 Gly), 
1.53 (6H, s, 2x βCH3 Aib), 1.52 (6H, s, 2x βCH3 Aib), 1.48 (6H, s, 2x βCH3 Aib), 1.41 (6H, s, 
2x βCH3 Aib). Data consistent with that reported in the literature.
[10a]
 
H-Aib4-GlyNH2.
[10a]
 N3Aib4-GlyNH2 (200 mg, 0.45 mmol) was dissolved in EtOH (20 mL) 
under a N2 atmosphere. Pd/C (10%, 30 mg) was carefully added and the reaction mixture 
stirred under an atmosphere of H2 for 24 h. The mixture was filtered through a pad of Celite, 
washed with EtOH and the filtrate concentrated under reduced pressure. The compound was 
recovered as a white solid (181 mg, 97%). 
1
H NMR (400 MHz, MeOD) δ 3.79 (2H, s, CH2 
Gly), 1.60 (6H, s, 2x βCH3 Aib), 1.49 (6H, s. 2x βCH3 Aib), 1.44 (6H, s, 2x βCH3 Aib), 1.39 
(6H, s, 2x βCH3 Aib). Data consistent with that reported in the literature.
[10a]
 
N3-Aib4-OMe. N3-Aib4-OH (400 mg, 1 mmol) was dissolved in 7.5 mL of THF/MeOH 3:2 
solution and a solution of TMSCHN2 2M in hexane (1.2 mL, 2.4 mmol) was added dropwise. 
The solution was stirred at r.t. for 3 h. Few drops of acetic acid were added and the solvent 
was removed under reduced pressure. The residue was dissolved in EtOAc, then washed with 
NaHCO3(aq) and 5%, brine. The organic phase was dried over MgSO4, filtered and 
concentrated. The crude was purified via flash chromatography (eluant: EtOAc/petroleum 
ether 65:35). The product was recovered as a white solid (300 mg, 72% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.15 (s, 1H, NH), 6.90 (s, 1H, NH), 6.24 (s, 1H, NH), 3.69 (s, 
3H, OMe), 1.53 (s, 6H, 2x βCH3 Aib), 1.50 (s, 12H, 4x βCH3 Aib), 1.47 (s, 6H, 2x βCH3 
Aib). Data consistent with that reported in the literature.
[33]
 
H-Aib4-OMe. N3-Aib4-OMe (300 mg, 0.75 mmol) was dissolved in 10 mL of EtOH under a 
nitrogen atmosphere. Pd/C (30 mg) was carefully added and the reaction mixture stirred under 
H2 atmosphere until TLC indicated complete conversion (24 h). The catalyst was removed by 
filtration through a pad of Celite and the filtrate concentrated under reduced pressure to yield 
the product as a white solid (270 mg, 97% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C17H33N4O5 ([M+H]
+
) 373.2451, found 373.2438. Mp 
150-151 °C. FT-IR ῡmax 3314, 2985, 1732, 1650, 1507, 1418, 1154 cm
-1
. 
1
H NMR (400 MHz, 
CDCl3) δ 8.13 (s, 1H, NH), 7.42 (s, 1H, NH), 6.37 (s, 1H, NH), 3.69 (s, 3H, OMe), 1.79 (s br, 
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2H, NH2), 1.51 (s, 6H, 2x βCH3 Aib), 1.48 (s, 6H, 2x βCH3 Aib), 1.46 (s, 6H, 2x βCH3 Aib), 
1.37 (s, 6H, 2x βCH3 Aib). 
13
C NMR (101 MHz, CDCl3) δ 178.05, 175.46, 173.60, 172.78, 
56.70, 56.65, 56.09, 55.06, 52.35, 28.93, 25.51, 25.24, 24.83. 
N3-Aib8-OMe. N3-Aib4-OH (150 mg, 0.4 mmol) was dissolved in 5 mL of dry CH2Cl2 and 
EDC∙HCl (75 mg, 0.4 mmol) was added. The solution was stirred at r.t. for 1 h. The solvent 
was removed under reduced pressure and the residue dissolved in EtOAc. The organic 
solution was washed with KHSO4, brine, dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude oxazolone was then placed under high vacuum before being 
dissolved in dry CH3CN. Then H-Aib4-OMe (140 mg, 0.37 mmol) was added. The reaction 
was stirred under reflux for 5 d under N2. The white precipitated was collected by filtration, 
yielding the compound as a white solid (170 mg, 60% yield). 
1
H NMR (400 MHz, CDCl3) δ 7.56 (s, 1H, NH), 7.52 (s, 1H, NH), 7.48 (s, 1H, NH), 7.45 (s, 
1H, NH), 7.34 (s, 1H, NH), 6.92 (s, 1H, NH), 6.15 (s, 1H, NH), 3.71 (s, 3H, OMe), 1.56 (s, 
6H, 2x βCH3), 1.53 (s, 6H, 2x βCH3), 1.52 (s, 6H, 2x βCH3), 1.50 (s, 6H, 2x βCH3), 1.48 (s, 
6H, 2x βCH3), 1.46 (s, 12H, 4x βCH3), 1.43 (s, 6H, 2x βCH3). 
Functionalized Aib oligomers 
OtBu-(αMe)Val-Fum-Aib4-Gly-NH2 (6a). 5a (140 mg, 0.49 mmol) and HOAt (70 mg, 0.51 
mmol) were dissolved in CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (94 mg, 
0.49 mmol) was added. After complete dissolution H-Aib4-Gly-NH2 (150 mg, 0.36 mmol) 
and DIPEA (100 μL, 0.57 mmol) were added and the reaction mixture stirred overnight at r.t. 
The solvent was removed under reduced pressure and the residue dissolved in EtOAc. The 
organic phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, 
filtered and concentrated. The crude was purified via flash chromatography (eluant: 
CH2Cl2/MeOH 92:8). The product was obtained as a white solid (190 mg, 77% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C32H55N7O9Na ([M+Na]
+
) 704.3959, found 704.3976. 
[ ] 
   = -8.5 (c 1, MeOH). Mp 263-265 °C. FT-IR ῡmax 3293, 2930, 1654, 1537, 1468, 1383, 
1364 cm
-1
. 
1
H NMR (500 MHz, CD3CN) δ 7.80 (s, 1H, NH Aib
3
), 7.79 (t, J = 6.5 Hz, 1H, NH 
Gly), 7.64 (s, 1H, NH Aib
4
), 7.43 (s, 1H, NH Aib
1
), 7.14 (s, 1H, NH Aib
2
), 7.11 (s br, 1H, 
NHa GlyNH2), 6.95 (d, J = 15.0 Hz, 1H, CH Fum), 6.90 (s, 1H, NH αMeVal), 6.85 (d, J = 
15.0 Hz, 1H, CH Fum), 5.65 (s, 1H, NHb GlyNH2), 3.67 (d, J = 6.4 Hz, 2H, CH2 Gly), 2.10-
2.06 (m, 1H, βCH αMeVal), 1.45 (s, 6H, 2x βCH3 Aib), 1.44 (s, 6H, 2x βCH3 Aib), 1.43 (s, 
6H, 2x βCH3 Aib), 1.41 (s, 9H, OtBu), 1.40 (s, 3H, βCH3 αMeVal), 1.35 (s, 5H, 2x βCH3 
Aib), 0.99 (d, J = 6.9 Hz, 3H, γCH3 αMeVal), 0.92 (d, J = 6.9 Hz, 3H, γCH3 αMeVal). 
13
C 
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NMR (101 MHz, CD3CN) δ 177.07, 176.60, 176.27, 175.30, 173.24, 172.59, 165.62, 164.18, 
134.74, 132.98, 81.41, 64.04, 57.72, 57.54, 57.51, 57.48, 43.60, 35.49, 28.07, 25.54, 25.21, 
25.10, 24.91, 17.67, 17.55, 17.44. 
Synthesis of OtBu-(αMeVal)-Fum-Aib8-Gly-NH2 (6b). OtBu-(αMe)Val-Mal-Aib4-OH (100 
mg, 0.16 mmol) was dissolved in 4 mL of dry CH2Cl2 and EDC∙HCl (38 mg, 0.2 mmol) was 
added. The solution was stirred at r.t. for 1 h. The solvent was removed under reduced 
pressure and the residue dissolved in EtOAc. The organic solution was washed with KHSO4, 
brine, dried over MgSO4, filtered and concentrated under reduced pressure The crude 
oxazolone was then placed under high vacuum before being dissolved in CH3CN. Then H-
Aib4-Gly-NH2 (100 mg, 0.24 mmol) was added. The reaction was stirred under reflux for 5 d. 
The solution was diluted with CH2Cl2 and the precipitate was recovered by filtration. After 
purification by flash chromatography (eluant: CH2Cl2/MeOH 95:5), the pure product was 
recovered as a white solid (55 mg, 33 % yield). 
HRMS (ES
+
 MeOH) m/z calcd. for C48H83N11O13Na ([M+Na]
+
) 1044.6064, found 1044.6060. 
[ ] 
   = -5.3 (c 1, MeOH). Mp decompose >270 °C. FT-IR ῡmax 3289, 2981, 1657, 1539, 
1384, 1363, 1228 cm
-1
. 
1
H NMR (500 MHz, CD3CN) δ 7.84 (m, 2H, 2x NH), 7.81 (s, 1H, 
NH), 7.79 (m, 3H, NH), 7.66 (s, 1H, NH), 7.51 (s, 1H, NH), 7.20 (s, 1H, NH), 7.12 (s, 1H, 
NH), 6.96 (d, J = 15.0 Hz, 1H, CH Fum), 6.91 (s, 1H, NH), 6.87 (d, J = 15.0 Hz, 1H, CH 
Fum), 5.65 (s, 1H, NH), 3.67 (d, J = 5.7 Hz, 2H, CH2 Gly), 2.08 (m, 1H, βCH αMeVal), 1.48 
(s, 6H, 2x βCH3 Aib), 1.45 (s, 6H, 2x βCH3 Aib), 1.44 (s, 18H, 6x βCH3 Aib), 1.43 (s, 6H, 2x 
βCH3 Aib), 1.42 (s, 6H, 2x βCH3 Aib), 1.41 (s, 9H, OtBu), 1.40 (s, 3H, βCH3 αMeVal), 1.36 
(s, 6H, 2x βCH3 Aib), 0.99 (d, J = 6.9 Hz, 3H, γCH3 αMeVal), 0.92 (d, J = 6.9 Hz, 3H, γCH3 
αMeVal). 13C NMR (101 MHz, CD3CN) δ 177.32, 177.09, 176.98, 176.95, 176.94, 176.30, 
175.39, 173.22, 172.56, 165.66, 164.18, 134.75, 132.99, 81.44, 64.07, 57.72, 57.57, 57.48, 
57.43, 57.33, 57.30, 57.27, 43.61, 35.47, 28.06, 25.19, 17.76, 17.53, 17.42. 
OtBu-Val-Fum-Aib4-Gly-NH2 (6c). 5b (65 mg, 0.24 mmol) and HOAt (35 mg, 0.26 mmol) 
were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (46 mg, 0.24 
mmol) was added. After complete dissolution H-Aib4-Gly-NH2 (50 mg, 0.12 mmol) and 
DIPEA (60 μL, 0.34 mmol) were added and the reaction mixture stirred overnight at r.t. The 
solvent was removed under reduced pressure and the residue dissolved in EtOAc. The organic 
phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and 
concentrated. The crude was purified via flash chromatography (eluant: CH2Cl2/EtOH, 
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increasing the solvent mixture polarity from 95:5 to 9:1). The product was obtained as a white 
solid (40 mg, 50% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C31H53N7O9K ([M+K]
+
) 706.3542, found 706.3536. [ ] 
   
= -3 (c 1, MeOH). Mp 249-250 °C. FT-IR ῡmax 3292, 2932, 1642, 1537, 1472, 1420, 1363 cm
-
1
. 
1
H NMR (500 MHz, MeOD) δ 7.15 (d, J = 15.1 Hz, 1H, CH Fum), 6.99 (d, J = 15.1 Hz, 
1H, CH Fum), 4.30 (d, J = 5.8 Hz, 1H, αCH Val), 3.87-3.80 (m, 2H, AB system Gly), 2.21-
2.15 (m, 1H, βCH Val), 1.52 (s, 3H, βCH3 Aib), 1.51 (s, 3H, βCH3 Aib), 1.50 (s, 6H, 2x βCH3 
Aib), 1.48 (s, 9H, OtBu), 1.47 (s, 6H, 2x βCH3 Aib), 1.39 (s, 6H, 2x βCH3 Aib), 0.98 (d, J = 
6.9 Hz, 6H, 2x γCH3 Val). 
13
C NMR (126 MHz, MeOD) δ 178.10, 177.81, 176.22, 175.39, 
171.96, 166.79, 166.24, 134.39, 134.00, 82.95, 60.29, 58.17, 58.07, 57.83, 57.78, 43.72, 
31.81, 28.28, 25.69, 25.55, 25.16, 25.07, 19.51, 18.43. 
OtBu-(αMe)Val-Fum-Aib-OMe (8a). 5a (35 mg, 0.12 mmol) and HOAt (17 mg, 0.12 
mmol) were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (23 
mg, 0.12 mmol) was added. After complete dissolution H-Aib-OMe∙HCl (37 mg, 0.24 mmol) 
and DIPEA (65 μL, 0.37 mmol) were added and the reaction mixture stirred overnight at r.t. 
The solvent was removed under reduced pressure and the residue dissolved in EtOAc. The 
organic phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, 
filtered and concentrated. The product was obtained as a white solid after precipitation from 
EtOAc/petroleum ether (40 mg, 85% yield). 
HRMS (ES
+
 MeOH) m/z calcd. for C19H33N2O6 ([M+H]
+
) 385.2333, found 385.2403. Mp 
149-152 °C. FT-IR ῡmax 3351, 2978, 1730, 1649, 1533, 1367, 1335, 1283, 1152 cm
-1
. 
1
H NMR (500 MHz, CD3CN) δ 7.09 (s, 1H, NH Aib), 6.87 (d, J = 15.1 Hz, 1H, CH Fum), 
6.80 (s, 1H, NH αMeVal), 6.75 (d, J = 15.1 Hz, 1H, CH Fum), 3.62 (s, 3H, OMe), 2.05 (dt, J 
= 13.8, 6.9 Hz, 1H, βCH αMeVal), 1.44 (s, 6H, 2x βCH3 Aib), 1.40 (s, 9H, OtBu), 1.38 (s, 
3H, βCH3 αMeVal), 0.97 (d, J = 6.9 Hz, 3H, γCH3 αMeVal), 0.90 (d, J = 6.9 Hz, 3H, γCH3 
αMeVal). 13C NMR (101 MHz, CD3CN) δ 175.24, 172.67, 164.38, 134.40, 132.99, 81.43, 
64.06, 56.93, 52.78, 35.51, 28.15, 25.21, 17.87, 17.60, 17.47. 
OtBu-(αMe)Val-Fum-Aib2-OMe (8b). 5a (35 mg, 0.12 mmol) and HOAt (17 mg, 0.12 
mmol) were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (23 
mg, 0.12 mmol) was added. After complete dissolution H-Aib2-OMe (48 mg, 0.24 mmol) and 
DIPEA (22 μL, 0.12 mmol) were added and the reaction mixture stirred overnight at r.t. The 
solvent was removed under reduced pressure and the residue dissolved in EtOAc. The organic 
phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and 
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concentrated. The product was obtained as a white solid after precipitation from 
EtOAc/petroleum ether (45 mg, 80% yield). 
HRMS (ES
+
 MeOH) m/z calcd. for C23H40N3O7 ([M+H]
+
) 470.2871, found 470.2853. Mp 89-
90 °C. FT-IR ῡmax 3356, 2980, 1733, 1652, 1532, 1367, 1277, 1151 cm
-1
. 
1
H NMR (500 MHz, 
CD3CN) δ 7.02 (s, 1H, NH Aib
1
), 6.96 (s, 1H, NH Aib
2
), 6.88 (d, J = 15.0 Hz, 1H, CH Fum), 
6.81 (d, J = 15.1 Hz, 2H, CH Fum and NH αMeVal), 3.60 (s, 3H, OMe), 2.05 (dt, J = 13.7, 
6.8 Hz, 1H, βCH αMeVal), 1.42 (s, 6H, 2x βCH3 Aib), 1.40 (s, 9H, OtBu), 1.39 (s, 3H, βCH3 
αMeVal), 1.37 (s, 6H, 2x βCH3 Aib), 0.97 (d, J = 6.9 Hz, 3H, γCH3 αMeVal), 0.91 (d, J = 6.8 
Hz, 3H, γCH3 αMeVal). 
13
C NMR (101 MHz, CD3CN) δ 175.78, 174.25, 172.67, 164.49, 
164.46, 133.95, 133.89, 81.45, 64.07, 57.88, 56.77, 52.59, 35.54, 28.16, 25.23, 25.21, 17.88, 
17.60, 17.47. 
OtBu-(αMe)Val-Fum-Aib4-OMe (8c). 5a (230 mg, 0.81 mmol) and HOAt (110 mg, 0.81 
mmol) were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (155 
mg, 0.81 mmol) was added. After complete dissolution H-Aib4-OMe (200 mg, 0.54 mmol) 
and DIPEA (140 μL, 0.81 mmol) were added and the reaction mixture stirred overnight at r. t. 
The solvent was removed under reduced pressure and the residue dissolved in EtOAc. The 
organic phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, 
filtered and concentrated. The crude was purified via flash chromatography using as eluent 
94:6 CH2Cl2/MeOH. The product was obtained as a white solid (280 mg, 81% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C31H54N5O9 ([M+H]
+
) 640.3916, found 640.3922. [ ] 
   = 
-8.1 (c 1, MeOH). Mp 136-137 °C. FT-IR ῡmax 3309, 2983, 1728, 1645, 1530, 1457, 1385, 
1365, 1273, 1222, 1151, 732 cm
-1
. 
1
H NMR (500 MHz, CD3CN) δ 7.42 (s, 1H, NH Aib
4
), 7.37 (s, 1H, NH Aib
1
), 7.34 (s, 1H, 
NH Aib
3
), 7.01 (s, 1H, NH Aib
2
), 6.93 (d, J = 15.0 Hz, 1H, CH Fum), 6.89 (s, 1H, NH 
αMeVal), 6.84 (d, J = 15.0 Hz, 1H, CH Fum), 3.58 (s, 3H, OMe), 2.06 (dq, J = 13.7, 6.9 Hz, 
1H, βCH αMeVal), 1.42 (s, 6H, 2x βCH3 Aib
3
), 1.42 (s, 6H, 2x βCH3 Aib
1
), 1.40 (s, 9H, 
OtBu), 1.39 (s, 9H, 2x βCH3 Aib
4
 and βCH3 αMeVal), 1.31 (s, 6H, 2x βCH3 Aib
2
), 0.98 (d, J 
= 6.9 Hz, 3H, γCH3 αMeVal), 0.92 (d, J = 6.9 Hz, 3H, γCH3 αMeVal). 
13
C NMR (101 MHz, 
CDCl3) δ 175.85, 174.80, 173.66, 173.02, 172.43, 164.97, 163.10, 135.26, 131.82, 82.14, 
64.12, 57.48, 57.03, 56.92, 55.98, 52.32, 34.37, 29.85, 28.12, 25.65, 25.39, 25.05, 24.98, 
18.65, 17.70, 17.67, 1.17. 
OtBu-(αMe)Val-Fum-Aib8-OMe (8d). 5a (100 mg, 0.35 mmol) and HOAt (50 mg, 0.37 
mmol) were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (70 
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mg, 0.36 mmol) was added. After complete dissolution, H-Aib8-OMe (obtained after catalytic 
hydrogenation of N3-Aib8-OMe and immediately used, 140 mg, 0.2 mmol) and DIPEA (60 
μL, 0.36 mmol) were added and the reaction mixture stirred overnight at r.t. The solvent was 
removed under reduced pressure and the residue dissolved in EtOAc. The organic phase was 
washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and 
concentrated. The product was obtained as a white solid after precipitation from 
EtOAc/petroleum ether (150 mg, 77% yield). 
HRMS (ES
+
 MeOH) m/z calcd. for C47H82N9O13 ([M+H]
+
) 980.6027, found 980.6179. Mp 
172-175 °C. FT-IR ῡmax 3310, 2986, 2942, 1733, 1659, 1535, 1467, 1458, 1385, 1364, 1229, 
1152 cm
-1
. 
1
H NMR (400 MHz, CDCl3) δ 7.92 (s, 1H, NH), 7.85 (s, 1H, NH), 7.80 (s, 1H, 
NH), 7.75 (s, 2H, 2x NH), 7.72 (s, 1H, NH), 7.49 (s, 1H, NH), 7.27 (s, 1H, NH), 7.08 (s, 1H, 
NH), 6.95-6.73 (m, 2H, AB system CH2 Fum), 3.69 (s, 3H, OMe), 2.34 (dt, J = 14.1, 6.9 Hz, 
1H, βCH αMeVal), 1.78 (s, 12H, 4x βCH3 Aib), 1.57 (s, 3H, βCH3 αMeVal), 1.52 (s, 12H, 4x 
βCH3 Aib), 1.49 (s, 12H, 4x βCH3 Aib), 1.47 (s, 15H, OtBu and 2x βCH3 Aib), 1.41 (s, 6H, 
2x βCH3 Aib), 1.02 (d, J = 6.8 Hz, 3H, γCH3 αMeVal), 0.93 (d, J = 6.8 Hz, 3H, γCH3 
αMeVal). 13C NMR (101 MHz, CDCl3) δ 176.49, 176.18, 176.09, 175.72, 175.22, 175.19, 
174.69, 172.47, 165.44, 81.97, 64.11, 57.41, 56.99, 56.87, 56.73, 56.70, 56.26, 52.42, 34.47, 
28.16, 25.12, 24.93, 18.83, 17.76. 
OtBu-(αMe)Val-Mal-Aib4-Gly-NH2 (7a). A solution of 6a (30 mg, 0.044 mmol) in 3 mL of 
MeOH was irradiated in a quartz cuvette at 254 nm for 2 h. The solvent was removed under 
reduced pressure obtaining the crude product. Pure compound 7a was obtained by 
semipreparative HPLC, after freeze-drying as a white solid. 
FT-IR ῡmax 3289, 2922, 1650, 1539, 1468, 1383, 1364 cm
-1
. 
1
H NMR (500 MHz, CD3CN) δ 
8.61 (s, 1H, NH Aib
2
), 7.84 (s, 1H, NH Aib
3
), 7.82 (t, J = 6.2 Hz, 1H, NH Gly), 7.70 (s, 1H, 
NH Aib
4
), 7.46 (s, 1H, NH Aib
1
), 7.10 (s br, 1H, GlyNH2), 7.05 (s, 1H, NH αMeVal), 6.29 (d, 
J = 12.0 Hz, 1H, CH Mal), 6.20 (d, J = 12.0 Hz, 1H, CH Mal), 5.64 (s, 1H, GlyNH2), 2.11-
2.06 (m, 1H, βCH αMeVal), 1.44 (s, 12H, OtBu and βCH3 Aib), 1.43 (s, 3H, βCH3 Aib), 1.42 
(s, 3H, βCH3 Aib), 1.41 (s, 6H, 2x βCH3 Aib), 1.38 (s, 3H, βCH3 αMeVal), 1.36 (s, 6H, 2x 
βCH3 Aib), 1.35 (s, 3H, βCH3 Aib), 0.99 (d, J = 6.9 Hz, 3H, γCH3 αMeVal), 0.92 (d, J = 6.9 
Hz, 3H, γCH3 αMeVal). 
13
C NMR (101 MHz, CD3CN) δ ppm 177.35, 176.93, 176.30, 
175.88, 173.26, 172.31, 168.69, 164.53, 136.05, 126.97, 81.63, 64.05, 57.71, 57.57, 57.33, 
43.60, 35.46, 28.19, 26.43, 26.17, 26.06, 24.66, 24.46, 24.33, 24.26, 17.52, 17.40, 17.37. 
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Maleamide derivatives 
OH-Mal-(αMe)Val-OtBu (Z5a). H-(αMe)Val-OtBu (150 mg, 0.8 mmol) was dissolved in 2 
mL of dry CH3CN and TEA (100 μL, 0.71 mmol) were added. Maleic anhydride (70 mg, 0.71 
mmol) was dissolved in 1 mL of dry CH3CN and added to the solution of the amino acid. The 
reaction mixture stirred overnight at r.t. The solvent was removed under reduced pressure and 
the residue dissolved in EtOAc. The organic phase was washed with KHSO4(aq) 5% and brine, 
dried over Na2SO4, filtered and concentrated. The product was obtained as a white solid (170 
mg, 74% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C14H24NO5 ([M+H]
+
) 286.1649, found 286.1703. Mp 
156-159 °C. FT-IR ῡmax 3306, 3002, 2980, 1727, 1712, 1632, 1593, 1558, 1490, 1368, 1147, 
858 cm
-1
. 
1
H NMR (500 MHz, CDCl3) δ 7.28 (s, 1H, NH), 6.36 (d, J = 12.8 Hz, 1H, CH Mal), 
6.29 (d, J = 12.9 Hz, 1H, CH Mal), 2.50-2.37 (m, 1H, βCH), 1.65 (s, 3H, βCH3), 1.49 (s, 9H, 
OtBu), 1.04 (d, J = 7.0 Hz, 3H, γCH3), 0.92 (d, J = 6.9 Hz, 3H, γCH3). 
13
C NMR (101 MHz, 
CDCl3) δ 171.71, 165.22, 164.68, 136.95, 131.52, 83.40, 65.32, 33.84, 27.88, 18.82, 17.53. 
OtBu-(αMe)Val-Mal-Aib-OMe (9a). 5a (50 mg, 0.17 mmol) and HOAt (23 mg, 0.17 mmol) 
were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (33 mg, 0.17 
mmol) was added. After complete dissolution H-Aib-OMe∙HCl (54 mg, 0.35 mmol) and 
DIPEA (90 μL, 0.52 mmol) were added and the reaction mixture stirred overnight at r.t. The 
solvent was removed under reduced pressure and the residue dissolved in EtOAc. The organic 
phase was washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine, dried over MgSO4, filtered and 
concentrated. The product was obtained as an oil (50 mg, 75% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C19H33N2O6 ([M+H]
+
) 385.2333, found 385.2435. FT-IR 
ῡmax 3280, 2978, 1748, 1729, 1671, 1620, 1578, 1548, 1368, 1286, 1263, 1149, 854 cm
-1
. 
1
H NMR (500 MHz, CD3CN) δ 8.94 (s, 1H, NH Aib), 8.70 (s, 1H, NH αMeVal), 6.12 (d, J = 
13.4 Hz, 1H, CH Mal), 6.06 (d, J = 13.4 Hz, 1H, CH Mal), 3.62 (s, 3H, OMe), 2.02 (dt, J = 
13.7, 6.9 Hz, 1H, βCH αMeVal), 1.44 (s, 3H, βCH3 Aib), 1.43 (s, 3H, βCH3 Aib), 1.40 (s, 9H, 
OtBu), 1.36 (s, 3H, βCH3 αMeVal), 0.98 (d, J = 6.9 Hz, 3H, γCH3 αMeVal), 0.91 (d, J = 6.9 
Hz, 3H, γCH3 αMeVal). 
13
C NMR (101 MHz, CD3CN) δ 175.15, 165.20, 134.14, 132.84, 
81.36, 64.09, 56.86, 52.76, 35.73, 28.15, 25.16, 25.08, 17.67, 17.61, 17.43. 
Carboxylic acids 
OtBu-(αMe)Val-Fum-Aib4-OH (10a). 8c (320 mg, 0.54 mmol) was dissolved in 15 mL of 
THF and a solution of LiOH (85 mg, 3.5 mmol) in 5 mL of water was added. The solution 
was stirred at 40°C for 24 h, until complete conversion (TLC). The organic solvent was 
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removed under reduced pressure and the aqueous phase was acidified with HCl 1M. The 
compound was extracted using EtOAc (3v). The organic phase was washed with KHSO4(aq) 
5% and brine, dried over MgSO4, filtered and concentrated under reduced pressure. The 
product was obtained as a white solid (230 mg, 73% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C30H51N5O9Na ([M+Na]
+
) 648.3579, found 648.3584. 
[ ] 
   = -8 (c 1, MeOH). Mp 152-154 °C. FT-IR ῡmax 3305, 2982, 1728, 1650, 1534, 1458, 
1385, 1260, 1225, 1151 cm
-1
. 
1
H NMR (400 MHz, CDCl3) δ 8.01 (s, 1H, NH), 7.89 (s, 1H, 
NH), 7.87 (s, 1H, NH), 7.23 (s, 1H, NH), 6.97 (s, 1H, NH), 6.87 (m, 2H, AB system CH2 
Fum), 2.40 (m, 1H, βCH αMeVal), 1.59 (s, 3H, βCH3 αMeVal), 1.56 (s, 6H, 2x βCH3 Aib), 
1.52 (s, 6H, 2x βCH3 Aib), 1.50 (s, 6H, 2x βCH3 Aib), 1.47 (s, 9H, OtBu), 1.43 (s, 6H, 2x 
βCH3 Aib), 1.01 (d, J = 6.7 Hz, 3H, γCH3 αMeVal), 0.91 (d, J = 6.7 Hz, 3H, γCH3 αMeVal). 
13
C NMR (101 MHz, CDCl3) δ 176.78, 175.75, 175.56, 174.53, 172.66, 165.39, 163.86, 
133.74, 133.07, 82.43, 64.30, 57.33, 56.97, 56.91, 34.21, 29.85, 28.11, 25.19, 24.85, 18.98, 
17.78, 17.73. 
OtBu-α-MeVal-Fum-Aib8-OH (10b). 8d (120 mg, 0.12 mmol) was dissolved in 10 mL of 
THF and a solution of LiOH (20 mg, 0.86 mmol) in 5 mL of water was added. The solution 
was stirred at 60 °C for 48 h, The solution was diluted with CH2Cl2 and the aqueous phase 
was acidified with HCl 1M. The compound was extracted using CH2Cl2 (3v). The organic 
phase was washed with KHSO4(aq) 5% and brine, dried over MgSO4, filtered and concentrated 
under reduced pressure. The crude was purified via flash chromatography (eluant: 
CH2Cl2/MeOH 93:7→8:2). The product was obtained as a white solid (80 mg, 68% yield). 
HRMS (ES
+
 MeOH) m/z calcd. for C46H80N9O13 ([M+H]
+
) 966.5870, found 966.6056. Mp 
190-193 °C. FT-IR ῡmax 3309, 2985, 2939, 1728, 1659, 1535, 1385, 1365, 1228 cm
-1
. 
1
H NMR (400 MHz, MeOD) δ 7.10 (d, J = 15.1 Hz, 1H, CH Fum), 6.92 (d, J = 15.1 Hz, 1H, 
CH Fum), 2.09 (dt, J = 13.6, 6.7 Hz, 1H, βCH αMeVal), 1.52 (s, 6H, 2x βCH3 Aib), 1.51 (s, 
6H, 2x βCH3 Aib), 1.49 (s, 6H, 2x βCH3 Aib), 1.48 (s br, 24H, 4x βCH3 Aib), 1.44 (s, 9H, 
OtBu), 1.42 (s, 3H, βCH3 αMeVal), 1.40 (s, 6H, 2x βCH3 Aib), 1.01 (d, J = 6.7 Hz, 3H, γCH3 
αMeVal), 0.96 (d, J = 6.7 Hz, 3H, γCH3 αMeVal). 
13
C NMR (101 MHz, MeOD) δ 177.63, 
177.48, 177.42, 177.15, 177.01, 176.74, 176.21, 173.54, 166.31, 166.02, 134.67, 133.75, 
82.33, 64.57, 57.95, 57.89, 57.83, 57.79, 57.73, 35.86, 28.24, 25.49, 25.14, 17.72, 17.69, 
17.56. 
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Helix-helix 
OEt-Fum-Aib4-Gly-NH2. Monoethyl fumarate (90 mg, 0.62 mmol) and HOAt (85 mg, 0.62 
mmol) were dissolved in dry CH2Cl2. The suspension was cooled to 0 °C and EDC∙HCl (120 
mg, 0.62 mmol) was added. After complete dissolution, H-Aib4-Gly-NH2 (130 mg, 0.31 
mmol) and TEA (90 μL, 0.65 mmol) were added and the reaction mixture stirred for 48 h at 
r.t. The precipitate collected and washed with CH2Cl2. The product was recovered after 
precipitation from MeOH/Et2O obtaining a white solid (100 mg, 60% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C24H40N6O8Na ([M+Na]
+
) 563.2805, found 563.2794. 
Mp 274-275 °C. FT-IR ῡmax 3264, 2985, 1720, 1652, 1533, 1455, 1386, 1363, 1281, 1223, 
1172 cm
-1
. 
1
H NMR (400 MHz, MeOD) δ 7.10 (d, J = 15.4 Hz, 1H, CH Fum), 6.74 (d, J = 
15.5 Hz, 1H, CH Fum), 4.26 (q, J = 7.1 Hz, 2H, CH2 Et), 3.83 (s, 2H, CH2 Gly), 1.50 (s, 6H, 
2x βCH3 Aib), 1.49 (s, 6H, 2x βCH3 Aib), 1.47 (s, 6H, 2x βCH3 Aib), 1.39 (s, 6H, 2x βCH3 
Aib), 1.31 (t, J = 7.1 Hz, 3H, CH3 Et). 
13
C NMR (101 MHz, MeOD) δ 178.09, 178.05, 
177.81, 176.09, 175.40, 166.79, 165.65, 137.58, 131.26, 62.32, 58.14, 58.03, 57.88, 57.79, 
43.68, 25.58, 25.27, 14.45. 
OH-Fum-Aib4-Gly-NH2 (16). OEt-Fum-Aib4-Gly-NH2 (70 mg, 0.13 mmol) was dissolved in 
6 mL of THF and a solution of LiOH (22 mg, 0.92 mmol) in 4 mL of water was added. The 
solution was stirred at r.t. for 1 h. The organic solvent was removed under reduced pressure 
and the aqueous phase was acidified with HCl 1M. After 24 h, the compound precipitated 
from the solution was recovered by filtration. The product was obtained as a white solid (50 
mg, 73% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C22H36N6O8Na ([M+Na]
+
) 535.2492, found 535.2493. Mp 
274-275 °C. FT-IR ῡmax 3300, 2986, 1659, 1537, 1386, 1224 cm
-1
. 
1
H NMR (400 MHz, MeOD) δ 7.07 (d, J = 15.4 Hz, 1H, CH Fum), 6.71 (d, J = 15.4 Hz, 1H, 
CH Fum), 3.83 (s, 2H, CH2 Gly), 1.50 (s, 6H, 2x βCH3 Aib), 1.49 (s, 6H, 2x βCH3 Aib), 1.47 
(s, 6H, 2x βCH3 Aib), 1.39 (s, 6H, 2x βCH3 Aib). 
13
C NMR (101 MHz, MeOD) δ 178.17, 
178.12, 178.11, 178.09, 177.92, 176.14, 175.41, 168.38, 165.86, 137.55, 131.85, 58.23, 58.14, 
57.85, 57.81, 43.68, 25.58, 25.30, 25.08. 
N3-Aib4-Ala-OtBu. N3-Aib4-OH (230 mg, 0.6 mmol) and HOAt (106 mg, 0.77 mmol) were 
dissolved in dry CH2Cl2. After cooling to 0 °C EDC∙HCl (120 mg, 0.6 mmol) was added. 
Then H-Ala-OtBu∙HCl (217 mg, 1.2 mmol) and TEA (250 μL, 1.8 mmol) were added and the 
reaction mixture stirred for 48 h at r.t. The reaction mixture was diluted with CH2Cl2 and 
washed with KHSO4(aq) 5%, NaHCO3(aq) 5%, brine. The organic phase was dried over MgSO4, 
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filtered and concentrated. The crude was purified via flash chromatography (eluant: 
CH2Cl2/MeOH 93:7), yielding the product as a white solid (260 mg, 85 % yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C23H41N7O6Na ([M+Na]
+
) 534.3016, found 534.3008. 
[ ] 
   = -53.1 (c 1, MeOH). Mp 164-166 °C. FT-IR ῡmax 3325, 2982, 2112, 1732, 1655, 1519, 
1457, 1382, 1365, 1223, 1152 cm
-1
. 
1
H NMR (400 MHz, MeOD) δ 4.19 (q, J = 7.3 Hz, 1H, αCH Ala), 1.53 (s, 3H; βCH3 Aib), 
1.52 (s, 6H, 2x βCH3 Aib), 1.49 (s, 3H, βCH3 Aib), 1.44 (s, 6H, 2x βCH3 Aib), 1.44 (s, 9H, 
OtBu), 1.42 (d, J = 7.4 Hz, 3H, βCH3 Ala), 1.39 (s, 3H, βCH3 Aib), 1.35 (s, 3H, βCH3 Aib). 
13
C NMR (101 MHz, MeOD) δ 177.21, 176.35, 176.25, 174.61, 173.64, 82.13, 64.75, 57.97, 
57.94, 57.80, 50.77, 28.22, 27.41, 26.74, 25.52, 24.53, 24.46, 24.17, 24.12, 23.91, 17.10. 
H-Aib4-Ala-OtBu (17). N3-Aib4-Ala-OtBu (210 mg, 0.41 mmol) was dissolved in 8 mL of 
EtOH under a nitrogen atmosphere. Pd/C catalyst (30 mg) was carefully added and the 
reaction mixture stirred under H2 atmosphere for 24 h. The catalyst was removed by filtration 
through a pad of Celite and the filtrate concentrated under reduced pressure to yield the 
product as a white solid (170 mg, 85% yield). 
HRMS (ES
+
, MeOH) m/z calcd. for  C23H43N5O6Na ([M+Na]
+
) 508.3111, found 508.3114. 
[ ] 
   = -52.3 (c 1, MeOH). Mp 179-181 °C. FT-IR ῡmax 3308, 2981, 1730, 1653, 1525, 1456, 
1382, 1363, 1226, 1165 cm
-1
. 
1
H NMR (400 MHz, MeOD) δ 4.20 (q, J = 7.3 Hz, 1H, αCH 
Ala), 1.52 (s, 3H, βCH3 Aib), 1.50 (s, 3H, βCH3 Aib), 1.44 (s, 15H, OtBu and 2x βCH3 Aib), 
1.42 (d, J = 7.4 Hz, 3H, βCH3 Ala), 1.40 (s, 3H, βCH3 Aib), 1.36 (s, 3H, βCH3 Aib), 1.33 (s, 
3H, βCH3 Aib), 1.32 (s, 3H, βCH3 Aib). 
13
C NMR (101 MHz, MeOD) δ 179.61, 177.26, 
176.62, 176.49, 173.66, 82.13, 57.96, 57.74, 57.40, 55.67, 50.75, 28.54, 28.23, 28.08, 27.43, 
26.83, 25.70, 24.20, 24.17, 24.00, 17.12. 
OtBu-Ala-Aib4-Fum-Aib4-Gly-NH2 (18). 16 (33 mg, 0.062 mmol) and HOAt (10 mg, 0.073 
mmol) were dissolved in dry CH2Cl2. After cooling to 0 °C EDC∙HCl (12 mg, 0.062 mmol) 
was added. Then 17 (35 mg, 0.072 mmol) and DIPEA (20 μL, 0.11 mmol) were added and 
the reaction mixture stirred for 48 h at r.t. The solid was recovered and washed with CH2Cl2. 
The crude product was purified via flash chromatography (eluant: CH2Cl2/MeOH 90:15). The 
product was recovered as a white solid (20 mg, 33 % yield). 
HRMS (ES
+
, MeOH) m/z calcd. for C45H78N11O13 ([M+H]
+
) 980.5781, found 980.5770. [ ] 
   
= +11 (c 0.1, MeOH). Mp >267 °C decompose. FT-IR ῡmax 3295, 2985, 1656, 1537, 1384, 
1364, 1226 cm
-1
.
1
H NMR (500 MHz, MeOD) δ 7.08 (s, 2H, CH2 Fum), 4.22 (q, J = 7.3 Hz, 
1H, αCH Ala), 3.83 (s, 2H, CH2 Gly), 1.53 (s, 3H, βCH3 Aib), 1.52 (s, 3H, βCH3 Aib), 1.51 
2. Short helical peptides 60 
(s, 12H, 4x βCH3 Aib), 1.50 (s, 3H, βCH3 Aib), 1.47 (s, 3H, βCH3 Aib), 1.47 (s, 6H, 2x βCH3 
Aib), 1.46 (s, 6H, 2x βCH3 Aib), 1.45 (s, 9H, OtBu), 1.44 (s, 3H, βCH3 Aib), 1.43 (d, J = 7.4 
Hz, 3H, βCH3 Ala), 1.38 (s, 3H, βCH3 Aib), 1.37 (s, 3H, βCH3 Aib), 1.34 (s, 3H, βCH3 Aib). 
 
Diastereoselection experiments 
Reactions of 5(4H)oxazolones with H-D,L-Val-OMe were performed in CH3CN or CH2Cl2 at 
controlled temperature using a thermostatic oil bath (20, 35, 45 and 70 °C). 
The carboxylic acid (10a-b or 11a-b) (0.05 mmol) was suspended in 5 mL of the appropriate 
solvent and EDC∙HCl (0.06 mmol) was added, and the solution stirred for 10 min at r.t. The 
quantitative formation of the oxazolone (12a-b or 13a-b) was controlled by HPLC. 
Separately H-D,L-Val-OMe∙HCl (0.31 mmol) and DIPEA (0.31 mmol) were suspended in 1 
mL of the appropriate solvent. 
In a typical experiment, the oxazolone solution (500 μL, 1 equiv.) and the racemate solution 
(125 μL, 8 equiv.) were mixed and the resulting solution was maintained under stirring in a 
thermostatic oil bath. The reaction was monitored by HPLC, by following the disappearance 
of the oxazolone accompanied by the formation of the two diastereomeric products. The 
formation of the two resulting peptides 15a-d (Z isomer) can be quantified directly by HPLC. 
Whereas in the case of 14a-d (E isomer), after the disappearance of the oxazolone reactant, 
the product mixture was irradiated at 254 nm and successively analyzed by HPLC. The 
independent preparation of each diastereomer was performed by reaction of the oxazolone 
with either D or L H-Val-OMe. 
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Table S1. Crystal data and structure refinement for 6a. 
 
Identification code  mc262b 
Empirical formula  C32 H55 N7 O9 
Formula weight  681.83 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P 21 21 21 
Unit cell dimensions a = 9.01420(14) Å α = 90°. 
 b = 10.94112(14) Å β = 90°. 
 c = 38.4416(6) Å  = 90°. 
Volume 3791.32(10) Å3 
Z 4 
Density (calculated) 1.195 Mg/m3 
Absorption coefficient 0.724 mm-1 
F(000) 1472 
Crystal size 0.25  0.20  0.05 mm3 
Theta range for data collection 2.299 to 70.959°. 
Index ranges -11  h  10, -13  k  12, -47  l  41 
Reflections collected 33257 
Independent reflections 7272 [R(int) = 0.0326] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.22453 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7272 / 0 / 433 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0406, wR2 = 0.1098 
R indices (all data) R1 = 0.0438, wR2 = 0.1126 
Absolute structure parameter 0.01(6) 
Largest diff. peak and hole 0.269 and -0.225 e.Å-3 
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Table S2. Selected torsion angles [°] for 6a. 
 
_________________________________________________________ 
Torsion angle 
__________________________________________________________ 
C1F-N6-C6A-C6 -58.4(3) 
N6-C6A-C6B1-C6G1 174.5(2) 
N6-C6A-C6B1-C6G2 -61.3(3) 
CT1-OT-C6-C6A 178.9(2) 
N6-C6A-C6-OT -47.9(3) 
C6A-N6-C1F-C2F -171.0(2) 
N6-C1F-C2F-C3F 159.6(3) 
C1F-C2F-C3F-C4F -174.6(3) 
C2F-C3F-C4F-N1 169.1(3) 
C3F-C4F-N1-C1A -176.2(2) 
C4F-N1-C1A-C1 -54.3(3) 
N1-C1A-C1-N2 -31.4(3) 
C1A-C1-N2-C2A -172.9(2) 
C1-N2-C2A-C2 -48.6(3) 
N2-C2A-C2-N3 -33.5(3) 
C2A-C2-N3-C3A -176.9(2) 
C2-N3-C3A-C3 -51.1(3) 
N3-C3A-C3-N4 -40.4(3) 
C3A-C3-N4-C4A -172.8(2) 
C3-N4-C4A-C4 -66.1(3) 
N4-C4A-C4-N5 -23.3(3) 
C4A-C4-N5-C5A 178.2(2) 
C4-N5-C5A-C5 66.2(4) 
N5-C5A-C5-NT -135.8(3) 
________________________________________________________________ 
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Table S3. Hydrogen bonds for 6a [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N3-H3...O2F 0.86 2.45 3.292(3) 168 
 N4-H4...O1 0.86 2.15 2.947(3) 155 
 N5-H5...O2 0.86 2.29 3.069(3) 151 
 N6-H6...O6#1 0.86 2.15 2.989(3) 164 
 N1-H1...O3#2 0.86 2.32 3.142(2) 161 
 N2-H2...O5#3 0.86 2.29 2.906(3) 128 
 NT-HT1...O3#4 0.86 2.37 3.197(4) 160 
 NT-HT2...O2#4 0.86 2.50 3.061(4) 124 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2, y-1/2, -z+1/2;   #2 x, y+1, z;    #3 x+1/2, -y+1/2, -z;  #4 x-1/2, -y-1/2, -z 
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3. Functionalized helical polypeptides: synthesis and self-assembly 
properties 
The construction of supramolecular architectures characterized by well-distinct shapes and 
functions is a relevant target in areas such as materials science, nanochemistry and 
biomimetic chemistry.
[1]
 The self-assembly process of polymers through non-covalent 
interactions, such as hydrogen bonding, van der Waals interactions, π–π stacking and 
hydrophobic interactions, has a great potential for creating such supramolecular 
architectures.
[2]
 Synthetic polypeptides are fascinating and unique for their ability to self-
assemble into ordered structures, making them attractive in those many applications where 
well-organized architectures are essential to accomplish a function.
[3]
 In fact they can self-
organize into highly ordered secondary structures, such as α-helix and β-sheets in solution 
phase or in solid state, same as those typically observed in proteins or peptides but 
inaccessible in other synthetic polymeric materials. Since in the past decade substantial 
progresses have been made in the synthesis of polypeptides via N-carboxyanhydrides 
(NCAs),
[4]
 recently several innovative polypeptide-based materials have been produced and 
studied.
[5]
 We chose the well-known rod-like α-helical polypeptide poly(γ-benzyl-L-
glutamate) (PBLG)
[6]
 and we explored the possibility to create self-assembled microstructures 
with different characteristics, shapes and functions from different PBLG-conjugates. In this 
chapter the results obtained after the functionalization of PBLG with carbon nanostructures, 
such as fullerene (C60)
[7]
 and carbon quantum dots (CQDs) will be discussed.
[8]
 Moreover the 
possibility to create “smart” supramolecular architectures was examined by the insertion of 
photoisomerizabile azobenzene moieties in PBLG systems.
[9]
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3.1 Poly(γ-Benzyl-L-Glutamate)-fullerene conjugates (PBLG-C60) 
Recently, thiol-ene click chemistry was successfully employed to prepare C60 (fullerene) 
polystyrene conjugates obtaining only the mono-addiction product.
[10]
 With the aim to 
synthesize mono and bis C60-PBLG conjugates (respectively 4 and 7, Scheme 3.1) and to 
study their self-assembly properties in water, we decided to apply a similar approach to 
functionalize PBLG via thiol-ene reaction. 
The first step of these studies was the synthesis of the PBLG with the thiol-group at the C-
terminus (1, Scheme 3.1). Thus BLG-NCA (1, 4 mmol) was polymerized in dioxane for 24 h 
at room temperature, using Trt-cysteamine 2 (Trt, triphenylmethyl) as initiator (0.04 mmol) 
(Scheme 3.1). Polymer 3 was obtained after precipitation with methanol in an 81% yield. 
Subsequently, the Trt-protecting group was removed under acidic conditions and the resulting 
polymer (0.01 mmol) was dissolved in DMF and added to toluene. Then, fullerene (0.05 
mmol) and AIBN (0.15 mmol) were added to the previous solution and the subsequent 
homogeneous mixture was heated at 90°C under stirring for 5 hrs. Subsequently, the solvent 
was removed and the resulting solid was suspended in DMF, passed through a 20 μm filter, 
and then precipitated by addition of methanol, giving polymer 4 as a brown solid in 85% 
yield. 
Scheme 3.1 Synthesis of polymers NH2-PBLG-C60 (4) and C60-PBLG-C60 (7). Reagents and 
Conditions: i) (tritylsulfanyl)ethanamine (2), dioxane, r.t., 24 h. ii) 50% TFA in CH2Cl2, TIS, 
r.t., 20 min. iii) C60, AIBN, DMF/toluene 2:8 (v/v), 90 °C, 5 h. iv) Trt-mercaptopropionic acid 
(5), EDC∙HCl, TEA, DMF, r.t. 48 h. 
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Moreover, polymer 4 was successively N-end capped with a large excess of pre-activated Trt-
mercaptopropionic acid (5), yielding polymer 6. Polymer 6 was C-terminus Trt-deprotected 
and placed to react in the same conditions described above for the synthesis of polymer 4, 
thus to generate the bis- conjugate C60-PBLG-C60, polymer 7 in 78 % yield. 
Since all the synthetized polymers possess the same PBLG part (as it comes from polymer 3), 
the differences in MWs determined by SEC constitute a first evidence for the addition of one 
or two fullerenes (Figure 3.1). 
Figure 3.1 Left: SEC traces of polymers 3, 4 and 7 in DMF solution. Right: table with 
molecular weights (Mw) and polydispersity index (PDI) determined for polymers 3, 4 and 7. 
A second evidence for the covalent attachment of fullerenes arises from the absorption spectra 
of 3, 4 and 7, which were recorded in THF solution (Figure 3.2 A). The observed patterns are 
close to that of fullerene, which shows high UV absorptions around λ=287, 330 nm and tails 
spanning over the 600 nm region. We assign the observed UV absorptions of mono (4) and 
bis (7) fullerene-conjugates to the fullerene moiety
[10]
 considering the small differences in the 
resonance frequencies with respect to the isolated fullerene due to perturbations of the 
electronic structure caused by the bonding with the PBLG polymer. The third indication of 
the formation of PBLG-conjugated fullerenes come from the thermal stability of 3, 4 and 7 
that was investigated via thermogravimetric analysis (TGA; 100-700 °C) under nitrogen flow 
with a heating rate of 10 °C min
-1
 (Figure 3.2 B). Accordingly, PBLG polymers undergo a 
thermal decomposition between 250-350 °C, whereas the thermally stable fullerene 
component keeps its stability up to almost 600 °C.
[10]
 The weight percentages of the 
components (polymer 4, C60/PBLG 4:96 %; polymers 7, C60/PBLG 7:93 %) determined by 
TGA are in agreement to those of SEC analysis. All of the experimental results suggested an 
average number of BLG amino acids, for polymer unit, close to 85. The secondary structure 
polymer MW PDI 
3 19100 1.11 
4 19550 1.09 
7 20300 1.11 
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of polymers 3, 4 and 7 was analyzed by CD (circular dichroism), which confirmed the 
preservation of the α-helical conformation for all the synthesized compounds (Figure 3.3), 
that in turn implies the rod-like shape of the polymers. 
Figure 3.2 (A) UV/Vis spectra of polymers 3, 4 and 7 in THF solution (concentration: 0.01 
mg/mL). (B) Thermogravimetric analysis comparison of polymers 3, 4 and 7. 
Figure 3.3 Comparison of CD spectra of polymers 3, 4 and 7 in HFIP solution. 
From polymer 4, doughnut-like morphologies were generated, in form of milk-like 
suspension, starting from a 20 mg (3:7, v/v) DMF/THF solution (10 mL) dialyzed (membrane 
cutoff, 12 KD) against ultrapure water for 48 hours (Figure 3.4). TEM (transmission electron 
microscopy) images showed toroidal shapes with an external diameter ranging between 200 
nm and 650 nm (Figures 3.4 A-B, stained and unstained samples, respectively), additionally 
confirmed by SEM (scanning electron microscopy) analysis (Figure 3.4 C). Moreover, AFM 
(atomic force microscopy) details of the selected nanodoughnut reported in Figure 3.4 D, 
4
7
3
4
3
7A B 
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revealed a diameter of 200 nm, a thickness of 70 nm and a hole of 30 nm (Figure 3.4 E). 
Additionally, after running the same self-assembly process but starting from a more dilute 
solution of 4 (2-5 mg in 10 mL), smaller but uniform in size (60 nm diameter) toroidal 
nanostructures were obtained as detected by AFM (Figure 3.4 F). 
Figure 3.4 TEM (A stained and B unstained, respectively) and SEM (C) images of the 
resulting self-assembled nanostructures obtained from polymer 4. (D and E) AFM micrograph 
and high-profile of the selected (1) toroidal nanostructure. (F) AFM image of toroid, obtained 
from a diluted solution of 4. 
Sphere-shaped aggregates were generated from polymer 7 under the same conditions 
described above for polymer 4 (Figure 3.5). TEM revealed the formation of deep-dark round 
morphologies (Figure 3.5 A) with diameters ranging between 250-700 nm. Moreover, these 
aggregates displayed an internal cavity as shown from the TEM image reported in Figure 3.5 
B; thus, the observed spherical morphologies can be attributed to hollow vesicle-like 
microstructures. These results were additionally confirmed by AFM (Figure 3.5 C) and SEM 
analyses (Figure 3.5 D). While polymers 4 and 7 were able to self-assemble into ordered 
structures, polymer 3, bearing a Trt group instead of fullerene, did not give any specific nano-
structuration under similar conditions. To get polymer 4 from 3, the Trt protecting group was 
removed in acidic conditions, thus in polymer 4 the N-terminus amine is protonated (NH3
+
). 
Importantly, when NaOH 0.2 M was added to a solution containing the toroidal objects 
obtained by self-assembly of 4, an immediate precipitation of the polymer was achieved. On 
the other hand, the addition of HCl 0.2 M did not affect the self-assembled structures, since 
doughnut-like structures could still be detected by TEM. This information suggested that: (i) 
F 
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fullerene is necessary for the formation of ordered nanostructures and (ii) the NH3
+
 group is 
mandatory for the formation of the toroid-shaped structures. 
Figure 3.5 (A and B) TEM (unstained) images of the resulting self-assembled nanostructures 
obtained from polymer 7. (C and D) AFM and SEM images, respectively, from the very same 
sample used for TEM analysis. 
Since, at fixed volume, a toroidal shape exposes a larger surface with respect to a spherical 
shape, our hypothesis is that in order to generate self-assembled toroid forms in water 
(starting from the hydrophobic polymer 4) the single polymer chain may firstly undergo a tail-
to-tail dimerization and successively a large scale, coil-coil spiral-like, self-assembly process. 
According to this hypothesis, all of the fullerenes could be aligned along an internal axle, thus 
to result buried by the PBLG hydrophobic helices, while the charged NH3
+
 groups may be 
exposed to water solution in accordance with previously reported similar, but much smaller, 
structures.
[11]
 This hypothesis is in agreement with the pH-depending experiments described 
above. 
In collaboration with Dr. M. Zerbetto (University of Padova), who performed the molecular 
dynamic simulations, calculus was used to support experimental observations and in 
particular to investigate the atomistic structure of the vesicles formed by polymer 7. 
To this purpose a bottom-up coarse graining protocol with the intent to set up a simulation 
able to independently recover the experimental observations was employed. To limit the 
computational weight of the whole procedure, a set of molecules of polymer 7 constituted by 
25 BLG units was used as a model. The coarse-graining representation sees each of the BLG 
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units and the two terminal moieties as single beads. Differently from other systems, in which 
a balance between attractive and repulsive forces of the building blocks drives the assembly, 
here the driving force of the self-assembly is the low affinity of the hydrophobic PBLG 
molecules with water. Thus, in these simulations the medium needs to be included explicitly 
to observe aggregation of polymer 7 molecules. A coarse-grained 4-water model for the 
solvent was employed, in which one bead is used to represent a cluster of 4 water molecules. 
A system containing 1600 polymer molecules and 1600608 water beads was simulated. In the 
starting configuration, the polymer molecules are randomly placed and oriented in space 
(Figure 3.6 A). 
Figure 3.6 (A) Initial random configuration of the 1600 PBLG molecules constituted by 25 
BLG amino acids. (B) Final configuration of the system after 5 ns of simulation time. (C) 
Details of a selected spherical aggregate with front and rear clipping planes applied to 
highlight the hollow part of the spherical aggregate. Water molecules have been omitted for 
clarity. The color scheme is: yellow to represent BLG beads, red for the N-terminal group, 
and blue for C-terminal group. 
After 5 ns of simulation time, the simulation box results populated by a small number of 
aggregates with different shapes (Figure 3.6 B). Most of them are spherical aggregates of 
dimensions ranging from 15 to 20 nm of diameter. However, a couple of assemblies are 
present showing a bent layer of about 4 nm of thickness (very close to the length of one 
polymer molecule) that can be thought to be a piece of a larger vesicle that could not be 
formed in this simulation due to an insufficient number of polymer molecules. A number of 
important observations can be drawn from the simulations. The first and most important 
observation reflecting the experiments is that in water the polymer molecules aggregate into 
ordered structures instead of creating an amorphous precipitate. Second, all the aggregates are 
formed by layers of limited size ranging from 4 to 6 nm, which is in the order of the length of 
the polymers. Third, the layer is not structured in a simple way as it happens in phospholipids: 
couples of polymers form coiled-coil super structures, which in turn create a network giving 
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origin to the layer, with the C60 termini preferentially exposed to the solvent. We shall also 
notice that, while being quite compact, the spherical structures obtained in the simulation are 
hollow (Figure 3.6 C). The obtained aggregates are in quite good accord with those observed 
experimentally. 
Conclusions 
We reported the one-pot synthesis of two novel PBLG-polymers C- and C/N-terminus capped 
with fullerenes, by means of thiol-ene chemistry. The self-assembly in water of such rod-like 
systems led to the formation of bulky, toroid-like or vesicle-like, nanostructures depending on 
the fullerene position over the main chain of the polymer. In conclusion, such polymer-
fullerene conjugates may be interesting systems to prepare organized, at nanoscale level, 
fullerene-based devices.  
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3.2 Poly(γ-Benzyl-L-Glutamate)-Carbon Quantum Dots conjugates 
(PBLG-CQDs) 
Carbon Quantum Dots (CQDs) are water-soluble carbon nanomaterials that show peculiar 
photoluminescence (PL) properties, such as multi-colour emission that varies with the 
excitation wavelength.
[12]
 Several procedures to prepare CQDs have been reported, according 
both to bottom-up
[13]
 and top-down
[14]
 approaches. Starting from natural precursors (e.g. 
carbohydrates, peanut skin, soy milk) and nitrogen-rich organic compounds using 
hydrothermal treatment it is possible to obtain CQDs with particular photoluminescence 
properties. CQDs can be prepared also from amino acids, which are abundant and inexpensive 
natural compounds, by microwave-assisted hydrothermal treatment.
[15]
 
We synthesized the starting CQDs by using arginine and 1,2-ethylendiamine precursors in 
order to maximize the number of available amine moieties with the aim to grow polymeric 
structures on the surface of CQDs (Figure 3.7 A). TEM analysis of the products (Figure 3.7 
C) revealed round particles of uniform size and a diameter of 1.4 ± 0.2 nm. High resolution 
TEM analysis (Figure 3.7 D) and Fast Fourier Transform (FFT) (Figure 3.7 D, inset) highlight 
an interplanar distance of 0.21 nm, compatible with the (0001) graphite facet. Elemental 
analysis yield 71.47% for C, 5.05% for H, 17.09% for N and 5.39% residual elements. 
Figure 3.7 (A) Schematic representation of CQDs synthesis. Reagents and conditions: (i) 
arginine and 1,2-ethylendiamine (1:1 mol/mol) in ultrapure water; (ii) domestic microwave, 
700 watt; (iii) dissolution in ultrapure water and centrifugation; (iv) lyophilisation; (v) 
dissolution in ultrapure water (left: under irradiation, visible-light; right: under irradiation, 
UV-light at 365 nm). (B) Hypothetic representation for the chemical structure of a single 
CQD. (C and D) TEM and HRTEM images of CQDs. 
B 
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MALDI analysis displayed a MW dispersion, as expected from the random combination of 
different atoms, centred at 1150 Da. Solid state FT-IR data are consistent with the presence of 
amines. XPS measurements were carried out to provide a deeper insight on the different 
chemical species introduced by the synthesis. The XPS survey spectrum reported in Figure 
3.8 A shows the C 1s, N 1s and O 1s photoemission lines centred at a binding energy (BE) of 
284.9 eV, 399.8 eV and 531.6 eV, respectively. The observed elemental composition (C 74.3 
%, N 18.8 % and O 6.9%) is in good agreement with that of the previous elemental analysis. 
The detailed scans of C 1s and N 1s lines were deconvoluted into single chemically-shifted 
components (Figures 3.8 B-C). 
The multicomponent analysis of the C 1s line confirms the presence of C-N bonds (285.2 eV) 
as well as that of several oxygen-bearing functional groups, such as C-O (286.5 eV), C=O 
(288.0 eV) and O-C=O (288.9 eV).
[16]
 The weak component on the low BE slope of the main 
peak can be attributed to C atoms around vacancy sites (283.8 eV).
[17]
 The fit of the N 1s line, 
on the other hand, shows five different chemical components centred at BEs of 398.0 eV, 
399.1 eV, 400.2 eV, 401.3 eV and 402.2 eV, corresponding to pyridinic, amine, pyrrolic, 
graphitic and pyridine oxide groups, respectively. In particular, the ratios between these last 
functional groups suggest that, on the average, each CQD contains 8-10 –NH2 groups (either 
aliphatic or aromatic, see Figure 3.7 B for a schematic representation). 
Figure 3.8 (A) XPS survey scan. (B) Multipeak analysis for the Carbon 1s and (C) Nitrogen 
1s photoemission lines. 
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The UV-Vis absorption spectrum of the as-prepared CQDs shows an absorption shoulder 
around 350 nm, typical of aromatic structures (Figure 3.9 A). Non-Normalized emission 
spectra are shown in Figure 3.9 B and display the distinctive features of CQDs, such as the 
dependence of the emission maxima on the excitation wavelength (normalized spectra, Figure 
3.9 B, inset). We evaluated the emission quantum yield upon 360 nm excitation as 30.1% 
using quinine sulphate as a reference, in line with data reported earlier by similar synthetic 
methods.
[12a,18]
 
Figure 3.9 (A) UV-Vis absorption spectrum of CQDs in water. (B) Non-normalized and 
normalized (inset) fluorescence emission spectra of CQDs in water obtained by excitation at 
different wavelengths. 
Primary amines can be used to promote controlled NCA-ROP processes.
[4]
 Thus, BLG-NCA 
was polymerized using CQDs as the amino-group-bearing initiator (Figure 3.10). 
Figure 3.10 Schematic representation of the synthesis of 8 and successive modification to 
obtain 10. Polymer 8: polymerization conditions: BLG-NCA, DMSO, 96 h, r.t., yield 78 %); 
polymer 10: (i) DMF, succinic anhydride, TEA, 40°C, 24 h; (ii) CQDs, DMF, DPPA, TEA, 
40°C, 24 h. 
A B
8
10
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The formation of PBLG arms from the CQDs core (hybrid material 8, Figure 3.10) was 
confirmed by NMR, FT-IR and circular dichroism (CD) spectra. CD data being related to the 
secondary, rod-like, α-helical, structure of PBLG (Figure 3.11 A). Size exclusion 
chromatography (SEC) showed an average MW of around 45 KDa (Figure 3.11 B). 
Termogravimetric analysis (TGA) yields a BLG:CQDs weight ratio of 97:3 (Figure 3.12). 
Like pristine CQD, 8 shows a dependence of its emission spectra on λex (Figure 3.13 B). 
Figure 3.11 (A) CD spectra of polymers 8 (red line) and 10 (black line) in HFIP solution 
(concentration 2 mg/mL). (B) SEC traces of polymers 8 (red line) and 10 (black line) in DMF. 
Figure 3.12 Thermogramivetric analysis comparison of a reference PBLG (black line), 
polymer 8 (red line) and polymer 10 (blue line). 
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Figure 3.13 (A) UV-Vis absorption spectrum of 8 in THF. (B) Non-normalized and 
normalized (inset) fluorescence emission spectra of 8 in THF obtained by excitation at 
different wavelengths. 
The CQD-PBLG-NH2 structure of 8 was further modified in its N-terminus position by 
reaction with a large excess of succinic anhydride in order to obtain the corresponding 
carboxylic derivative, CQD-PBLG-COOH (9). A negative Kaiser test (ninhydrin) confirmed 
the absence of primary amine groups upon reaction with the anhydride. The carboxylic groups 
of this intermediate were further derivatized, by activation with diphenylphosphoryl azide and 
reaction with a large excess of CQDs. The SEC trace of the resulting material 10 confirmed 
the addition of several CQDs per core, by showing an increase of the MW, in comparison to 8, 
of ca. 10 KDa (Figure 3.11 B). TGA analysis corroborated this finding, indicating a 22% 
increase of the CQDs abundance with respect to PBLG in comparison to hybrid 8 (Figure 
3.12). By assuming a MW of 1150 Da for CQDs, we estimate a covalent attachment of an 
average of nine peripheral CQDs per core for hybrid 10. 
In order to observe the structure of 10, we exploited the electron-donating capabilities of 
photoexcited CQDs, that enable the reduction of silver salts to the corresponding silver 
nanoparticles (AgNPs) on the surface of the CQDs themselves.
[19] 
To this end, a THF solution 
of 10 was photoexcited with ultraviolet irradiation in presence of silver nitrate. The formation 
of AgNPs brought a change in color from yellow to brown (Figure 3.14, upper part). AgNPs 
are expected to form on the surface of the external layer of 10, which is composed by CQDs. 
TEM analysis of the resulting organic-inorganic hybrid 11 shows the formation of star-shaped 
nanostructures with sizes in the 30-60 nm range, carrying several 5 nm AgNPs (Figure 3.14). 
According to previous studies,
[19]
 the templating and clustering effect of CQD supports has a 
dramatic effect on the plasmonic properties of the NPs. This is demonstrated by a broad 
surface plasmon resonance peak in the UV-Vis absorption spectrum of 11, between 400 and 
520 nm (Figure 3.13). The remarkable broadening of the UV-Vis spectrum of 11 compared to 
A B
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that of free-standing AgNPs in a similar size range (with a sharp absorption peak at 400 nm), 
is due to the compact arrangement of the AgNPs in 11, that results in strong plasmonic 
coupling interactions.
[20]
 
Figure 3.14 Upper part: schematic representation of the photoreaction to generate 11. Bottom 
part left: UV-Vis absorption spectra for 10, 11 and single AgNPs. Bottom part right: Two 
TEM images of single units of 11. 
Finally, we made use of the self-aggregation properties of PBLG to generate self-assembled 
microstructures from hybrids 8 and 10. To this end, we solubilized 8 or 10 in a THF/DMF 
mixture and dialyzed against water for 48 h. The resulting milky, light-brown (8) and dark-
brown (10) solutions were submitted to a size exclusion gel-filtration (water as eluant) and the 
main fractions were collected and examined by TEM (without uranyl-acetate staining) and 
SEM (Figure 3.15). In both cases spherical aggregates with diameters ranging from 100 to 
300 nm were observed. When 8 was used, the surfaces of the aggregates showed a smooth 
profile (Figure 3.15 A), whereas in the case of 10 the surfaces appear rough, with limited flat 
areas (Figure 3.15 B). This is compatible with the exposure of the hydrophilic CQDs on the 
surface of the aggregate formed by 10. Furthermore, the aggregated structures obtained in this 
last case, still displayed the multicolour emission characteristics described previously for 
CQDs and hybrids 8 and 10. We were able to picture it directly in the fluorimeter by using a 
digital camera, as shown on the top of Figure 3.15. 
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Figure 3.15 (A) and (B) TEM and SEM images of microstructures generated by self-
assembling of 8 and 10, respectively. Upper part: emission colours occurring from 10 
microstructures. 
Conclusions 
In conclusion, we reported the synthesis and characterization of CQDs bearing amino groups 
at their edges, as demonstrated by elemental and XPS analyses. Functionalization of dots with 
poly-γ-benzyl-L-glutamate gave the first reported CQD/polypeptide polymeric systems of star 
shaped fashion that were further decorated with an outer shell of CQDs. We tracked the 
spectroscopic properties of the materials throughout the syntheses, and exploited the electron-
donating capabilities of photoexcited CQDs to grow silver nanoparticles. These, in turn, 
allowed visualization of the structure of the resulting hybrid materials by TEM imaging 
thanks to their contrasting effect. Finally, we assembled supramolecular aggregates of 
spherical shape with evidence of rough surfaces profile in the case of CQD-capped hybrid 
materials, which may indicated the presence of aggregated areas of CQDs on the external 
layer. These microstructures are able to retain the characteristic emission properties of the 
native CQDs. The approach developed in this study is a facile, but highly efficient approach 
to the synthesis of fluorescent, peptide-based materials, attractive for many applications 
including optical sensing, biolabelling, imaging, targeted drug delivery/tracking and even UV 
protection for optical devices.  
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3.3 Poly(γ-benzyl-L-glutamate)-azobenzene conjugates 
With the aim to obtain “smart” supramolecular architectures with light-responsive 
behavior we decided to incorporate a photoresponsive moiety in the polypeptide chain. In 
addition to study the effect of geometry (cis/trans isomerization) on the response behavior of 
azobenzene-functionalized PBLG microstructures, bifunctional (Scheme 3.2) or trifunctional 
(Scheme 3.3) initiators with C2- or C3- type symmetry were exploited. 
The synthetic strategy to obtain the bis-aminoester (16) (initiator of the C2-symmetry) 
followed a modification of the reported protocol.
[21]
 The synthesis involved condensation of 
two L-Phe derivatives, bearing an amino (13) and a nitroso (14) moiety, respectively (Scheme 
3.2). After Boc-protection of the N-terminus of H-L-Phe(pNO2)-OMe (12), the following 
catalytic hydrogenation yielded the p-amino derivative (13). Nitroso derivative (14), obtained 
upon reduction of 12 with Zn dust and subsequent treatment with FeCl3, was immediately 
condensed with 13 in acetic acid (AcOH), yielding the Boc-protected bis-azo-L-Phe 
compound (15). Finally, compound 16 was obtained by a TFA treatment of 15. 
Scheme 3.2 Synthesis of H-bisazo-L-Phe-OMe (16), C2-Symmetry initiator. Reagents and 
Conditions: i) Boc2O, TEA, 1:1 CH3CN/H2O, r.t., 18 h. ii) Pd/C, H2, MeOH, r.t., 40 min. iii) 
Zn, NH4Cl, 5:1 EtOH/H2O, r.t., 2 h. iv) FeCl3, 5:1 EtOH/H2O, 0 ºC, 30 min. v) AcOH, r.t., 24 
h. vi) 50% TFA in CH2Cl2, r.t., 40 min. 
The synthesis of the initiator with C3-symmetry (22) initially involved the preparation of the 
azo compound (19)
[22]
 (Scheme 3.2). The amino group of p-nitrobenzylamine was Boc-
protected (17) and then the nitroso moiety of 18 was prepared via Zn/Fe redox treatment. The 
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condensation of 18 with p-aminobenzoic acid in AcOH afforded 19. The C3- platform (20) 
was easily obtained via thiol-ene “click” chemistry starting from the tris-alkene core 2,4,6-
triallyloxy-1,3,5-triazine and 2--mercaptoethanol, by UV irradiaton (= 365 nm) and using 
DMPA as photoinitiator. Condensation of compounds 19 and 20 using the EDC/DMAP C-
activation protocol yielded the amino-protected compound (21), which after acidic treatment 
(50% TFA) gave the trifunctional amine initiator (22). 
Scheme 3.3 Synthesis of C3-symmetry initiator (22). Reagents and conditions: i) Boc2O, 
TEA, 1:1 CH3CN/H2O, r.t., 18 h. ii) Zn, NH4Cl, 5:1 EtOH/H2O, r.t., 2 h. iii) FeCl3, 5:1 
EtOH/H2O, 0 ºC, 40 min. iv) AcOH, p-aminobenzoic acid, r.t., 48 h. v) 10% mol DMPA, 2-
mercaptoethanol, λ=365 nm, 40 min. vi) EDC, DMAP, DMF, r.t., 18 h. vii) 50% TFA in 
CH2Cl2, r.t., 2 h. 
 
The photo-isomerization of the two initiators (16) and (22) in solution was monitored by UV-
Vis absorption spectroscopy and HPLC (Figure 3.16). Compound 16 can efficiently isomerize 
in the cis form by irradiation with light at 365 nm for 40 s (Figure 3.16 B). In Figure 3.16 C 
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we show the four isomers expected from the photoisomerization of 22 and the co-presence of 
the four species can be detected by HPLC (Figure 3.15 D). A more prolonged irradiation at 
365 nm is able to quantitatively isomerize the trans form to the cis form. 
Figure 3.16 (A) Schematic representation of the light-driven, reversible photoisomerization 
process occurring for 16. (B) HPLC profiles of a solution of 16 before (top) and after 
(bottom) irradiation at 365 nm. (C) Schematic representation of the light-driven, reversible 
photoisomerization process occurring for 22. (D) HPLC profile of solution of 22 irradiated at 
365 nm for 40 s, which revealed formation of all (four) of its possible isomers. 
The PBLG hybrids with C2- and C3-symmetries were obtained via NCA-ROP (ring opening 
polymerization) using compounds 16 and 22, respectively, as the initiators. The 
polymerizations using BLG-NCA were performed in 1,4-dioxane or DMF. The solid PBLG 
hybrids, obtained after precipitation with MeOH, were characterized by SEC analysis. We 
obtained a MW distribution of 63,500 Da, PDI 1.16 (C2-symmetry PBLG) and 46,800 Da, PDI 
1.56 (C3-symmetry PBLG). 
all trans all cis
cis/trans
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D
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Scheme 3.4 Synthesis of PBLG Hybrid with C2-Symmetry (23). Inset: schematic 
representation of polymer 23. 
Scheme 3.5 Synthesis of PBLG Hybrid with C3-Symmetry (24). Inset: schematic 
representation of polymer 24. 
The C2-symmetry PBLG hybrid (23) was studied in terms of photoresponsive behavior 
(Figure 3.17 A). After UV irradiation at = 365 nm of a PBLG hybrid solution in THF, 
isomerization of the azobenzene moiety from trans-to-cis was observed, as indicated by the 
decrease of the π-π* transition band at 328 nm and the concomitant increase of the n-π* 
transition band at 440 nm (Figure 3.17 B). This process was found reversible for several 
cycles (repeated irradiation at 365 and 420 nm). 
n
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Figure 3.17 (A) Schematic representation of the cis/trans photoisomerization underwent by 
the C2-symmetry PBLG hybrid (23). (B) UV-Vis absorption spectra of the cis and trans 
isomers of the C2-symmetry PBLG hybrid in THF solution, two cycles of irradiation are 
represented. (C) SEC analysis which shows different elution profiles occurring for the cis and 
the trans forms of the C2-symmetry PBLG hybrid. (D) CD spectra of the cis and trans 
isomers of the C2-symmetry PBLG hybrid in HFIP solution (the cis red trace was slightly 
shifted up for clarity). 
Interestingly, the cis and trans isomers can be differentiated by SEC analysis (Figure 3.17 C). 
Specifically, the cis form is characterized by a longer elution time, indicative of a more 
compact 3D-shape, with respect to the trans form. Conversely, as expected, cis/trans 
isomerization does not affect the polypeptide secondary structure of the PBLG hybrid, the CD 
spectra of which are almost identical for both isomers and indicative of an overwhelmingly 
prevailing α-helical conformation (Figure 3.17 D). 
The self-assembly properties of the C2-symmetry PBLG hybrid were investigated in aqueous 
environment.
[5b]
 Starting from a solution of this hybrid in an organic solvent mixture (20 mg 
in 10 mL of 3:7 DMF/THF v/v), a milk-like suspension was obtained after dialysis against 
ultrapure water for 48 h (membrane cutoff, 12 KD). Few drops of this suspension, examined 
by TEM and SEM revealed formation of aggregates which display polydisperse spherical 
morphologies with diameters of 100-500 nm (Figures 3.18 A-B). The relative high and 
positive value of the Z-potential function (+30 mV)
[23]
 (related to the degree of electrostatic 
repulsion between adjacent, similarly charged particles) obtained from these experiments 
3. Functionalized helical polypeptides 87 
provides evidence for the presence of electrostatic net charges, due to the protonated N-
terminal amino groups, present at least in the outer layer of these microstructures. Moreover, 
high Z-potential values are often associated to double-layer systems, such as vesicles. Indeed, 
our rod-like PBLG hybrid, largely hydrophobic but carrying protonated amino groups at both 
termini, might give rise to a vesicle-like self-assembly (Figure 3.18 C). By considering that 
this hybrid has an average MW of 63,500, which corresponds to about 280 BLG units, and the 
elevation per residue in the -helix is 0.15 nm,
[24]
 the wall thickness of the vesicles might be 
of the order of 40 nm. 
Upon UV irradiation (= 365 nm) of the suspension, a rapid and progressive collapse of these 
ordered structures was observed, most likely driven by the change in 3D-geometry of few 
polymeric molecules as a consequence of the azobenzene isomerization from trans to cis 
(Figures 3.18 D-G). 
Figure 3.18 TEM (A) and SEM (B) images of the self-assembled structures obtained from the 
C2-symmetry PBLG hybrid (23) in aqueous suspension. (C) Tentative model of the self-
assembled structures. (D-G): TEM images of the microstructure transitions occurring after 
different irradiation times under UV light at = 365 nm (20, 40, 60 and 80 sec, respectively). 
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Evidence for the vesicular nature of the self-assembled structures was obtained by the 
carboxyfluorescein (CF)-entrapped technique.
[25]
 The self-assembly process described above 
was repeated in the presence of CF in the starting organic medium. After dialysis, the 
resulting suspension was submitted to SEC, thus allowing removal of the non-entrapped CF 
and the isolation of a red-orange colored main fraction, consisting of spherical self-assembled 
structures, homogeneous in size (200 nm), according to a TEM and DLS analyses (Figure 
3.19, upper part). 
Figure 3.19 Upper part: TEM image spherical aggregates of the C2-symmetry PBLG hybrid 
(23) formed in the presence of CF. Lower part: (A) Comparison of the fluorescence emission 
spectra of the CF-encapsulated aggregates before (red line) and after (black line) UV 
irradiation at 365 nm. (B) Time evolution of the release of CF from the spherical aggregates 
as a result of either UV irradiation (365 nm) or denaturation by addition of 10 % MeOH (v/v) 
or 5% 0.1 M NaOH (v/v). 
We recorded the fluorescence spectra of a diluted water solution of the spherical aggregates 
prior and after exposure to UV light at = 365 nm (Figure 3.19 A). The UV-induced collapse 
of the aggregates (demonstrated above) is accompanied by a dramatic enhancement in the CF 
fluorescence. This result strongly supports the view that our spherical aggregates of the C2-
symmetry PBLG hybrid are indeed vesicles, hosting in their inner cavity CF molecules at 
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relatively high concentration. This phenomenon gives rise to a low fluorescence emission 
owing to the self-quenching effect. Upon disruption of the vesicles, diluted CF is released in 
the medium, fully restoring its strong fluorescence. As shown in Figure 3.19 B, the maximum 
fluorescence intensity is reached after 6 min irradiation at 365 nm. This represents a much 
longer time than the 20-80 sec required for the collapse of the empty vesicles reported in 
Figure 3.18. Such a discrepancy might be rationalized by observing that CF absorbs part of 
the irradiating light. Beside via UV-induced trans-cis isomerization, the 
disruption/destabilization of the vesicles leading to CF release within a few minutes can be 
achieved also by addition to the aqueous suspension of either MeOH (it dissolves the 
polymeric vesicles) or a diluted NaOH solution (it removes the positive charges on the surface 
of the vesicle that are fundamental to prevent the aggregation effect of this colloidal form) as 
shown in Figure 3.19 B. 
We also investigated the self-assembly properties of the C3-symmetry PBLG hybrid (24) in 
aqueous environment. The microstructures formed starting from an organic solution upon 
dialysis against water are characterized by an oval shape and dimensions of 100-400 nm 
(Figure 3.20). 
Figure 3.20 TEM (left) and SEM (right) images of the self-assembled structures obtained 
from the C3-symmetry PBLG hybrid (24) in aqueous suspension. 
After UV irradiation for increasing times up to 30 min, we observed the reorganization of the 
microstructures in smaller aggregates as detected by TEM analyses (Figures 3.21 A-F). In 
particular, after 5 min of irradiation a partial disassembling of the oval aggregates was 
detected, whereas prolonged irradiation (up to 20-30 min) led to the formation of smaller 
organizations of spherical nature (20-40 nm) as showed by SEM experiments (Figure 3.21, 
lower part). Since each molecule of the hybrid contains three azobenzene units, in all 
probability the disassembly of the large, oval aggregates is related to a partial conversion to 
the cis form. Upon prolonged irradiation the all-cis hybrid is formed, which can reorganize 
into novel, smaller microstructures. 
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Figure 3.21 Upper part, left: TEM images of the microstructures obtained from the C3-
symmetry PBLG hybrid (24) in water after UV irradiation (= 365 nm) for different times (A, 
no irradiation; B, 5 min; C and D, 10 min; E, 20 min; F, 30 min). Central part right: 
Schematic representation of the light-induced microstructure reorganization. Lower part: 
SEM images showing the microstructures before (left) and after (right) 30 min UV irradiation. 
Finally, we investigated the photoresponsive behavior of a C3-symmetry PBLG hybrid 
characterized by a higher MW (154,000 Da). In this case, the self-assembly process obtained 
upon dialysis against water led again to the formation of oval microstructures. At variance 
with the lower MW polypeptide, however, no variation of morphology could be detected even 
after prolonged UV irradiation. Therefore, inspired by a recent publication on electrospun α-
helical PBLG fibers
[26]
 and considering the characteristics of our C3-symmetry PBLG hybrid 
(it has a MW comparable to that reported in ref. 26), we decided to process our high MW C3- 
symmetry PBLG hybrid via the electrospinning technique. The characterization of the 
resulting material is illustrated in Figure 3.22. The densely packed fibrillar network detected 
by SEM (Figure 3.22 A) corresponds, to the macroscopic level, to a solid layer (Figure 3.22 
B). We tested the photoresponsive behavior of this solid layer under UV irradiation. The 
fibers, originally remarkably homogenous in shape, tend to progressively “swell” into larger 
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domains after 30-60 min of irradiation (Figures 3.22 C-D). A total collapse of the fiber 
morphology was achieved after 200 min UV irradiation (Figure 3.22 E). 
Figure 3.22 (A) SEM image of the fibers obtained from the high MW C3-symmetry PBLG 
hybrid after processing by the electrospinning technique. (B) Imagine showing the 
macroscopic material collected by electrospinning. (C-E) SEM images of the microstructure 
transition occurring at different irradiation time at λ= 365 nm (30, 60, and 200 min, 
respectively). 
Interestingly, application of the electrospinning technique to the C2-symmetry PBLG hybrid 
also led to the formation of a fibrillar network. In this case, however, the fiber morphology 
did not change even after prolonged UV irradiation (up to 3 h). In all probability, the packing 
of polypeptide chains within the fibers of this linearly organized material is tighter than in the 
case of the C3-symmetry PBLG hybrid. 
Conclusions 
We took advantage from two azobenzene-based amino acids as polymerization initiators for 
the construction of “smart” supramolecular systems endowed with photoswitchable behavior. 
The two starting materials are an N

-protected derivative of the (4-
aminomethyl)phenylazobenzoic acid (19)
[22]
 and the azo-bridged di-α-amino-diester 4,4’-
diazenediyldi-L-Phe (16).
[21]
 In particular, the NCA polymerization methodology was utilized 
to prepare two PBLG hybrid molecules characterized by either C2- or C3-symmetry. In the 
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first case, the bis-initiator was the di-α-amino-diester (16) itself, while in the second case the 
tris-initiator was the three-branched compound 22 with a triazinic central core. 
These azobenzene-containing compounds and materials were reversibly trans-to-cis 
photoisomerized, and the micro- and macroscopic changes in their 3D-structures, self-
aggregation properties and overall characteristics were carefully analyzed by chromatography 
and UV-Vis/CD spectroscopies as well as by TEM/SEM nanomaterial techniques. In 
particular, the results reported here clearly indicate that the morphology of the self-aggregated 
systems can be finely tuned by a geometric (trans vs. cis) modification of one (azobenzene) of 
the building blocks. 
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3.4 Experimental Section 
Instruments and Methods 
Nuclear Magnetic Resonance.
 1
H and 
13
C NMR spectra were recorded at room temperature on 
a Bruker AC-200 (200 MHz) instrument using TMS (tetramethylsilane) as the internal 
reference. The multiplicity of a signal is indicated as s, singlet; d, doublet; t, triplet; m, 
multiplet, br, broad. Chemical shifts (δ) are expressed in ppm. 
Fourier Transform-Infrared Spectroscopy. FT-IR absorption spectra in KBr disc were 
recorded with a Perkin-Elmer 1720X spectrophotometer. The ῡ maxima for the main 
absorption bands are given. 
High-Resolution Mass Spectroscopy. Mass spectra were obtained by electrospray ionization 
(ESI) on a Perseptive Biosystem Mariner ESI-ToF 5220 spectrometer. Data were collected in 
the positive mode. 
UV-Vis Absorption. Absorption spectra were recorded using a Shimadzu model UV-2501 PC 
spectrophotometer. A 1-cm path length quartz cell was used. 
Circular Dicroism. CD measurements were carried out at room temperature using a Jasco J-
715 spectropolarimeter. Fused quartz cells of 1-mm or 0.2-mm path length (Hellma) were 
used. 
Dynamic Light Scattering. DLS measurements were carried out at 25 °C on a Malvern 
Zetasizer Nano-S instrument using a He- Ne laser (633 nm) and a scattering angle of 176°. 
Transmission Electron Microscopy. Samples were analyzed on a Jeol 300PX instrument. 
Samples were prepared immediately before use, by dilution of the dialyzed solutions with 
MilliQ water. A small drop of solution was floated on a glow discharged carbon coated grid 
and excess was removed by #50 hardened Whatman filter paper. For the samples with 
negative staining, the grid was then floated on 2% uranyl acetate solution for 10 seconds, and 
the excess was removed by #50 hardened Whatman filter paper. 
Scanning Electron Microscopy. A Carl Zeiss Merlin field emission SEM operating at 5 kV 
accelerating voltage was used. A small drop of the suspension was placed on a microscope 
glass cover slip and allowed to dry overnight. 
Atomic Force Microscopy. AFM experiments were performed on Agilent Technologies 5500 
scanning probe microscope, operating in acoustic AC AFM mode (tapping mode) with a 
silicon Asylum Reasearch high frequency cantilever displaying a resonance frequency of 305 
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kHz. A small drop of sample was placed on a mica or silicon surface and allowed to dry in air 
for at least 60 min before measurement. 
Size Exclusion Chromatography. SEC analyses were performed on a Agilent 1260 Infinity 
system equipped with 1260 isopump, 1260 TCC, 1260 VWD VL, 1260 RID, Phenogel 5u 
linear/mixed guard column (30  4.6 mm), followed by Phenomenex Phenogel 5u 104 Å (300 
 4.6 mm) column working at 60 °C. DMF was used as eluant at a flow rate of 1 mL/min. 
Before SEC analysis, the samples were filtered through a 0.2 µm PTFE filter (15 mm, 
Phenomenex). The MWs were calculated according to calibration using polystyrene standards. 
MALDI-TOF. Mass spectra were recorded with an AB SCIEX 4800 MALDI TOF/TOF 
Analyzer (AB SIEX Pte Ltd, Massachusetts, USA), using reflector mirror and positive ion 
detection. A dual microchannel plate reflector detector was used. LDI was performed with 
the 355 nm (3-7 ns) pulses of a Nd:YAG laser at a repetition rate of 200 Hz. We used 70% of 
maximum laser power for all measurements. Each spectrum was averaged over 400 laser 
shots and analyzed with the AB SCIEX 4000 Series Explorer Software (AB SCIEX Pte Ltd, 
Massachusetts, USA). Matrix: 2,5-dihydroxybenzoic acid 1 M in 1:1 methanol/water 
solution. 
X-ray photoemission spectroscopy. XPS measurements were carried out on dialysed and 
lyophilised CQDs powder. Core level photoemission spectra were taken on a VG ESCALAB 
MKII spectrometer using Mg anode of a conventional non-monochromatized X-ray source 
(K=1253.6 eV). The electron analyser pass energy was set to 50 eV for the survey wide 
scans and to 20 eV for the single spectral region. The measurements were taken at r.t. with a 
detection direction perpendicular to the sample surface. The calibration of the binding energy 
(BE) scale was carried out using Au 4f as reference. In order to characterize the chemical 
states of carbon and nitrogen, the C 1s and N 1s peaks were de-convoluted into individual 
components (after Shirley background removal) using a Doniach-Šunjić shape for the C sp2 
component and symmetrical Voigt functions for the fitting of the molecular-like components. 
The χ2 minimization was ensured by the use of the nonlinear least squares routines. 
Microstructures Preparation. Typically, 20 mg of polymer were dissolved in 10 mL of a 
DMF/THF 3:7 (v/v) solvent mixture. This solution was put into a cellulose dialysis tubing 
with a MW cutoff of 12 KD (flat width 35 mm, Sigma). The dialysis process was carried out 
against deionized water for 48 h. 
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High-Performance Liquid Chromatography. The HPLC measurements were performed on an 
Agilent 1200 apparatus equipped with a UV detector at 226 nm. Conditions: Phenomenex C18 
(100Å) (stationary phase), 5-80% B, 25 min, 1 mL/min (eluants: A=9:1 H2O/CH3CN, 0.05% 
TFA; B= 1:9 H2O/CH3CN, 0.05% TFA). 
Electrospinning of PBLG Fibres. Three solutions at different concentrations (4, 8, and 12 
wt%) were prepared by dissolving PBLG in dicloroacetic acid at 50°C. A 2 mL SGE syringe 
with stainless steel needle was used as an electrode. Syringes with 8 mL of each concentration 
were loaded in a syringe pump (Genei™ Plus Syringe pump, Kent Scientific), to control the 
flow rate of the polypeptide solutions. Electrospinning was performed at ambient conditions 
with a constant applied voltage of +8 kV at needle and −5 kV at collector with the flow rate 
set at 0.01 mL/min to maintain a constant size of droplet at the tip of the syringe needle. A 
circular aluminium plate was used as a collector. The tip to collector distance was kept at 15 
cm. Electrospinning was performed for about 2 h to obtain a non-woven, continuous fibre 
mat. All fibres were dried prior to use for the photostimuli experiments. 
 
Materials 
-Benzyl-L-glutamate (BLG), succinic anhydride, arginine, p-nitrobenzylamine and 4-
dimethylaminopyridine (DMAP) were obtained from Fluka. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC∙HCl) and 1-hydroxy-7-aza-1,2,3-
benzotriazole (HOAt) was purchased from GL Biochem (Shanghai). Triphosgene, 
triisopropylsilane (TIS), cysteamine hydrochloride, triphenylmethanol, 1,2-ethylendiamine, 
diphenylphosphoryl azide (DPPA), di-tert-butyl dicarbonate (Boc2O), triethylamine (TEA), p-
aminobenzoic acid, 2,2’-dimethoxy-2-phenylacetophenone (DMPA), 2-mercaptoethanol, p-
nitro-L-phenylalanine methyl ester hydrochloride [H-L-Phe(pNO2)-OMe·HCl], 2,4,6-
triallyloxy-1,3,5-triazine, trifluoroacetic acid (TFA), and α-pinene were obtained from Sigma-
Aldrich. The deuterated solvents CDCl3 and DMSO-d6 were purchased from Euriso-Top. 
Catalyst 10% Pd/C was obtained from Acros-Janssen. All other chemicals and solvents are 
Sigma-Aldrich, Fluka or Acros products and were used as provided without further 
purification. Dialysis tubes with molecular weight cutoff 1 KD were obtained from Spectrum 
Labs and 12 KD cutoff from Sigma-Aldrich. 
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Synthesis and Characterization 
γ-Benzyl-L-glutamate N-carboxyanhydride (BLG-NCA, 1).[27] BLG (5.05 g, 21.3 mmol) 
and α-pinene (6.64 g, 48.7 mmol) were dissolved in EtOAc (70 mL) in a three-neck flask and 
heated under reflux. Triphosgene (4.24 g, 14.2 mmol) was dissolved in EtOAc (25 mL) and 
added slowly with a dropping funnel once the reflux started. After 4h of reaction, heating was 
interrupted and most of the solvent was evaporated under reduced pressure. The compound 
was precipitated by addition of petroleum ether and the recovered solid was recrystallized 
twice, subsequently filtered and washed with petroleum ether. BLG-NCA was recovered as a 
white solid (4.6 g, 84%). 
1
H-NMR (200 MHz, CDCl3): δ 7.35 (s, 5H, ArH), 6.61 (s, 1H, NH), 5.14 (s, 2H, Ar-CH2-), 
4.37 (t, J= 6 Hz, 1H, αCH), 2.59 (t, J= 6.8 Hz, 2H, γCH2), 2.36-2.02 (m, 2H, βCH2). Data 
consistent with that previously reported in the literature.
[27] 
 
a) Synthesis of PBLG-C60 conjugates 
2-(tritylsulfanyl)ethanamine (2).
[28]
 A solution of cysteamine hydrochloride (1.04 g, 9.17 
mmol) and triphenylmethanol (2.18 g, 8.37 mmol) in TFA (5 mL) was stirred at room 
temperature for 1 h. After co‐evaporation with acetonitrile the residue was dissolved in ethyl 
acetate and washed with NaOH(aq) 1 M, water and brine. The organic layer was dried over 
Na2SO4, filtered and the solvent was evaporated under reduced pressure. The compound was 
recovered as white solid (2.4 g, yield 89 %). 
1
H NMR (200 MHz, CDCl3) δ 7.48-7.43 (m, 7H, ArH), 7.35-7.23 (m, 8H, ArH), 2.61 (t, 2H, 
CH2), 2.35 (t, 2H, CH2), 1.42 (s, 2H, NH2). Data consistent with that previously reported in 
the literature.
[28]
 
3-(tritylsulfanyl)propanoic acid (5). To a suspension of triphenylmethanol (2.6 g, 10 
mmol) in 10 mL of TFA was added 3-mercaptopropionic acid (1.4 g, 13 mmol). The mixture 
was stirred for 1 h at room temperature. After that the TFA was removed under vacuum and 
the residue was dissolved in ethyl acetate and washed with NaHCO3(aq) 5%, KHSO4(aq) 
10%,water and brine. The organic layer was dried over Na2SO4, filtered and the solvent was 
evaporated under reduced pressure. The compound was recovered as white solid (3.05 g, 
yield 88 %). 
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1
H NMR (200 MHz, CDCl3) δ 7.47-7.40 (m, 6H, ArH), 7.35-7.22 (m, 9H, ArH), 2.49 (t, 2H, 
CH2), 2.25 (t, 2H, CH2). Data consistent with that previously reported in the literature.
[29]
 
PBLG derivatives 
NH2-PBLG-S-Trt (3). BLG-NCA (1) (1 g, 3.8 mmol) was dissolved in 3 mL of dry dioxane 
under N2 atmosphere and the flask was cooled with a MeOH/ice bath. Then 
(tritylsulfanyl)ethanamine (2) (12 mg, 0.038 mmol) dissolved in 500 µL of dry dioxane was 
added to the solution and the cool bath was removed. The reaction was stirred at 25 °C for 
one day, until the mixture became very viscous. The product was precipitated by adding 
MeOH to the solution, the polymer was filtered and dried in vacuo. The polymer was 
recovered as a white fibrous solid (810 mg, recovered yield 81 %). 
SEC MW: 19100 (PDI 1.11). 
1
H NMR (200 MHz, CDCl3) δ 7.27 (s, 5H), 5.05 (s, 2H), 3.94 
(s, 1H), 2.57 (s, 2H), 2.26 (s, 2H). 
13
C NMR (50 MHz, CDCl3) δ 175.54, 172.20, 136.11, 
128.60, 128.26, 66.29, 30.95, 25.67. 
NH2-PBLG-C60 (4). The removal of Trt protective group was performed by treatment of 
polymer 1 (200 mg, 10.5 μmol) with 4 mL of a solution 50% TFA in CH2Cl2 with TIS for 20 
min. The solvent was evaporated under reduced pressure and the residue was suspended in 
Et2O, filtered and washed with Et2O. The resulting polymer was dissolved in 10 mL of a 
solution of DMF/toluene 2:8 v/v. Then fullerene (37 mg, 0.052 mmol) and AIBN (24 mg, 
0.16 mmol) were added. The reaction mixture was heated at 90 °C for 5 h, after that the 
solvent was removed under reduced pressure. The residue was suspended in DMF and 
filtered through a 20 µm filter to eliminate the non-reacted fullerene. The polymer was 
precipitated from the filtrate solution by adding MeOH. The solid was filtered and washed 
several times with MeOH and acetone to remove the fullerene by-products. The polymer 3 
was recovered as brown solid (171 mg, yield 85 %). 
SEC MW: 19550 (PDI 1.09). 
1
H NMR (200 MHz, CDCl3) δ 7.27 (s, 5H), 5.05 (s, 2H), 3.95 
(s, 1H), 2.55 (s, 2H), 2.27 (s, 2H). 
13
C NMR (50 MHz, CDCl3) δ 175.53, 172.24, 136.08, 
128.59, 128.24, 66.29, 30.94, 25.72. 
Trt-S-PBLG-C60 (6). Trt-mercaptopropionic acid (5) (60 mg, 0.17 mmol) and HOAt (24 
mg, 0.17 mmol) were dissolved in 3 mL of anhydrous DMF, cooled at 0 °C and then 
EDC·HCl (33 mg, 0.17 mmol) was added. The mixture was stirred for 15 min at 0 °C. 
Polymer 3 (90 mg, 4.6 μmol) was dissolved in 2 mL of DMF and added with TEA (50 µL, 
0.36 mmol) to the solution of active ester. After stirring the solution at r.t. for 48 h, the 
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polymer was precipitated by adding MeOH, then filtered and washed several times with 
MeOH. The polymer was dry to obtain a brown solid (92 mg, yield 98%). 
C60-PBLG-C60 (7). Polymer 4 (75 mg, 3.8 μmol) was treated with 4 mL of a solution 50% 
TFA in CH2Cl2 with TIS for 20 min. The solvent was evaporated under reduced pressure and 
the residue was suspended in Et2O, filtered and washed with Et2O. The obtained compound 
was dissolved in 5 mL of a solution of DMF/toluene 2:8 v/v. Successively fullerene (15 mg, 
0.021 mmol) and AIBN (10 mg, 0.061 mmol) were added. The mixture was heated at 90 °C 
for 5 h, after that the solvent was removed under reduced pressure. The residue was 
suspended in DMF and filtered through a 20 µm filter. To the filtrated solution MeOH was 
added to precipitate the polymer. The compound was filtered and washed several times with 
MeOH and acetone. The compound was obtained as a brown solid (60 mg, yield 78 %). SEC 
MW: 20300 (PDI 1.11). 
1
H NMR (200 MHz, CDCl3) δ 7.28 (s, 5H), 5.05 (s, 2H), 3.95 (s, 1H), 2.56 (s, 2H), 2.28 (s, 
2H). 
13
C NMR (50 MHz, CDCl3) δ 175.52, 172.21, 136.14, 128.61, 128.27, 66.32, 31.07, 
25.61. 
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b) Synthesis of PBLG-CQDs conjugates 
CQDs. Arginine·HCl (5.6 g, 26.6 mmol) and 1,2-ethylendiamine (1.78 mL, 26.6 mmol) were 
dissolved in 13.3 mL of ultrapure water. The solution was placed in a domestic microwave 
oven and heated at 700 W for 180 s. The brown-burned resulting solid was suspended in 50 
mL of ultrapure water and centrifuged several times. The water solution was placed in a 
dialysis sack (1 KD cutoff) and dialyzed against ultrapure water for 24 h. Finally the aqueous 
solution was lyophilized giving 1.2 g of solid CQDs. 
FT-IR absorption: ῡ 3399, 2934, 1623, 1451, 1382 cm-1. 
PBLG derivatives 
Polymer 8. BLG-NCA (450 mg, 1.7 mmol) was dissolved in 1 mL of dry DMSO under N2 
atmosphere. Then CQDs (20 mg) dissolved in 2 mL of DMSO were added to the NCA 
solution. The reaction was left to stir at r.t. for 96 h. The polymer was precipitated by adding 
MeOH to the solution. The polymer was filtered, washed several times with MeOH and Et2O, 
and dried in vacuo. The polymer was recovered as a brown solid (350 mg, yield 78%). 
FT-IR absorption: ῡ 3298, 3063, 3034, 2952, 1735, 1651, 1545, 1161 cm-1. 1H NMR (200 
MHz, CDCl3): δ ppm 7.24 (s, 5H, ArH), 6.61 (s, 1H, NH), 5.00 (s, 2H, Ar-CH2), 3.56 (s, 1H, 
αCH), 3.56 (t, 2H, γCH2), 2.19 (br s, 2H, β CH2). 
COOH-PBLG-CQD (intermediate, 9). Polymer 8 (160 mg) was dissolved in 2 mL of dry 
DMF. Succinic anhydride (100 mg, 1 mmol) was dissolved in 1 mL of dry DMF and added to 
the solution of the polymer together with TEA (50 μL, 0.36 mmol). After 24 h under stirring 
at 40 °C, aqueous acetic acid (1 mL) was added to the reaction mixture. Then the polymer 
was precipitated by adding MeOH and washed several times with MeOH and Et2O. The 
polymer was recovered as a brown solid (140 mg). 
FT-IR absorption: ῡ 3294, 3064, 3034, 2952, 1735, 1650, 1545, 1452, 1158 cm-1. 
Polymer 10. Polymer 9 (100 mg) was dissolved in dry DMF and activated with DPPA (200 
μL, 0.93 mmol) and TEA (250 μL, 1.8 mmol). CQDs (50 mg) were added to this mixture and 
maintained at 40 °C under stirring for 24 h. The polymer was precipitated from the mixture by 
adding acidic water and MeOH, washed several times and obtained as a brown solid (80 mg). 
FT-IR absorption: ῡ 3295, 3063, 3033, 2951, 1735, 1651, 1545, 1452, 1160 cm-1. 
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Functionalization with silver nanoparticles
[19]
 
Compound 11. CQDs and AgNO3 blend solution (1:4, w/w) in EtOH was prepared at a 
concentration of 2 mg/mL and placed in a UV quartz cuvette (1×1×5 cm). This solution was 
exposed to UV light with wavelength of 254 nm for 30 min using a 6W UV (mineralight 
lamp, Model UVGL-54). The cell was kept 3 cm apart from the light source. After UV 
irradiation for few minutes, the color of solution start to change from light yellow to dark 
brown, implying the reduction of Ag ions and the formation of Ag nanoparticles. 
Silver nanoparticles (AgNPs). AgNO3 was dissolved in N-methyl-2-pyrrolidone at a 
concentration of 4 mg/mL. This solution was treated with same procedure as 11, but UV 
irradiation was carried out for 1 h. Free AgNPs prepared in this manner had an average 
diameter of 3 nm, equal to the diameters of AgNPs synthesized using CQDs.  
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c) Synthesis of PBLG-Azobenze conjugates 
H-bisazo-L-Phe-OMe (16), C2-symmetry initiator
[21]
 
Boc-L-Phe(pNO2)-OMe (12). H-L-Phe(pNO2)-OMe·HCl (4.9 g, 18.8 mmol) was dissolved 
in an 1:1 CH3CN/H2O solvent mixture (20 mL) and TEA was added to pH = 9. Then, Boc2O 
(5.50 g, 25.2 mmol), dissolved in CH3CN (10 mL), was added. The mixture was stirred at r.t. 
for 18 h. The mixture was concentrated under reduced pressure and the residue was diluted 
with EtOAc. The organic layer was washed with 5% KHSO4(aq), 5% NaHCO3(aq), and brine. 
After drying over Na2SO4, the solvent was removed under reduced pressure and the 
compound was obtained as solid (5.9 g, 97%). 
FT-IR absorption: ῡ 3358, 2985, 1732, 1689, 1524, 1346 cm-1. HRMS (ESI+): m/z calcd. for 
C15H20N2O6 324.1321, found 325.3298 [M+H]
+
. 
1
H NMR (200 MHz, CDCl3):  1.40 (s, 9H), 
3.11 (dd, J=13.7, 6.2 Hz, 1H), 3.27 (dd, J=13.7, 6.2 Hz, 1H), 3.73 (s, 3H), 4.58-4.68 (m, 1H), 
5.06 (d, J=7.7 Hz, 1H), 7.31 (d, J=8.7 Hz, 2H), 8.6 (d, J=8.7 Hz, 2H). 
Boc-L-Phe(pNH2)-OMe (13). Boc-L-Phe(pNO2)-OMe (2.40 g, 7.4 mmol) was dissolved in 
MeOH (50 mL) and N2 was bubbled in the solution for 10 min. Then, Pd/C (300 mg) was 
added and the mixture was stirred at r.t. under an atmospheric pressure of H2 gas for 1 h. The 
catalyst was removed by filtration through celite. The solvent was evaporated and the residue 
was purified via flash chromatography (eluant: EtOAc/hexane 1:1). The product was 
recovered as a solid (2.1 g, 96%). 
FT-IR absorption: ῡ 3397, 3374, 3232, 1741, 1690, 1515 cm-1. HRMS (ESI+): m/z calcd. for 
C15H22N2O4 294.1579, found 295.1732 [M+H]
+
. 
1
H NMR (200 MHz, CDCl3):  1.40 (s, 9H), 
2.96 (d, J=5.7 Hz, 2H), 3.44 (s br, 2H), 3.70 (s, 3H), 4.45-4.55 (m, 1H), 4.95 (d, J=7.9 Hz, 
1H); 6.61 (d, J=8.4 Hz, 2H), 6.89 (d, J=8.4 Hz, 2H). 
Boc-L-Phe(pNO)-OMe (14). Boc-L-Phe(pNO2)-OMe (1.07 g, 3.3 mmol) and NH4Cl (790 
mg, 14.8 mmol) were dissolved in a 5:1 EtOH/H2O (42 mL) solvent mixture. Then, Zn dust 
(600 mg, 9.2 mmol) was added. The resulting suspension was stirred at r.t. for 2 h, then 
filtered through celite, and washed with a cold mixture of 5:1 EtOH/H2O (40 mL) to remove 
the excess of Zn. The filtrate was cooled to 0 ºC and a cold solution of FeCl3·6H2O (6.33 g, 
23.4 mmol) in 5:1 EtOH/H2O (35 mL) was added. The mixture was stirred at 0 ºC for 30 min, 
diluted with brine and extracted with EtOAc. The combined organic phases were washed with 
brine, dried over anhydrous Na2SO4, and filtered. The solvent was removed under reduced 
pressure and the residue was purified rapidly via flash chromatography (eluant: CH2Cl2/EtOH 
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30:1). Compound 14 was obtained as a green oil (910 mg, 89%), which was immediately used 
for the next synthetic step. 
Boc-bis-azo-L-Phe-OMe (15). A solution of freshly prepared compound 13 (1.0 g, 3.4 mmol) 
in glacial AcOH (15 mL) was added to a solution of compound 14 (1.15 g; 3.7 mmol) in 
glacial AcOH (15 mL). The mixture was stirred at r.t. for 24 h. The solvent was evaporated 
and the crude product was purified via flash chromatography (eluant: 50:1 CH2Cl2/EtOH). 
After precipitation from EtOAc/hexane, compound 15 was recovered as an orange solid (830 
mg, 43%). 
FT-IR absorption: ῡ 3356, 1752 1735, 1688, 1520 cm-1. HRMS (ESI+): m/z calcd. for 
584.2846, found 585.2832 [M+H]
+
. 
1
H NMR (200 MHz, CDCl3):  1.42 (s, 18H), 3.14-3.20 
(m, 4H), 3.73 (s, 6H), 4.58-4.68 (m, 2H), 5.03 (d, J=7.27 Hz, 2H), 7.27 (d, J=8.3 Hz, 4H), 
7.84 (d, J=8.3 Hz, 4H). 
H-bis-azo-L-Phe-OMe (16). The removal of the Boc protecting group was obtained by 
treating Boc-bis-azo-L-Phe-OMe (175 mg, 0.29 mmol) with an 1:1 TFA/CH2Cl2 mixture (10 
mL) at r.t. under stirring for 40 min. Then, the solvent was evaporated and the residue 
suspended in water and lyophilized. Product 16 was obtained as an orange solid (170 mg, 
98%). 
FT-IR absorption: ῡ 3425, 3007, 1748, 1674 cm-1. HRMS (ESI+): m/z calcd. for 384.1797, 
found 385.2035 [M+H]
+
. 
1
H NMR (200 MHz, DMSO-d6): δ 3.21 (d, J=5.3 Hz, 4H), 3.70 (s, 
6H), 4.42 (t, 2H), 7.46 (d, J=8.4 Hz, 4H), 7.86 (d, J=8.4 Hz, 4H), 8.59 (s br, 4H). 
13
C NMR 
(50 MHz, DMSO-d6) δ 169.41, 151.22, 138.51, 130.66, 122.84, 53.05, 52.81, 35.82. 
Compound (22), C3-symmetry initiator 
Boc-p-nitrobenzylamine (17). Solid Boc2O (4.5 g, 20.8 mmol) was added to a solution of p-
nitrobenzylamine (2 g, 10.6 mmol) and TEA (2 mL, 14.4 mmol) in CH2Cl2 (45 mL) cooled to 
0 °C. The mixture was stirred at r.t.  for 18 h. Then, the mixture was diluted with CH2Cl2 and 
washed with 5% KHSO4(aq) and brine. The organic phase was dried over MgSO4, filtered, and 
concentrated under reduced pressure. After precipitation from CH2Cl2/petroleum ether, 
compound 17 was recovered as a solid (1.8 g, 67%). 
FT-IR absorption: ῡ 3325, 2984, 2935, 2914, 1688, 1520, 1165 cm-1. HRMS (ESI+): m/z 
calcd. for C12H16N2O4 252.1110, found 197.0652 [M-tBu+H]
+
. 
1
H NMR (200 MHz, CDCl3): 
 1.46 (s, 9H), 4.40 (d, J=6.2 Hz, 2H), 4.98 (s br, 1H), 7.44 (d, J=8.7 Hz, 2H), 8.19 (d, J=8.7 
Hz, 2H). 
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Boc-4-(aminomethyl)phenylazobenzoic acid (19).
[22]
 Boc-p-nitrobenzylamine (1 g, 4 mmol) 
and NH4Cl (690 mg, 13 mmol) were dissolved in 5:1 EtOH/H2O (25 mL). Then, Zn dust (940 
mg, 14.4 mmol) was added and the obtained suspension was stirred at r.t. for 2 h. The 
suspension was filtered through celite, the filtrate was cooled to 0 ºC and a cold solution of 
FeCl3·6H2O (6.33 g, 23.4 mmol) in 5:1 EtOH/H2O (35 mL) was added. The mixture was 
stirred at 0 ºC for 30 min, diluted with brine, and extracted with EtOAc. The combined 
organic phases were washed with brine, dried over anhydrous Na2SO4, and filtered. The 
solvent was evaporated and the crude was rapidly purified via flash chromatography (eluant: 
100:1 CH2Cl2/MeOH), affording compound (18) as a green solid (880 mg), which was 
immediately used for the next synthetic step. This compound was dissolved in glacial AcOH 
(10 mL) and a solution of p-aminobenzoic acid (0.746 g, 5.4 mmol) in glacial AcOH (5 mL) 
was added. After 48 h under stirring at r.t., the mixture was concentrated and diluted with 
EtOAc. The organic solution was washed with 5% NaHCO3(aq), 5% KHSO4(aq), and brine. 
After drying over MgSO4, the filtrate was concentrated and the crude purified via flash 
chromatography (eluant: CH2Cl2/EtOAc, increasing the solvent mixture polarity from 9:1 to 
1:1). The compound was obtained as an orange solid after precipitation from 
EtOAc/petroleum ether (370 mg, 28%). 
FT-IR absorption: ῡ 3343, 2980, 1682, 1507, 1426, 1168 cm-1. HRMS (ESI+): m/z calcd. for 
C19H21N3O4 355.1532, found 356.1691 [M+H]
+
. 
1
H NMR (200 MHz, DMSO-d6):  1.41 (s, 
9H), 4.24 (d, J=6 Hz, 2H), 7.47 (d, J=8.4 Hz, 2H), 7.88-7.97 (m, 4H), 8.14 (d, J=8.4 Hz, 2H), 
13.18 (s, 1H). 
Compound (20). 2,4,6-Triallyloxy-1,3,5-triazine (5.03 g, 20.2mmol), 2-mercaptoethanol 
(8.66 g, 110.8 mmol) and DMPA (2,2-dimethoxy-2-phenyl-acetophenone) (376 mg, 1.5 
mmol) were mixed in a becker  and stirred under irradiation at 365 nm with a UV lamp for 40 
min. The mixture was diluted with MeOH (10 mL) and Et2O was added until the precipitation 
of an oily compound took place. The supernatant was removed and the oily compound was 
washed twice with Et2O. Compound 20 was recovered as a colorless oil (8.2 g, 84%). 
FT-IR absorption: ῡ 3389, 2920, 1567, 1417, 1332, 1140 cm-1. HRMS (ESI+): m/z calcd. for 
C18H33N3O6S3 483.1531, found 484.1626 [M+H]
+
. 
1
H NMR (200 MHz, CDCl3):  2.00-2.13 
(m, 6H), 2.30 (s br, 3H), 2.65-2.75 (m, 12H), 3.72 (t, J=6.2 Hz, 6H), 4.49 (t, J=6.2 Hz, 6H). 
Compound (21). To a solution of compound 19 (320 mg, 0.91 mmol), compound 20 (120 
mg, 0.25 mmol) and DMAP (36 mg, 0.29 mmol) in 10 mL of anhydrous DMF cooled to 0 °C, 
EDC·HCl (190 mg, 0.97 mmol) was added and the reaction mixture was stirred at r.t. for 48 
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h. The solvent was removed under reduced pressure, the residue dissolved in CH2Cl2 and 
washed with 5% KHSO4(aq) and brine. After drying over MgSO4, the filtrate was concentrated 
and the crude was purified via flash chromatography (eluant: CH2Cl2/MeOH, increasing the 
solvent mixture polarity from 60:1 to 40:1). Compound 21 was recovered as an orange solid 
(270 mg, 70%). 
FT-IR absorption: ῡ 3335, 2975, 1716, 1684, 1513, 1167 cm-1. HRMS (ESI+): m/z calcd. for 
C75H90N12O15S3 1494.5810, found 1495.6822 [M+H]
+
. 
1
H NMR (200 MHz, CDCl3):  1.48 
(s, 27H), 2.01-2.20 (m, 6H), 2.78 (t, J=7.1 Hz, 6H), 2.90 (t, J=7.1 Hz, 6H), 4.39 (s, 6H), 4.46-
4.53 (m, 12H), 4.95 (s br, 3H), 7.43 (d, J=8.4 Hz, 6H), 7.89-7.85 (m, 12H), 8.17 (d, J=8.6 Hz, 
6H). 
Compound (22). The removal of the Boc protecting group was obtained by treating 
compound 21 (61 mg, 0.041 mmol) with an 1:1 TFA/CH2Cl2 mixture (4 mL) at r.t. under 
stirring for 2 h. The solvent mixture was evaporated, the residue suspended in water and 
lyophilized. Product 22 was obtained as an orange solid (47 mg, 96%). 
FT-IR absorption: ῡ 3423, 2955, 1715, 1561, 1271 cm-1. HRMS (ESI+): m/z calcd. for 
C60H66N12O9S3 1194.4237, found 1195.5364 [M+H]
+
. 
1
H NMR (200 MHz, DMSO-d6):  
1.95-2.01 (m, 6H), 2.67-2.74 (m, 6H), 2.89-2.85 (m, 6H), 4.17 (s, 6H), 4.34-4.48 (m, 12H), 
7.70 (m, 6H), 7.98 (m, 12H), 8.13-8.17 (m, 6H), 8.41 (s, 12H). 
13
C NMR (50 MHz, DMSO-
d6): δ 172.52, 164.92, 154.38, 151.69, 149.90, 138.19, 131.66, 130.58, 130.01, 122.98, 
122.75, 66.34, 64.17, 59.30, 41.88, 32.56, 29.67, 28.17, 27.64. 
PBLG derivatives 
C2-Symmetry PBLG Hybrid (23). BLG-NCA (1.10 g, 4.2 mmol) was dissolved in dry 1,4-
dioxane (2 mL) under an N2 atmosphere and the solution was cooled to 0 °C. Then, a solution 
of compound (5) (5 mg, 0.013 mmol) in 2:1 1,4-dioxane/DMF (600 µL) solvent mixture was 
added and the mixture was stirred at 25 °C for 48 h. The mixture was diluted with 1,4-dioxane 
and the polypeptide hybrid was precipitated by adding MeOH. The obtained solid was 
filtered, washed with MeOH and Et2O, and dried in vacuo. The polypeptide hybrid was 
recovered as a light yellow solid (680 mg, 62%). 
SEC MW: 63500 (PDI 1.16). FT-IR absorption: ῡ 3295, 3003, 2951, 1734, 1653, 1546, 1163, 
cm
-1
. 
C3-Symmetry PBLG Hybrid (24). BLG-NCA (1.00 g, 3.81 mmol) was dissolved in dry 1,4-
dioxane (2.3 mL) under an N2 atmosphere and the solution was cooled to 0 °C . Then, a 
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solution of compound 22 (12 mg, 0.010 mmol) in DMF (1 mL) was added and the mixture 
was stirred at 25 °C for 72 h. The mixture was diluted with 1,4-dioxane and the polypeptide 
hybrid was precipitated by adding MeOH. The obtained solid was filtered, washed with 
MeOH and Et2O, and dried in vacuo. The polypeptide hybrid was recovered as a light yellow 
solid (750 mg, 76%). 
SEC MW: 46800 (PDI 1.56). FT-IR absorption: ῡ 3331, 3064, 2940, 1734, 1653, 1545, 1161 
cm
-1
. 
This synthesis was repeated under similar conditions by using a higher monomer/initiator 
ratio (500:1) and a prolonged reaction time (5 d). The polypeptide hybrid was recovered as a 
light yellow solid (550 mg, 56%). 
SEC MW: 154000 (pdi 1.66). FT-IR absorption: ῡ 3329, 3062, 2941, 1732, 1651, 1542, 1161 
cm
-1
. 
  
3. Functionalized helical polypeptides 106 
References 
[1] (a) A. R. Hirst, B. Escuder, J. F. Miravet, D. K. Smith, Angew. Chem. Int. Ed., 2008, 
47, 8002-8018; (b) G. M. Whitesides, M. Boncheva, Proc. Natl. Acad. Sci. USA, 2002, 
99, 4769-4774. 
[2] (a) G. M. Whitesides, B. Grzybowski, Science, 2002, 295, 2418-2421; (b) O. Ikkala, 
G. ten Brinke, Science, 2002, 295, 2407-2409; (c) J. A. A. W. Elemans, A. E. Rowan, 
R. J. M. Nolte, J. Mater. Chem., 2003, 13, 2661-2670. 
[3] (a) K. Numata, Polymer Journal, 2015, 47, 537-545; (b) J. Guo, Y. Huang, X. Jing, X. 
Chen, Polymer 2009, 50, 2847–2855; (c) F. Segura-Sánchez, V. Montembault, L. 
Fontaine, M. E. Martínez-Barbosa, K. Bouchemal, G. Ponchel, Int. J. Pharm. 2010, 
387, 244–252. 
[4] (a) H. Lu, J. Wang, Z. Song, L. Yin, Y. Zhang, H. Tang, C. Tu, Y. Lin, J. Cheng, 
Chem. Commun., 2014, 50, 139-155; (b) N. Hadjichristidis, H. Iatrou, M. Pitsikalis, G. 
Sakellariou, Chem. Rev., 2009, 109, 5528-5578. (c) H. R. Kricheldorf, Angew. Chem. 
Int. Ed., 2006, 45, 5752-5784. (d) Y. Shen, X. Fu, W. Fu, Z. Li Chem. Soc. Rev., 2015, 
44, 612-622. 
[5] (a) M. Zelzer, R. V. Ulijn, Chem. Soc. Rev., 2010, 39, 3351-3357; (b) J. Huang, A. 
Heise, Chem. Soc. Rev., 2013, 42, 7373-7390. 
[6] H. Block, Poly(-benzyl-L-glutamate) and Other Glutamic Acid Containing Polymers; 
Gordon and Breach: New York, NY, 1983. 
[7] D. Mazzier, M. Mba, M. Zerbetto, A. Moretto, Chem. Commun., 2014, 50, 4571-4574. 
[8] D. Mazzier, M. Favaro, S. Agnoli, S. Silvestrini, G. Granozzi, M. Maggini, A. 
Moretto, Chem. Commun., 2014, 50, 6592-6595. 
[9] D. Mazzier, M. Maran, O. Polo Perucchin, M. Crisma, M. Zerbetto, V. Causin, C. 
Toniolo, A. Moretto, Macromolecules, 2014, 47, 7272-7283. 
[10] B. Iskin, G. Yilmaz, Y. Yagci, Chem. Eur. J., 2012, 18, 10254-10257. 
[11] Y. Kim, W. Li, S. Shin, M. Lee, Acc. Chem. Res., 2013, 46, 2888-2897. 
[12] (a) S. N. Baker, G. A. Baker, Angew. Chem. Int. Ed., 2010, 49, 6726-6744; (b) S. Y. 
Lim, W. Shen, Z. Gao, Chem. Soc. Rev., 2015, 44, 362-381. 
3. Functionalized helical polypeptides 107 
[13] (a) H. P. Liu, T. Ye, C. D. Mao, Angew. Chem. Int. Ed., 2007, 46, 6473-6475; (b) K. 
Linehan, H. Doyle, RSC Adv., 2014, 4, 18-21; (c) L. Tian, D. Ghosh, W. Chen, S. 
Pradhan, X. Chang, S. Chen, Chem. Mater., 2009, 21, 2803-2809; (d) J. Hou, J. Yan, 
Q. Zhao, Y. Li, H. Ding, L. Ding, Nanoscale, 2013, 5, 9558-9561; (e) R. L. Liu, D. Q. 
Wu, S. H. Liu, K. Koynov, W. Knoll, Q. Li, Angew. Chem., 2009, 121, 4668-4671; 
Angew. Chem. Int. Ed., 2009, 48, 4598-4601; (f) W. Kwon, J. Lim, J. Lee, T. Park, S-
W. Rhee, Mater. Chem. C, 2013, 1, 2002-2008; (g) J. Zhou, X. Shan, J. Ma, Y. Gu, Z. 
Qian, J. Chena, H. Feng, RSC Adv., 2014, 4, 5465-5468. 
[14] (a) L. Cao, X. Wang, M. J. Meziani, F. S. Lu, H. F.Wang, P. J. G. Luo,Y. Lin, B. A. 
Harruff, L. M. Veca, D. Murray, S. Y. Xie, Y. P. Sun, J. Am. Chem. Soc., 2007, 129, 
11318-11319; (b) S. L. Hu, K. Y. Niu, J. Sun, J. Yang, N. Q. Zhao, X.W. Du, J. 
Mater. Chem., 2009, 19, 484-488; (c) Y. P. Sun, X. Wang, F. S. Lu, L. Cao, M. J. 
Meziani, P. J. G. Luo, L. R. Gu, L. M. Veca, J. Phys. Chem. C, 2008, 112, 18295-
18298; (d) X. Wang, L. Cao, F. S. Lu, M. J. Meziani, H. Li, G. Qi, B. Zhou, B. A. 
Harruff, F. Kermarrec, Y. P. Sun, Chem. Commun., 2009, 25, 3774-3776; (e) J. Peng, 
W. Gao, B. K. Gupta, Z. Liu, R. Romero-Aburto, L. Ge, L. Song, L. B. Alemany, X. 
Zhan, G. Gao, S. A. Vithayathil, B. A. Kaipparettu, A. A. Marti, T. Hayashi, J-J. Zhu, 
P. M. Ajayan, Nano Lett., 2012, 12, 844-849. 
[15] J. Jiang, Y. He, S. Li, H. Cui, Chem. Commun., 2012, 48, 9634-9636. 
[16] (a) Y. Li, Y. Zhao, H. Cheng, Y. Hu, G. Shi, L. Dai, L. Qu, J. Am. Chem. Soc., 2012, 
134, 15-18; (b) L. Li, G. Wu, G. Yang, J. Peng, J. Zhao, J-J. Zhu, Nanoscale, 2013, 5, 
4015-4039. 
[17] M. Favaro, S. Agnoli, C. Di Valentin, C. Mattevi, M. Cattelan, L. Artiglia, E. 
Magnano, F. Bondino, S. Nappini, G. Granozzi, Carbon, 2014, 68, 319-329. 
[18] P. Zhang, W. Li, X. Zhai, C. Liu, L. Dai, W. Liu, Chem. Commun., 2012, 48, 10431-
10433. 
[19] H. Choi, S-J. Ko, Y. Choi, P. Joo, T. Kim, B. R. Lee, J.-W. Jung, H. J. Choi, M. Cha, 
J-R. Jeong, I-W. Hwang, M. H. Song, B-S. Kim, J. Y. Kim, Nat. Photonics, 2013, 7, 
732-738. 
[20] P. K. Jaina, M. A. El-Sayed, Chem. Phys. Lett., 2010, 487, 153-164. 
3. Functionalized helical polypeptides 108 
[21] (a) J. Juodaityte, N. Sewald, J. Biotechnol. 2004, 112, 127-138; (b) P. Fatás, J. Bachl, 
S. Oehm, A. I. Jiménez, C. Cativiela, D. Díaz Díaz, Chem. Eur. J., 2013, 19, 8861-
8874. 
[22] R. Behrendt, M. Schenk, H. J. Musiol, L. Moroder, J. Pept. Sci., 1999, 5, 519-529. 
[23] H. Robson Marsden, J.-W. Handgraaf, F. Nudelman, N. A. J. M. Sommerdijk, A. 
Kros, J. Am. Chem. Soc., 2010, 132, 2370-2377. 
[24] M. Crisma, F. Formaggio, A. Moretto, C. Toniolo, Biopolymers (Pept. Sci.), 2006, 84, 
3-12. 
[25] M. El Hajji, S. Rebuffat, T. Le Doan, G. Klein, M. Satre, B. Bodo, Biochim. Biophys. 
Acta, 1989, 978, 97-104. 
[26] Farrar, D.; Ren, K.; Cheng, D.; Kim, S.; Moon, W.; Wilson, W. L.; West, J. E.; Yu, S. 
M. Adv. Mater., 2011, 23, 3954-3958. 
[27] G. J. M. Habraken, M. Peeters, C. H. J. T. Dietz, C. E. Koning, A. Heise, Polym. 
Chem., 2010, 1, 514-524. 
[28] K. Görmer, M. Bürger, J. A. W. Kruijtzer, I. Vetter, N. Vartak, L. Brunsveld, P. I. H. 
Bastiaens, R. M. J. Liskamp, G. Triola, H. Waldmann, Chem Bio Chem, 2012, 13, 
1017-1023. 
[29] A. Polidori, N. Michel, A. S. Fabiano, B. Pucci, Chem. Phys. Lipids, 2005, 136, 23-46. 
4. Self-assembling short peptides 109 
 
4. Self-assembling short peptides: synthesis and nanostructures 
formation 
The generation of many biological nanostructures, that plays a fundamental role in nature, 
occurs through the self-assembly process. Taking inspiration from nature, the bottom-up self-
assembly strategy has emerged as one of the most applicable approaches to create ordered 
structures from small molecule arrangements.
[1]
 The self-assembly process is mediated 
through a combination of intramolecular/intermolecular interactions including van der Waals, 
electrostatic, hydrogen bonding, and stacking interactions.
[2]
 The creation of ordered 
aggregates characterized by discrete 3D-architectures with specific shapes, dimensions and 
functions finds application in areas ranging from chemistry to materials science and medicine. 
In this connection, peptides offer important advantages as building blocks for the construction 
of self-assembled nanostructures
[3]
 because of their biocompatibility and structural/functional 
diversity. 
Nanotubes and nanofibers predominate as molecular architectures among the self-assemblies 
formed by short peptides
[4]
 of which the phenylalanine homo-dipeptide H-Phe-Phe-OH is the 
most extensively investigated example.
[5]
 Conversely, spherical nanostructures based 
exclusively on low molecular-weight peptides are much less common.
[6]
 
The chemical diversity of peptides may be further expanded with the use of non-proteinogenic 
α-amino acid residues. In the group where I carried out my PhD, a symmetrically α,α-
disubstituted glycine, bis[p-(phenylazo)benzyl]glycine (pazoDbg), that contains two side-
chain azobenzene moieties and undergoes reversible cis-trans isomerization upon exposure to 
light of the appropriate wavelength, has been already described
[7]
. In this chapter, the 
synthesis and self-assembly properties of derivatives and short peptides containing this 
photoswitchable α-amino acid will be presented.[8] 
In addition the self-assembly behaviour of a hydrophobic, terminally protected dipeptide Boc-
L-Leu-L-Cys(Me)-OMe and of its diacetylene derivative will be discussed.
[9]
 These 
compounds revealed the formation of nano‐, micro‐ and macroscale complex architectures in 
different conditions. 
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4.1 Photocontrolled self-assembly of azobenzene-containing peptides 
Intermolecular π-π stacking interactions involving aromatic side chains are a potent driving 
force for peptide self-assembly.
[6]
 Phe-Phe has been recognized as the minimal self-
assembling peptide sequence.
[5,10]
 The Fmoc protected derivative (Fmoc-Phe-Phe-OH) usually 
self-assembles in supramolecular nanostructures with fibrillar shape due to the additional 
aromatic interactions that involve the Fmoc group.
[11]
 We started our investigation with the 
substitution of one Phe residue with the photoswitchable α-amino acid pazoDbg, obtaining the 
dipeptide 1 (Fmoc-Phe-pazoDbg-OH, Figure 4.1 A). Compound 1 was synthesized by 
solution-phase methods. The reversible isomerization between the all trans (t) and all cis (c) 
forms [(t)1↔(c)1] upon irradiation with UV (350 nm) or Vis (450 nm) light was studied in 
MeOH solution by HPLC, CD, and UV-Vis absorption experiments (Figures 4.1 B-D and 
4.2). 
Figure 4.1 (A) Chemical structures of Fmoc-Phe-pazoDbg-OH (1); the all trans (t), cis/trans 
and trans/cis, and all cis (c) forms are shown. HPLC profiles of (t)1 solution (1 mM in 
MeOH) before irradiation (B), and after irradiation at 350 nm for 1 min (C) and 3 min (D). 
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The (t)1→(c)1 conversion was complete within 3 minutes. The HPLC profile obtained after 
1-minute UV irradiation of (t)1 (Figure 4.1 C) shows the presence of intermediate species in 
which only one azobenzene group has isomerized (note that pazoDbg becomes chiral in this 
state
[7]
). The UV-Vis absorption and CD spectra of (t)1 and (c)1 exhibit significant 
differences in the region above 220 nm (Figure 4.2) that we assigned primarily to different 
relative dispositions of the aromatic ring in the chiral Phe residue with respect to those in the 
achiral pazoDbg for the (c)1 and (t)1 forms, which allow for a more effective chirality transfer 
in (t)1. However, it should be noted that also the Fmoc chromophore is known to contribute to 
the electronic absorption and CD above 250 nm.
[12] 
Figure 4.2 (A) UV-Vis absorption spectra of (t)1 and (c)1 (0.1 mM solution in MeOH). (B) 
CD spectra of (t)1 and (c)1 (1 mM solution in MeOH). 
The self-assembly properties of 1 were investigated in an aqueous environment. The 
lyophilized dipeptide was dissolved in DMSO at a concentration of 50 mg/mL. A 20 μL 
aliquot of this solution was dropped into 1980 μL of water and vortexed for a few seconds.[10] 
The resulting suspension was submitted to size-exclusion chromatography by gel filtration 
(Sephadex G75) and eluted with water. Dynamic light scattering (DLS), transmission electron 
microscopy (TEM), scanning electron microscopy (E-SEM, FE-SEM), and atomic force 
microscopy (AFM) revealed that (t)1 forms spherical vesicle-like nanostructures with 
diameters of 50-200 nm (Figure 4.3).
 
BA
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Figure 4.3 Left: TEM (unstained, A) and SEM (B, field emission; C, environmental) images 
of the nanostructures formed by (t)1 in water. Right (top): AFM image of the (t)1 
nanostructures; the brightest spots correspond to the highest parts of the surface. Bottom: 
height profiles of selected nanospheres. 
The close similarity of the microscopy images obtained after the sample was let to stand at 
room temperature for several weeks indicates a high stability for the system. Irradiation at 350 
nm for 5 minutes to generate (c)1 resulted in deformation of the nanospheres to yield 
elongated shapes (Figure 4.4). This morphological change proved to be reversible as the 
spherical assemblies were recovered after illumination with Vis light [(c)1→(t)1]. The 
reversibility of the isomerization process was also confirmed by UV-Vis absorption 
spectroscopy along two cycles. Longer UV irradiation times resulted in complete disruption 
of the vesicles (Figure 4.4). These latter results suggest that the (t)1→(c)1 isomerization is 
somewhat hindered in the assembled structure (note that a 3-minute exposure to UV light 
allowed for complete isomerization in solution, Figure 4.1 C). Accordingly, the trans-to-cis 
isomerization of only a fraction of azobenzene moieties induces a slight rearrangement of the 
assembly, but the intermolecular attractive forces are still capable of essentially preserving the 
three-dimensional self-assembled structure. However, when the ratio of azobenzene moieties 
in the non-planar cis form reaches a certain level, the intermolecular packing mode is so 
strongly perturbed (due to shape change and less effective π-π stacking) that the ordered 
supramolecular architecture is not maintained and the spherical assemblies are transformed 
into amorphous aggregates. 
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Figure 4.4 TEM images (unstained) showing the morphological modification of the t(1) 
nanospheres upon exposure to UV light for 5 min (A, elongated spheres) or 15 min (B, 
disruption of the vesicles). 
A potential application of this photosensitive process to induce the controlled release of 
substances entrapped in the nanoassemblies was evaluated. A 20 μL aliquot of the above 
mentioned solution of (t)1 in DMSO was mixed with 1980 μL of a 10 mg/mL aqueous 
solution of gold nanoparticles (GNps, 2 nm size) coated with a helical undecapeptide.
[13]
 After 
a short vortex agitation, the suspension obtained was submitted to gel filtration and thus 
separated from the non-encapsulated peptide-coated GNps. Microscopy studies revealed the 
presence of nanostructures similar in morphology to those formed by (t)1 in the absence of 
GNps. UV irradiation of the gel-filtered sample (10 min) resulted in partial disruption of the 
vesicles with concomitant release of the encapsulated peptide-coated GNps, as detected by 
TEM (Figure 4.5).
 
Figure 4.5 TEM images (unstained) showing: (A) nanospheres formed by (t)1 and peptide-
coated GNps; (B) the nanospheres disassembly induced by UV irradiation; (C) details of 
released GNps (black dots). 
B 
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Recently, novel, stimulus-responsive supramolecular structures in the form of fibers, gels, and 
spheres, derived from an azobenzene-containing benzenetricarboxamide derivative, were 
described by Kim and coworkers.
[14]
 Therefore, we next decided to conjugate H-(pazoDbg)-
OEt to 1,3,5-trichlorotriazine with the aim at exploring the supramolecular stimuli response of 
a novel C3-symmetrical tris-azobenezene system (compound 2, Figure 4.6 A). H-(pazoDbg)-
OEt, 1,3,5-trichlorotriazine and triethylamine were mixed in a DMF solution for 48 hours, 
affording 2 in 69 % yield. All six azobenzene units were able to switch reversibly in a MeOH 
solution from the (t)↔(c) states (Figure 4.6 A) under appropriate irradiation. The 
intermediates were detected by HPLC. 
Figure 4.6 (A) Chemical structure and isomerization process of compound 2 formed by our 
pazoDbg-containing building block tris-conjugated to the 1,3,5-triazine template. (B) TEM 
images of the light-driven, microstructure morphological transition of this system, generated 
from a DMSO/H2O suspension. 
Spherical microstructures were generated (in form of milk-like suspension) from a 15 mM 
(1:7) DMF/THF solution dialyzed (membrane cutoff, 1 KD) against ultrapure water (48 h) 
(Figure 4.6 B, left). Under (20 min) UV irradiation, a morphological transition from the 
suspension to gel was observed. We recorded TEM images over different times of irradiation. 
The analysis revealed a conversion from spheres to elongated spheres (5 min), and eventually 
to a mixture of spherical/elongated fibers (20 min) (Figure 4.6 B, center and right, 
respectively). Irradiation of the gel with Vis light resulted in gel disruption, followed by 
precipitation of the obtained amorphous aggregates which do not undergo light-induced 
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conversion any further. The formation of vesicles and hydrogel microstructures was also 
confirmed by AFM analysis (Figure 4.7). 
Figure 4.7 AFM images of vesicles (left) and fibers (hydrogel, right) obtained from 2. 
Finally, we expanded the use of our pazoDbg amino acid to the synthesis of the “octopus” 
system 3 (Figure 4.8 A) to generate photoresponsive C4-symmetrical, dendrimeric-like, 
multiazobenzene systems. Tfa-(pazoDbg)-OH (Tfa, trifluoroacetyl), reacted with 
pentaerythritol in presence of N,N'-diisopropylcarbodiimide and N,N-dimethylaminopyridine 
afforded 3 in a remarkable 90 % yield. The resulting system is characterized by as many as 
eight azobenzene moieties and can be viewed as a central core surrounded by a shell of 
azobenzene groups at the periphery. 
Figure 4.8 (A and B) Chemical structure and isomerization process of the system (3) formed 
by our pazoDbg-containing building block tetra-conjugated to the pentaerythritol template. 
(C) HPLC profile of a solution in MeOH of 3 irradiated at 350 nm for 3 min. 
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Up to eleven (out of the possible fifteen, Figure 4.8 B) discrete states produced by trans-to-cis 
isomerizations of the individual azobenzene units were observed by reverse-phase HPLC 
depending on the time of exposure of 3 (in a MeOH solution) to the UV light (Figure 4.8 C). 
This process is fully reversible (cis-to-trans) under Vis light irradiation for several cycles. 
Moreover, this system shows a high propensity to self-assemble in a variety of organic (DMF, 
DMSO, THF, MeOH, CH3CN)/aqueous solutions (even at low concentration, below 1 mM) to 
generate supramolecular vesicles as revealed by TEM experiments (Figure 4.9 A). These 
vesicles were able to rearrange, depending on the exposure time to UV light, to: (i) a sponge-
like microstructure (10 min) (Figure 4.9 B and inset) and (ii) to fibers (40 min) (Figure 4.9 C). 
These microstructure rearrangement was reversibly controlled under exposure to Vis light, 
which produced sponge-like microstructures (20 min) (Figure 4.9 D), followed by a mixture 
of fiber, sponge-like and spherical microstructures (1 h) (Figure 4.9 E) and finally by almost 
only spherical microstructures (2 h) (Figure 4.9 F). 
Figure 4.9 TEM images of the light-driven, reversible, vesicle-to-sponge-to-fiber 
microstructure transitions underwent by 3. 
The vesicle-to-sponge-to-fiber microstructure transition occurring for 3 was additionally 
studied by AFM. Vesicles and fibers are reported, respectively, in Figures 4.10 A and B. The 
sponge-like microstructures (Figure 4.10 C) were characterized in a mixture with fiber, under 
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same conditions as those reported for Figure 9B. The height profiles of selected sponges 
reveal the irregular 3D-morphology present on their surface.  
Figure 4.10 AFM images of vesicles (A) and fibers (B) from 3. (C) AFM image of a mixture 
of sponges and fibers from 3, and height profiles of selected nano-sponges. 
Conclusions 
In summary, the compounds described, containing the photoresponsive amino acid pazoDbg 
and characterized by different geometries, are able to promote the formation of well-ordered 
supramolecular nanostructures in water. Moreover the presence of the light-responsive 
azobenzene moieties renders photoresponsive the microstructures, thus allowing triggering of 
reversible transitions between different morphologies transition upon irradiation with light at 
the appropriate wavelength. 
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4.2 Self-assembled architectures from a hydrophobic dipeptide 
 
Molecular architectures obtained by the self-assembly of short unprotected peptides 
predominate in the field of peptide supramolecular chemistry.
[4]
 Conversely, only a few 
examples of terminally-protected peptides, the crystal structures of which are characterized by 
a nanotube architecture, were reported, but their self-assembly properties have not been 
further explored.
[15]
 In this context, we synthetized a hydrophobic, terminally protected 
dipeptide Boc‐L‐Cys(Me)‐L‐Leu‐OMe (4) (where Boc is tert‐butoxycarbonyl, Cys(Me) is S‐
methyl cysteine, and OMe is methoxy) (Figure 4.11 A) that is able to self‐assemble producing 
nano‐, micro‐ and macroscale complex architectures. 
The X‐ray diffraction structure of 4 was determined on a single crystal grown from MeOH 
(Figure 4.11 B). The conformation adopted by both α‐amino acid residues is semiextended, 
and the N‐H groups of Cys and Leu point to opposite directions. In the packing mode (Figure 
4.11 C), the N1‐H group is intermolecularly H‐bonded to the (y, ‐x+y, z+1/6) symmetry 
equivalent of the (urethane carbonyl) O0 atom, and the N2‐H group is H‐bonded to the (x‐y, x, 
z‐1/6) symmetry equivalent of the (amide) O1 atom. As a result, H‐bonded molecules wrap 
around the sixfold screw axis along the c direction, each molecule being connected to the next 
by two H‐bonds. The left-handed, supramolecular sixfold helix thus generated is characterized 
by a very narrow internal lumen, about 2.5 Å in diameter (Figure 4.11 C, bottom). 
Figure 4.11 (A) Chemical formula of dipeptide 4. (B) X‐Ray diffraction structure of 4 with 
atom numbering. (C) Packing mode of 4 in the crystal. A single helical row of molecules is 
shown as viewed perpendicularly (upper part) and down (lower part) the sixfold screw axis. 
Intermolecular H‐bonds are indicated by dashed lines. (D) Overall packing of 4 molecules as 
viewed nearly down the c axis. Carbon, grey; nitrogen, blue; oxygen, red; sulphur, yellow. 
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The Cys(Me) and Leu side chains, as well as the N‐ and C‐terminal Boc and OMe groups of 
each molecule are located on the external surface. Each helical row of molecules is 
surrounded by six counterparts (Figure 4.11 D). Lateral stabilization between rows is 
provided, in addition to van der Waals interactions, by C‐H∙∙∙O interactions taking place 
between the (Boc) C02‐H02B group and the (x‐1, y‐1, z) symmetry equivalent of the (methyl 
ester) OT atom. 
Dipeptide 4 is able to adopt a well‐organized, micro 3D arrangement when allowed to self‐
assemble under appropriate conditions. As a first experiment, upon slow evaporation of a 
concentrated solution of 4 in 1,1,1,3,3,3‐hexafluoroisopropanol (HFIP), flower‐like 
microstructures, homogenous in size and characterized by large and empty cavities were 
obtained (SEM images, Figure 4.12).  
Figure 4.12 (A) SEM image of 4 after slow evaporation from HFIP solution. Inset: frontal 
detail of one flower‐like microstructure. (B) SEM detail (lateral view) of one flower‐like 
microstructure. 
Conversely, the slow evaporation of concentrated solutions of 4 in either EtOAc, CH3CN or 
acetone led to the formation of long, aligned rods (up to 10 cm in length) as shown in Figures 
4.13 A and B. Interestingly, such are rods characterized by an overall parallelepiped shape 
that present an empty inner cavity (Figure 4.13 B). Smaller and packed rods of 4 (at the 
microscale level) were obtained by interfacial crystallization between water and EtOAc, as 
revealed by SEM images (Figure 4.13 C). Moreover, by adding a diluted solution of 4 in 
MeOH to a large excess of water, formation of micrometric, isolated rods was observed 
(Figure 4.13 D). According to a SEM analysis (Figures 4.13 E and F), even at this microscale 
level, the rods are characterized by an empty inner cavity while maintaining the overall 
parallelepiped shape found at the macroscale level. 
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Figure 4.13 (A) Camera picture of macroscopic rods from 4 obtained after evaporation from a 
concentrated solution in CH3CN. (B) Camera picture showing details of a macroscopic rod 
obtained from a CH3CN solution. (C) SEM image of micrometric rods from 4 obtained from a 
water/EtOAc interfacial crystallization. (D) SEM image of micrometric rods from 4 obtained 
from a water/MeOH solution. (E,F): SEM images showing details of the rods (obtained from 
a water/MeOH solution). 
Peptide 4 was further studied by circular dichroism in CH3CN solution and as solid-state rods 
obtained after evaporation from the same solvent (Figures 4.14 A and B). Notably, 4 shows a 
strong aggregation propensity in CH3CN solution at concentrations above 1 mg/mL (Figure 
4.14 A). This conclusion is justified by the change of the Cotton effect near 195 nm from 
weakly positive at 0.3 mg/mL concentration to strongly negative at concentrations in the 
range 2-10 mg/mL, accompanied by a marked increase in ellipticity of the positive Cotton 
effect at about 218 nm. The CD spectra of the most concentrated solutions nicely resemble the 
spectrum obtained in the solid state (Figure 4.14 B), i.e. that of the rod structure, although the 
latter would be entirely red-shifted, albeit slightly. 
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Figure 4.14 (A) CD spectra of 4 at different concentrations in CH3CN solution. (B) Solid-
state CD spectra of rods obtained from CH3CN. (C) Comparison of simulated PXRD 
measurements (from single-crystal X-ray diffraction) with experimental results on rods 
obtained from the CH3CN and MeOH/water preparation methods. (D) Comparison of Raman 
spectra of the rods obtained from the EtOAc/water and CH3CN preparation methods. 
The powder X-ray diffraction (PXRD) technique was exploited in order to check whether 
formation of rods characterized by an empty cavity at the macro- and microscale level 
(prepared from CH3CN and MeOH/water, respectively) could be ascribed to a supramolecular 
organization different from that determined at the single crystal level. The PXRD patterns of 
the rods prepared by the two methods (CH3CN and MeOH/water) are identical to each other 
all over the 2θ range investigated, and virtually overlapping to the simulated pattern of the 
single crystal X-ray diffraction sample (Figure 4.14 C). In addition, the values of the unit cell 
parameters extracted from the two experimental PXRD patterns are in excellent agreement 
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with those of the single crystal. These results clearly indicate that, although different 
preparation methods lead to different morphologies, the 3D-supramolecular organization 
adopted by 4 in the crystal state is shared by the micro- and macro-hollow rods. Similar 
conclusions were extracted from a Raman study (Figure 4.14 D). Indeed, the rods obtained 
from the EtOAc/water and CH3CN preparation methods exhibit identical Raman signatures. 
To gain in-depth information on the nature of the rod architectures, we investigated the 
mother liquor remained after the MeOH/water preparation method. The transmission electron 
microscopy (TEM) analysis of this mixture carried out on stained (uranyl acetate) samples 
showed the presence of nano- and micrometric rods (Figure 4.15 A). 
Figure 4.15 (A) Stained TEM image after filtration of the macroscopic rods from a 
MeOH/water solution of 4. (B) Stained TEM image showing details of the self-assembled 
rods. (C) Stained TEM image showing details of the multiwall nature of a nanoscopic rod. 
A more detailed investigation of these samples revealed two interesting features. First, we 
observed the presence of “incompletely folded” rods, which confirmed the tubular nature of 
such type of architecture (Figure 4.15 B). Second (Figure 4.15 C), we noticed a multilayer 
structure of the external part of the rod. In a few cases, our TEM analysis of the same, but 
non-stained, sample (Figure 4.16 A) revealed the typical structure of a multiwall nanotube 
characterized by two parallel, dark lines, associated to a higher material density, occurring at 
the boundaries of the rods. Interestingly, these images are similar to those that can be obtained 
from the TEM analysis performed on multi-walled carbon nanotubes samples.
[16]
 To prove the 
existence of such a type of hollow superstructure, we made use of citrate-passivated (water 
soluble) gold nanoparticles (10-nm diameter)
[17]
 which were added to the MeOH/water 
solution. After the self-assembly process, the results of TEM analysis (non-stained samples, 
Figure 4.16 B), energy-dispersive X-ray spectroscopy (EDX) (Figure 4.16 C), and optical 
microscopy (polarized light, Figures 4.16 D and E) clearly showed that the gold nanoparticles 
are incorporated into the rod structures. 
5 mm 2 mm 500 nm
A
B
C
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Figure 4.16 (A) Non-stained TEM image of a nanorod from 4. (B) Non-stained TEM image 
showing the encapsulation of water-soluble gold nanoparticles into a rod. (C) SEM image and 
EDX pattern of the 4-nanotube/gold nanoparticles hybrid rods. (D) Optical microscopy image 
of 4-rods prepared from MeOH/water under polarized light. (E) Optical microscopy image of 
co-assembled 4-rods/gold nanoparticles under polarized light. 
Interestingly, the positional isomer of peptide 4, Boc-L-Leu-L-Cys(Me)-OMe (5, Figure 
4.17), turned out to be also amenable to a single-crystal X-ray diffraction analysis. Peptide 5 
crystallizes in the orthorhombic space group P212121. The packing mode of 5 is characterized 
by the occurrence of two intermolecular H-bonds, namely between the N1-H group and the 
(x+1, y, z) translational equivalent of the (urethane carbonyl) O0 atom, and between the N2-H 
group and the (x-1, y, z) translational equivalent of the (peptide) O1 atom. Although the H-
bond donor and acceptor atoms are the same as in the intermolecular H-bonding scheme of 4, 
the different symmetry operators involved result in a completely different overall packing 
arrangement. Indeed, at variance with the helical packing of 4, the packing mode of 5 can be 
described as a highly corrugated arrangement of molecules in the bc plane, with the 
intermolecular H-bonds connecting molecules along the a direction (Figure 4.17 C). 
However, 5 was unable to generate any superstructure, thus suggesting a strong connection 
between packing mode and self-assembly behaviour. Interestingly, quite recently a strictly 
related observation was published, namely that sequence exchange in an unprotected 
dipeptide (Val-Ala vs. Ala-Val) strongly affects its molecular structure and the related self-
assembly tendency.
[18]
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Figure 4.17 (A) Molecular formula of 5. (B) X-Ray diffraction structure of 5 with atom 
numbering. Only the major occupancy site for the disordered Leu side chain is shown. (C) 
Overall packing of 5 as viewed nearly down the b axis. The intermolecular H-bonds are 
indicated by dashed lines. 
Subsequently, we decided to chemically modify 4, to explore effects of the modifications on 
its self-assembly propensity. To this aim 4 was first converted to 6 via transamination with 
propargylamine in the presence of catalytic DBU (Scheme 1).
[19]
 
Then the corresponding diacetylene 7 was prepared via Ni-catalyzed oxidative homocoupling 
reaction of terminal alkynes (Scheme 4.1).
[20] 
Scheme 4.1 Synthesis of 6 and 7. Reagents and conditions: i) propargylamine, DBU (20% 
mol), r.t., 48 h; ii) CuI (5% mol), NiCl2∙H2O (5% mol), TMEDA(20% mol), THF, r.t., 48 h. 
Compound 7 showed different propensity to aggregate compared to 4, in fact it is able to form 
an organogel in CH2Cl2 (Figure 4.18, right). 
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It is known that diacetylenes undergo radical polymerization by heating or under UV-light 
irradiation without the need for chemical initiators or catalysts.
[21]
 The polydiacetylenes thus 
obtained are π-conjugated polymers that have alternating ene–yne backbone structures. These 
conjugated polymers generally have intense color and several intriguing properties indeed 
they have received much attention as conductive and non-linear optical materials. Howecer, a 
necessary condition for the topochemical polymerization of diacetylenes is that the 
diacetylene groups are aligned and placed in the appropriate spatial proximity. To test the 
possibility to obtain the polydiacetilene from derivative 7, we applied UV light at 254 nm to 
the organogel (Figure 4.18, bottom). A polymeric orange film was then obtained, confirming 
that the proximity condition was satisfied. 
Figure 4.18 Top: images of solution and organogel obtained from 7 in CH2Cl2 (20 mg/mL); 
left: Schematic representation of light induced polymerization occurring for diacetylenes. 
Bottom: Images of the organogel obtained from 7 in CH2Cl2 before, during and after UV-light 
irradiation. 
TEM, SEM and AFM analysis of the organogel revealed the formation of a dense network of 
small fibers (Figures 4.19 A, D and E). Successively, TEM and AFM analysis of the sample 
irradiated with UV light showed that the dense network of small fibers was almost replaced 
by longer and larger new structures (Figures 4.19 B, C and F). 
Compound 7 is also able to self-assemble forming sponge-like 3D microstructures upon slow 
evaporation of a concentrated solution in MeOH. These microstructures are homogenous in 
size (5-10 μm) and shape (SEM images, Figures 4.20 A-C). The polymerization was obtained 
UV irradiation
or heat
UV irradiation l=254 nm
Solution
in CH2Cl2
gel
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after irradiation even in these objects, obtaining red polydiacetilene spheres (Figures 4.20 E-
F). 
Figure 4.19 TEM images of organogel obtained from 7 in CH2Cl2 (A), after irradiation for 30 
min (B) and for 1 h (C). (D) SEM images of the organogel. AFM images of the organogel 
before (E) and after (F) irradiation for 1 h. 
Figure 4.20 (A-C) SEM images of microstructures obtained from slow evaporation of 
methanolic solution of 7. Optical microscopy images of microstructures obtained from slow 
evaporation of methanolic solution of 7 before (D) and after irradiation at 254 nm for 1 h (E) 
and 2 h (F). 
A B 
C 
D E F 
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Conclusions 
To summarize, we showed that a terminally protected, hydrophobic dipeptide, Boc-L-
Cys(Me)-L-Leu-OMe (4), is able to hierarchically self-assemble in well-defined structures. In 
particular, evaporation from organic solvents (e.g., EtOAc, CH3CN, acetone) or interfacial 
(EtOAc/water and MeOH/water) crystallizations led to the formation of hollow rods ranging 
from the nano- to the macroscale. In addition, the diacetylene derivative (7) obtained by 
chemical modification of (4) is able to assemble in an organogel in CH2Cl2 or to form sponge-
like spheres by slow evaporation from MeOH. After irradiation of these microstructures it is 
possible to obtain the orange polydiacetylene derivative. 
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4.3 Experimental Section 
Instruments and Methods 
Nuclear Magnetic Resonance. 
1
H and 
13
C NMR spectra were recorded at room temperature 
on a Bruker AC-200 (200 MHz) and Bruker AC-300 (300 MHz) instruments using the 
partially deuterated solvent as the internal reference. Chemical shifts (δ) are expressed in 
ppm. The multiplicity of a signal is indicated as: br - broad, s - singlet, d - doublet, t - triplet, 
m - multiplet, etc. 
High resolution Mass Spectrometry.. Mass spectra were obtained by electrospray ionization 
(ESI) on a Perseptive Biosystem Mariner ESI-ToF spectrometer (Foster City, CA). Data were 
collected in positive mode. 
Fourier Transform-Infrared Spectroscopy. FT-IR absorption spectra in KBr disc were 
recorded with a Perkin-Elmer 1720X spectrophotometer. The ῡ maxima for the main 
absorption bands are given. 
High-Performance Liquid Chromatography. HPLC was performed on an Agilent 1200 series 
apparatus equipped with a UV detector at variable wavelengths. Conditions: Phenomenex 
C18 (100Å) (stationary phase), 45-100% B in 25 min, 1 mL/min (eluants: A=9:1 
H2O/CH3CN, 0.05%TFA; B=1:9 H2O/CH3CN, 0.05% TFA). 
UV-Vis Absorption. The UV-Vis absorption spectra were recorded using a Shimadzu model 
UV-2501 PC spectrophotometer. A 1-cm path length quartz cell was used. 
Circular Dicroism. CD measurements were carried out at room temperature using a Jasco J-
715 spectropolarimeter. A fused quartz cell of 0.2-mm path length (Hellma) was used. 
Transmission Electron Microscopy. Samples were analyzed on a Jeol 300 PX instrument. 
Samples were prepared immediately before use. A small drop of solution was floated on a 
glow discharged carbon coated grid and excess was removed by #50 hardened Whatman 
filter paper. For the samples with negative staining, the grid was then floated on 2% uranyl 
acetate solution for 10 seconds, and the excess was removed by #50 hardened Whatman 
filter paper. 
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Field Emission Scanning Electron Microscope. A Carl Zeiss Merlin FE-SEM operating at 5 
kV accelerating voltage was used. A small drop of the aqueous suspension was placed on a 
microscope glass cover slip and allowed to dry overnight. 
Environmental Scanning Electron Microscope. Samples were analyzed on a Quanta FEG 
250 E-SEM operating at 10–20 kV and using a gaseous secondary electron detector. 
Measurements were carried out in the wet mode (52–100% humidity) at 1 °C. 
Atomic Force Microscopy. A small drop of sample was placed on a mica or silicon surface 
and allowed to dry in air for at least 60 min before measurement. AFM experiments were 
performed on two different instruments: 
(i) Ntegra Aura (NT-MDT) instrument operating in tapping mode at 200−400 kHz drive 
frequency and using a single crystal silicon tip coated with TiN (NSG01/TiN, 0.01-0.025 Ω-
cm, antimony dope). 
(ii) Agilent Technologies 5500 scanning probe microscope, operating in acoustic AC AFM 
mode (tapping mode) with a silicon Asylum Research high frequency cantilever displaying a 
resonance frequency of 305 kHz.  
Dynamic Light Scattering (DLS). Particle size analyses were carried out at 25 °C on a 
Malvern Zetasizer Nano-S instrument using a He-Ne laser (633 nm) and a scattering angle of 
176°. 
X-Ray diffraction. Single crystals of Boc-L-Cys(Me)-L-Leu-OMe (4) and Boc-L-Leu-L-
Cys(Me)-OMe (5) were grown by slow evaporation from MeOH. Relevant crystal data, 
structure refinement parameters and details specific to the individual structures are given 
below (Tables S1-5). CCDC-1057628 and 1057629 contain the supplementary 
crystallographic data. These data can be obtained from The Cambridge Crystallographic Data 
Centre 
(i) Single crystal X-ray diffraction data were collected with an Agilent Technologies Gemini 
E four-circle kappa diffractometer equipped with a 92 mm EOS CCD detector, using graphite 
monochromated Cu K radiation (l = 1.54178 Å). Data collection and reduction were 
performed with the CrysAlisPro software (version 1.171.36.28; Agilent Technologies). A 
semi-empirical absorption correction based on the multi-scan technique using spherical 
harmonics, implemented in the SCALE3 ABSPACK scaling algorithm, was applied. The 
structures were solved by ab initio procedures of the SIR 2002 program,
[22]
 and refined by 
full-matrix least-squares on F
2
 using all data, by application of the SHELXL-97 program,
[23]
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with anisotropic displacement parameters for all of the non-H atoms. H-Atoms were 
calculated at idealized positions and refined using a riding model. 
(ii) Powder X-ray diffraction measurements (PXRD) were carried out by means of a Bruker 
D8 Advance diffractometer equipped with a Göbel mirror and a Cu Kα source (40 kV, 40 
mA). Powder pattern indexing was performed by use of the N-TREOR
[24]
 software in the 
framework of the EXPO2013
[25]
 package. 
 
Materials 
1-hydroxy-7-aza-1,2,3-benzotriazole (HOAt) was purchased from GL Biochem (Shanghai) 
Ltd. H-Cys(Me)-OH, H-Leu-OMe∙HCl, Boc-Leu-OH, Fmoc-Phe-OH and N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC∙HCl) were obtained from 
Iris Biotech (Germany). Trifluoroacetic anhydride, N,N'-diisopropylcarbodiimide (DIC), 
2,4,6-trichloro-1,3,5-triazine, 4-(dimethylamino)pyridine (DMAP), di-tert-butyl dicarbonate 
(Boc2O), thionyl chloride, propargylamine, 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU), 
Triethylamine (TEA), N,N,N′,N′-Tetramethylethylenediamine (TMEDA), copper(I) iodide 
and nickel(II) chloride hydrate were obtained from Sigma-Aldrich. The deuterated solvent 
DMSO-d6, CDCl3 was purchased from Euriso-Top (France). All other chemicals and 
solvents were purchased from Sigma-Aldrich, Fluka or Acros products and used as provided 
without further purifications. 
H-pazoDbg-OH and H-pazoDbg-OEt have been previously synthesized in our laboratory.
[7]
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Synthesis and Characterizations 
a) Synthesis of azobenzene-containing peptides 
Tfa-pazoDbg-OH. To a 1:1 solution of trifluoroacetic anhydride/CH2Cl2 (8 mL), solid 
HCl·H-pazoDbg-OH was added. The mixture was allowed to stir under reflux for 12 h. The 
solvent was removed under reduced pressure and the obtained residue was dissolved in 
EtOAc, washed successively with 10% KHSO4(aq) and water, dried over Na2SO4, and EtOAc 
evaporated to dryness, giving Tfa-pazoDbg-OH in 90 % yield.  
HRMS (ESI+): m/z calcd. for C30H24F3N5O3 559.1831, found 560.2048 [M+H]
+
. FT-IR 
absorption: ῡ 3327, 3060, 2938, 1719, 1602, 1519 cm-1. 1H NMR (CDCl3, 200 MHz) δ 3.44 
(d, 2H, J=11.8 Hz), 3.65 (s br, 2H), 7.19 (d, 6H, J=7.4 Hz), 7.41-7.38 (m, 7H), 7.66-7.74 (m, 
8H). 
13
C NMR (CDCl3, 50 MHz) δ 40.26, 67.89, 112.64, 118.64, 122.66, 123.14, 123.79, 
129.11, 130.72, 131.34, 139.03, 151.75, 152.33, 157.00, 177.11. 
Fmoc-L-Phe-pazoDbg-OH t(1). Fmoc-Phe-OH (250 mg, 0.65 mmol) and HOAt (88 mg, 
0.65 mmol) were dissolved in dry DMSO (8 mL) at 0 oC. N,N'-diisopropylcarbodiimide (DIC) 
(79 μL, 0.65 mmol) was added and the resulting mixture was vigorously stirred for 30 min. 
Next, a solution of H-pazoDbg-OH (300 mg, 0.65 mmol) in DMSO (2 mL) was added, 
followed by TEA (180 μL, 1.3 mmol), and the mixture was stirred at 50 °C for 2 days. The 
reaction mixture was diluted with water and the resulting suspension was centrifuged. The 
residue obtained was taken up in EtOAc and washed successively with 10% KHSO4(aq), water, 
5% NaHCO3(aq), 0.5 M HCl and water, dried over Na2SO4(aq) and evaporated to dryness. 
Purification by flash chromatography (eluant: CHCl3/MeOH 95:5) afforded pure t(1) in 78% 
yield. 
HRMS (ESI+): m/z calcd. for C52H44N6O5 832.3373, found 833.3887 [M+H]
+
. FT-IR 
absorption: ῡ 3393, 3053, 2932, 1715, 1673, 1602, 1499 cm–1. 1H NMR (DMSO-d6, 300 
MHz) δ 2.72 (dd, 1H, J=15.0, 3.0Hz), 3.04 (dd, 1H, J=15.0, 12.0 Hz), 3.20–3.50 (m, 2H), 
3.71 (d, 1H, J=12.5 Hz), 3.81 (d, 1H, J=13.0 Hz), 3.90–4.20 (m, 4H), 7.05–7.95 (m, 31H). 
13
C NMR (DMSO-d6, 75 MHz) δ 37.91, 47.14, 58.67, 66.65, 66.98, 120.69, 122.67, 123.09, 
125.94, 126.22, 126.99, 127.79, 128.25, 128.89, 129.65, 129.95, 130.07, 130.14, 131.06, 
131.79, 131.97, 139.50, 141.30, 144.55, 151.06, 151.24, 152.78, 156.36, 171.83, 172.72. 
C3 symmetrical system t(2). To a solution of 2,4,6-trichloro-1,3,5-triazine (39 mg, 0.16 
mmol) and TEA (170 ml, 1.28 mmol) in anhydrous DMF (4 mL), solid HCl·H-pazoDbg-OEt 
(0.35 g, 0.64 mmol) was added. The mixture was allowed to stir at r.t. for 48 h. The solvent 
was removed under reduced pressure and the crude was purified by flash-chromatography 
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(eluant: CHCl3/MeOH 95:5) giving t(2) as a red oil in 69 % yield. 
HRMS (ESI+): m/z calcd. for C93H84N18O6 1548.6821, found 1549.7334 [M+H]
+
. FT-IR 
absorption: ῡ 3376, 3060, 2978, 2929, 1731, 1691, 1446 cm-1. 1H NMR (200 MHz, CDCl3) δ 
1.29 (t, 9H, J = 7.1 Hz), 2.79 (s, 3H), 3.01 (d, 6H, J = 13.1 Hz), 3.51 (d, 6H, J = 13.1 Hz), 
4.18 (q, 6H, J = 7.1 Hz), 7.60-7.30 (m, 30H), 7.99-7.72 (m, 24H). 
13
C NMR (200 MHz, 
CDCl3) δ 14.38, 46.34, 61.47, 63.22, 122.58, 122.95, 123.76, 129.20, 131.14, 132.73, 
137.44, 137.44, 152.73, 152.83, 175.68. 
C4 symmetrical system t(3). To a solution of pentaerythritol (25 mg, 0.18 mmol), Tfa-
pazoDbg-OH (0.51 g, 0.92 mmol) and 4-(dimethylamino)pyridine (23 mg, 0.18 mmol) in 5 
mL of anhydrous DMF, N,N'-diisopropylcarbodiimide (0.18 g, 1.44 mmol) was added and the 
reaction was allowed to stir at 50 °C for 4 days. The solvent was removed under reduced 
pressure and the crude was purified by flash-chromatography (eluant: CH2Cl2/EtOH 98:2) 
giving t(3) as a red glass-solid in 90 % yield. 
HRMS (ESI+): m/z calcd. for C125H100N20O12 2300.7638, found 1151.4121 [M+2H]
2+
. FT-IR 
absorption: ῡ 3384, 3058, 2940, 1726, 1529 cm-1. 1H NMR (CDCl3, 200 MHz) δ 3.30 (d, 8H, 
J= 14.0 Hz), 3.51 (d, 8H, J= 14.0 Hz), 3.83 (s, 8H), 6.82 (s, 4H), 7.04-7.08 (m, 16H), 7.40-
7.47 (m, 24 H), 7.75-7.83 (m, 32 H). 
13
C NMR (CDCl3, 50 MHz) δ 40.71, 43.25, 63.04, 
66.22, 67.13, 112.54, 118.28, 122.79, 123.26, 123.62, 124.01, 129.15, 130.48, 131.35, 137.11, 
152.07, 152.55, 157.00, 170.22. 
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b) Synthesis of peptides containing Cys(Me) 
Boc-Cys(Me)-OH. H-Cys(Me)-OH (5 g, 36.7 mmol) was dissolved in 80 mL of solvent 
mixture of CH3CN/H2O (1:1 v/v) with TEA (6 mL, 43 mmol). Boc2O (8.4 g, 38.4 mmol) was 
dissolved in 25 mL of CH3CN and added to the solution of amino acid. The mixture was 
stirred at r.t. for 18 h. The organic solvent was removed under reduced pressure and the 
aqueous residue was acidified with HCl 1M. The precipitate was extracted with EtOAc (3v), 
then the organic phase was washed with water (2v) and brine. The organic layer was dried 
over Na2SO4, filtered and evaporated to dryness under reduced pressure. The product was 
recovered as an oil (8.2 g, 94% yield). 
HRMS (ESI+): m/z calcd. for C9H17NO4S 235.0878, found 236.1029 [M+H]
+
. FT-IR 
absorption: ῡ 3318, 3103, 2979, 2924, 1716, 1510, 1394, 1368, 1249, 1164, 1056 cm-1. 
1
H NMR (200 MHz, CDCl3) δ 7.60 (s br, 1H, COOH), 5.42 (d, J = 6.9 Hz, 1H, NH), 4.54 (d, 
J = 5.5 Hz, 1H, αCH), 2.97 (d, J = 4.6 Hz, 2H, βCH2), 2.14 (s, 3H, SMe), 1.44 (s, 9H, 3CH3 
Boc). 
13
C NMR (50 MHz, CDCl3) δ 175.52, 155.70, 80.74, 53.02, 36.46, 28.42, 16.39. 
Boc-Cys(Me)-Leu-OMe (4). Boc-Cys(Me)-OH (6.76 g, 28.6 mmol) was dissolved in CH2Cl2 
and activated with HOAt (3.9 g, 28.6 mmol) and EDC∙HCl (5.48 g, 28.6 mmol). Separately 
H-Leu-OMe∙HCl (10.4 g, 38.8 mmol) was dissolved in CH2Cl2 with addition of TEA (10 mL, 
71.8 mmol) and the obtained solution was added to the active ester. The mixture was stirred at 
r.t. for 18 h. The solvent was removed under reduced pressure and the residue dissolved in 
EtOAc. The organic phase was washed with 5% KHSO4(aq) (4v), 5% NaHCO3(aq) (3v) and 
brine. The organic layer was dried over Na2SO4, filtered and evaporated under reduced 
pressure. The residue was dissolved in EtOAc and precipitated by addition of petroleum ether. 
After filtration and drying, the product was obtained as a white solid (8.35 g, 84% yield). 
HRMS (ESI+): m/z calcd. for C16H30N2O5S 362.1875, found 363.1966 [M+H]
+
. FT-IR 
absorption: ῡ 3342, 3281, 3085, 2973, 2920, 1756, 1682, 1656, 1557, 1522, 1315, 1274, 1251, 
1225, 1197, 1158, 1020 cm
-1
. 
1
H NMR (200 MHz, CDCl3) δ 6.84 (d, J = 8.1 Hz, 1H, NH 
amide), 5.37 (d, J = 6.0 Hz, 1H, NH urethane), 4.66-4.55 (m, 1H, αCH), 4.30-4.20 (m, 1H, 
αCH), 3.73 (s, 3H, OMe), 2.98-2.67 (m, 2H, βCH2 Cys), 2.17 (s, 3H, SMe), 1.68-1.60 (m, 3H, 
βCH2 and CH Leu), 1.46 (s, 9H, 3CH3 Boc), 0.93 (d, 6H, δCH3 Leu). 
13
C NMR (50 MHz, 
CDCl3) δ 173.08, 170.68, 155.53, 80.65, 53.59, 52.46, 51.09, 41.63, 36.41, 28.40, 24.93, 
22.92, 22.02, 16.04. 
H-Cys(Me)-OMe∙HCl. H-Cys(Me)-OH (5 g, 37 mmol) was suspended in 120 mL of dry 
MeOH and cooled in a MeOH/ice bath. Then SOCl2 (10 mL) was added dropwise to the 
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mixture. After removal of the bath, the mixture was refluxed for 2 days. The residual solid 
was removed by filtration and the filtrate was evaporated under reduced pressure. The residue 
was dissolved in the minimal amount of MeOH and precipitated by addition of Et2O. The 
product was recovered by filtration obtaining a white solid (4.8 g, 70% yield). 
HRMS (ESI+): m/z calcd. for C5H11NO2S 149.0510, found 150.3091 [M+H]
+
. FT-IR 
absorption: ῡ 3003, 2864, 2633, 2500, 1743, 1594, 1571, 1507, 1434, 1316, 1235, 1206, 1064 
cm
-1
. 
1
H NMR (200 MHz, DMSO-d6) δ 8.91 (s, 3H, NH2∙HCl), 4.23 (t, J = 5.8 Hz, 1H, αCH), 
3.74 (s, 3H, OMe), 3.04 (d, J = 5.8 Hz, 2H, βCH2), 2.11 (s, 3H, SMe). 
13
C NMR (50 MHz, 
DMSO) δ 168.73, 52.82, 51.63, 33.37, 15.38. 
Boc-Leu-Cys(Me)-OMe (5). Boc-Leu-OH (2 g, 8.65 mmol) was dissolved in 40 mL of 
CH2Cl2 and activated with HOAt (1.18 g, 8.67 mmol) and EDC∙HCl (1.65 g, 8.64 mmol). 
Separately H-Cys(Me)-OMe∙HCl (1.6 g, 8.62 mmol) was dissolved in CH2Cl2 with addition 
of TEA (2.4 mL, 10.7 mmol) and the solution was added to the active ester. TEA was added 
to the resulting mixture until basic pH. The mixture was stirred at r.t. for 48 h. The solvent 
was removed under reduced pressure and the residue dissolved in EtOAc. The organic phase 
was washed with 5% KHSO4(aq) (4v), 5% NaHCO3(aq) (3v) and brine. The organic layer was 
dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was dissolved 
in EtOAc and precipitated by addition of petroleum ether. After filtration and drying, the 
product was obtained as a white solid (2 g, 64 % yield). 
HRMS (ESI+): m/z calcd. for C16H30N2O5S 362.1865, found 363.3309 [M+H]
+
. FT-IR 
absorption: ῡ 3325, 2955, 2921, 1747, 1740, 1689, 1649, 1525, 1443, 1276, 1208, 1169 cm-1. 
1
H NMR (200 MHz, CDCl3) δ 6.88 (d, J = 7.1 Hz, 1H, NH amide), 4.87 (d, 1H, NH 
urethane), 4.84 - 4.66 (m, 1H, αCH), 4.14 (d, J = 5.8 Hz, 1H, αCH), 3.76 (s, 3H, OMe), 2.95 
(dd, 2H, βCH2 Cys), 2.10 (s, 3H, SMe), 1.77-1.56 (m, 3H, βCH2 and CH Leu), 1.44 (s, 9H, 3 
CH3 Boc), 0.94 (dd, J = 6.1, 2.4 Hz, 6H, δCH3 Leu). 
13
C NMR (50 MHz, CDCl3) δ 172.60, 
171.23, 155.70, 80.33, 53.21, 52.74, 51.78, 41.25, 36.45, 28.42, 24.84, 23.05, 22.06, 16.32. 
Boc-Cys(Me)-Leu-NH-CH2-C≡CH (6). A mixture of Boc-Cys(Me)-Leu-OMe (500 mg, 1.38 
mmol), propargylamine (1 mL, 15.6 mmol) and DBU (40 μL, 0.27 mmol) was stirred at r.t. 
for 48 h. The mixture was diluted with EtOAc and the organic phase was washed with 5% 
KHSO4(aq) (3v) and brine. The solution was dried over Na2SO4, filtered and the solvent was 
evaporated under reduced pressure. The product was obtained as a white solid (490 mg, 92 % 
yield). 
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HRMS (ESI+): m/z calcd. for C18H31N3O4S 385.2035, found 386.2110 [M+H]
+
. FT-IR 
absorption: ῡ 3283, 3079,2959, 2929, 2871, 1693, 1646, 1548, 1525, 1391, 1367, 1278, 1250, 
1170 cm
-1
. 
1
H NMR (200 MHz, CDCl3) δ 7.00 (s, 1H, NH amide), 6.70 (d, J = 8.2 Hz, 1H, 
NH amide), 5.41 (d, J = 6.2 Hz, 1H, NH urethane), 4.50 (m, 1H, αCH), 4.24 (m, 1H, αCH), 
4.01 (m, 2H, CH2 propargyl), 2.87 (d, J = 5.2 Hz, 2H, βCH2 Cys), 2.19 (t, J = 2.5 Hz, 1H, -
C≡CH), 2.14 (s, 3H, SMe), 1.91–1.52 (m, 3H, βCH2 and CH Leu), 1.45 (s, 9H, Boc), 0.92 (t, 
J = 6.2 Hz, 6H, δCH3 Leu). 
13
C NMR (50 MHz, CDCl3) δ 171.42, 171.10, 155.92, 81.14, 
79.46, 71.67, 54.07, 51.91, 40.61, 36.17, 29.34, 28.41, 24.92, 23.17, 21.81, 15.92. 
[Boc-Cys(Me)-Leu-NH-CH2-C≡C-]2 (7). CuI (5 mol%) and NiCl2∙H2O (5 mol%) were 
dissolved in 500 μL of THF, then TMEDA (20 mol%) was added. The solution was stirred at 
r.t. under air for 2 min. Boc-Cys(Me)-Leu-NH-CH2-C≡CH (500 mg, 1.30 mmol) was 
dissolved in 3 mL of THF. The mixture was stirred at r.t. under air for 48 h. The solvent was 
removed under reduced pressure and the residue was purified by flash chromatography 
(eluant: CH2Cl2/MeOH 97:3). The product was recovered as a white solid (260 mg, 50 % 
yield). 
HRMS (ESI+): m/z calcd. for C36H60N6O8S2 768.3914, found 769.3878 [M+H]
+
. FT-IR 
absorption: ῡ 3287, 2959, 2930, 2871, 1693, 1647, 1521, 1391, 1367, 1280, 1248, 1169 cm-1. 
1
H NMR (200 MHz, CDCl3) δ 7.57 (t, 2H, NH amide), 7.07 (d, J = 8.2 Hz, 2H, NH amide), 
5.51 (d, J = 6.9 Hz, 2H, NH urethane), 4.58 (m, 2H, αCH), 4.46–4.10 (m, 4H, αCH and CH2 
propargyl), 3.90 (m, 2H, CH2 propargyl), 2.88 (d, J = 4.8 Hz, 4H, βCH2 Cys), 2.14 (s, 6H, 
SMe), 1.87–1.52 (m, 6H, βCH2 and CH Leu), 1.46 (s, 18H, Boc), 0.92 (dd, J = 8.1, 6.0 Hz, 
12H, δCH3 Leu). 
13
C NMR (50 MHz, CDCl3) δ 171.65, 171.35, 155.88, 80.91, 74.39, 68.01, 
54.03, 51.91, 40.71, 36.49, 30.08, 28.43, 24.93, 23.07, 21.94, 16.01. 
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Table S1. Crystal data and structure refinement for Boc-L-Cys(Me)-L-Leu-OMe (4). 
 
 
Identification code  mc237f 
Empirical formula  C16H30N2O5S 
Formula weight  362.48 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  Hexagonal 
Space group  P 65 
Unit cell dimensions a = 11.4458(2) Å = 90°. 
 b = 11.4458(2) Å = 90°. 
 c = 27.7551(5) Å  = 120°. 
Volume 3148.95(10) Å3 
Z 6 
Density (calculated) 1.147 Mg/m3 
Absorption coefficient 1.580 mm-1 
F(000) 1176 
Crystal size 0.20  0.05  0.01 mm3 
Theta range for data collection 4.46 to 51.25°. 
Index ranges -11  h  11, -11  k  11, -27  l  27 
Reflections collected 18290 
Independent reflections 2281 [R(int) = 0.0441] 
Completeness to theta = 51.25° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.81551 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2281 / 31 / 217 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma(I)] R1 = 0.0403, wR2 = 0.1040 
R indices (all data) R1 = 0.0468, wR2 = 0.1083 
Absolute structure parameter -0.01(3) 
Largest diff. peak and hole 0.307 and -0.145 e.Å-3 
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Table S2. Crystal data and structure refinement for Boc-L-Leu-L-Cys(Me)-OMe (5). 
 
 
Identification code  mc238f 
Empirical formula  C16H30N2O5S 
Formula weight  362.48 
Temperature  293(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 5.08911(7) Å = 90°. 
 b = 12.09583(13) Å = 90°. 
 c = 32.4406(4) Å  = 90°. 
Volume 1996.95(4) Å3 
Z 4 
Density (calculated) 1.206 Mg/m3 
Absorption coefficient 1.661 mm-1 
F(000) 784 
Crystal size 0.80  0.06  0.02 mm3 
Theta range for data collection 2.72 to 69.34°. 
Index ranges -5  h  4, -14  k  14, -39  l  38 
Reflections collected 14108 
Independent reflections 3652 [R(int) = 0.0220] 
Completeness to theta = 69.34° 98.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.63618 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3652 / 50 / 245 
Goodness-of-fit on F2 1.035 
Final R indices [I>2sigma(I)] R1 = 0.0391, wR2 = 0.1077 
R indices (all data) R1 = 0.0406, wR2 = 0.1091 
Absolute structure parameter 0.00(2) 
Largest diff. peak and hole 0.280 and -0.173 e.Å-3 
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Table S3. Selected backbone and side-chain torsion angles [°] for Boc-L-Cys(Me)-L-Leu-
OMe (4) and Boc-L-Leu-L-Cys(Me)-OMe (5). 
 
 
Boc-L-Cys(Me)-L-Leu-OMe Boc-L-Leu-L-Cys(Me)-OMe 
Torsion angle   Torsion angle   
C01-OU-C0-N1 1 179.0(3) C01-OU-C0-N1 1 -179.00(18) 
OU-C0-N1-C1A 0 -175.2(3) OU-C0-N1-C1A 0 -179.10(15) 
C0-N1-C1A-C1 1 -95.2(4) C0-N1-C1A-C1 1 -116.68(18) 
N1-C1A-C1-N2 1 132.9(3) N1-C1A-C1-N2 1 108.45(17) 
C1A-C1-N2-C2A 1 171.1(3) C1A-C1-N2-C2A 1 -173.14(15) 
C1-N2-C2A-C2 2 -66.3(4) C1-N2-C2A-C2 2 -159.11(15) 
N2-C2A-C2-OT 2 158.5(3) N2-C2A-C2-OT 2 -172.42(16) 
C2A-C2-OT-CT T 176.6(5) C2A-C2-OT-CT T 176.39(19 
N1-C1A-C1B-S1 1
1
 -73.8(4) N1-C1A-C1B-C1G 1
1
 -82.1(3) / -51.0(4)
a
 
C1A-C1B-S1-C1D 1
2
 -74.4(4) C1A-C1B-C1G-C1D1 1
2,1
 65.9(5) / -58.7(9)
b
 
N2-C2A-C2B-C2G 2
1
 -72.8(4) C1A-C1B-C1G-C1D2 1
2,2
 
-171.3(3) / 
178.5(6)
c
 
C2A-C2B-C2G-C2D1 2
2,1
 163.0(3) N2-C2A-C2B-S2 2
1
 71.18(19) 
C2A-C2B-C2G-C2D2 2
2,2
 -74.7(4) C2A-C2B-S2-C2D 2
2
 -80.84(18) 
 
a 
Minor occupancy conformer N1-C1A-C1B-C1G'. 
b
 Minor occupancy conformer C1A-C1B-C1G'-C1D3. 
c
 Minor occupancy conformer C1A-C1B-C1G'-C1D4. 
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Table S4. Hydrogen bond parameters [Å and °] for Boc-L-Cys(Me)-L-Leu-OMe (4). 
____________________________________________________________________________ 
  D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
N1-H1...O0#1 0.86 2.09 2.929(4) 164 
N2-H2...O1#2 0.86 2.01 2.868(4) 179 
C02-H02B…OT#3 0.96 2.54 3.485(5) 168 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1:  y,-x+y,z+1/6;   #2:  x-y,x,z-1/6;   #3:  x-1, y-1, z 
 
 
 
Table S5. Hydrogen bond parameters [Å and °] for Boc-L-Leu-L-Cys(Me)-OMe (5). 
____________________________________________________________________________ 
 D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
N1-H1...O0#1 0.86 2.12 2.965(2) 166.7 
N2-H2...O1#2 0.86 2.25 3.093(2) 167.1 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1:  x+1,y,z;    #2:  x-1,y,z  
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